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 scope of the thesis 
 
2General introduction
1 Biomaterials in tissue engineering and 
regenerative medicine
R egenerative medicine is an innovative scientific field in which the problems and problem-solving approaches of clinical medicine are integrated into the natural and engineering sciences. In the 
broadest sense, regenerative medicine is concerned with the restoration 
of function to cells, tissues, and organs either by biological replacement, 
such as with tissues cultured in vitro, or by stimulating the body’s own 
reparative and regenerative mechanisms. The focus of this field extends 
beyond the replacement of organs and tissues (tissue engineering) to 
encompass both innovation and advancement in classical transplantation 
medicine and cell therapy, including stem cell technologies and 
pharmacological approaches to targeted stimulation of tissue regeneration 
in vivo. The goal of regenerative medicine is to translate research findings 
into the development and establishment of therapeutic options in clinical 
medicine. 
Due to the morbidity shift over the past few decades, clinical medicine 
today is increasingly concerned with diseases that bring about a gradual 
decline in the function of vital cell and organ systems. It is expected 
that the solutions offered by regenerative medicine to replace destroyed 
or degenerating tissues with functional substitutes will prove to be the 
curative therapy that could obviate symptomatic treatment. Regenerative 
medicine often makes use of implantable biomaterials. The development 
of successful therapies for regenerative medicine is currently evolving 
towards the paradigm that the opportunities for biomimetic or bioartificial 
materials significantly exceed those of existing prosthetic implants. It was 
a widely held belief that prostheses must be biologically inert, i.e., that 
they must not interact with the surrounding cells and tissues. Recently, 
a more advanced view has emerged that is based on the principle of the 
Introduction and scope of the thesis
3
construction of materials that most closely imitate the tissue in which 
they are implanted and that actively interact with cells. Presumably, the 
materials used in the construction of biomimetic implants must possess 
proper physical (strength, elasticity, texture, etc.) and chemical (non-
inflammatory and non-toxic) characteristics. These materials must 
furnish the cells with a hospitable environment that provides all of the 
major signals to direct cell physiology and metabolism to enhance tissue 
repair. 
The progress of biomaterials during the past 50 years can be 
understood in terms of three different generations: a first generation 
(bioinert materials), a second generation (bioactive and biodegradable 
materials), and a third generation (biomaterials designed to stimulate 
specific cellular responses at the molecular level). It is worth noting that 
this classification of the materials used for biomedical purposes does not 
imply that a new generation of materials excludes the use of preceding 
ones. Indeed, first-generation biomaterials are still successfully used for a 
wide range of applications. 
The progress in biomaterials has resulted from the continuous addition 
of new demands to the list of required properties. New biomaterials have 
been developed in response to these demands to address new needs in the 
field. Concepts such as the foreign body reaction (FBR), stress shielding, 
biocompatibility, biodegradability, bioactivity and osteoinduction are 
some of the demands that have guided the search for new biomaterials. 
In the beginning, the main concern was to develop or select materials 
that combined the necessary physical properties for the devices in which 
they were used to match the functionality of the substituted tissue, 
with minimal toxicity to the host. Consequently, the first generation of 
biomaterials mainly comprised inert materials. 
Inertness reduces the toxicity to the host; however, it does not 
eliminate the FBR and the formation of a fibrous layer that envelopes 
the implant or device, thereby preventing direct contact between the 
surface of the material and the surrounding tissue. Second-generation 
biomaterials are characterised by the development of materials that 
overcome the formation of the fibrous layer that hinders the surface/
tissue interaction. This goal was achieved by two different means: (a) by 
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promoting a specific biological response and (b) by using biodegradable 
materials that progressively degrade as the new tissue is regenerated. 
This was the generation of “bioactive materials” and “biodegradable 
materials”. Biomaterials developed during the third generation were 
designed to trigger specific cellular responses at the molecular level. 
During this generation, the biodegradability and bioactivity concepts 
were combined to generate biomaterials that were both degradable and 
bioactive. In addition to these two properties, materials that had the 
ability to stimulate specific cellular events and behaviours, depending on 
their final application, were also sought. 
Without discounting the advances in the field, the utility and potential 
application of a biomaterial can be determined only after an assessment 
of its biocompatibility. The first step in this usually long-term process is 
the in vitro culturing of the appropriate cells on the surface of the material 
followed by the assessment of the behaviour of the cells. The capacity of 
a biomaterial to provide cells with the correct adhesivity and to ensure 
proliferation and formation of an extracellular matrix (features that are 
essential for successful implantation in a living organism) is evaluated 
through diverse cell and molecular biology methods. After a series of 
in vitro assays, a material must also be implanted in vivo to study the 
performance of the material in the context of the host.
Once a biomaterial is implanted in vivo, it directly contacts the 
physiological environment, which consists of a highly corrosive 
aqueous medium containing various ions, molecules such as proteins, 
polysaccharides and enzymes, and different types of cells (non-adherent 
as well as adherent). The initial events that occur on the surface of 
biomaterial after implantation will strongly influence the lifespan of the 
implant. 
The cascade of reactions by the host to the implanted material is 
called the tissue response or FBR. The FBR is essentially an inflammatory 
response that persists as long as there is a foreign body (implanted 
material) present. The reaction is characterised by the presence of 
inflammatory cells, especially macrophages, at the implant surface and 
a walling-off by a capsule that is arranged parallel to the implant surface. 
Interactions between implanted materials and the host tissue are of 
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great importance for the fate of the implanted scaffold. The interactions 
affect both the healing response and the long-term organisation of the 
surrounding tissues. 
Although a wide variety of biomaterials has been developed for 
regenerative medicine, few have been systematically investigated with 
respect to their effect on the FBR. Consequently, we can make few 
predictions about the fate of a biomaterial once it is implanted into the 
body. Collagen, a natural polymer, is one biomaterial that is widely used 
for a variety of applications. Part of our research has focused on the FBR 
that is elicited by collagen and by gelatin, a collagen derivative.
Collagen is a major component of mammalian connective tissues. 
Currently, over 20 different types of collagen have been described, among 
which type-I collagen is the most abundant. Collagen is composed 
of three polypeptide chains that intertwine to form a triple helix. The 
polypeptide chains consist of repeated sequences of Gly-X-Y, in which 
X and Y are most frequently proline and hydroxyproline. The presence 
of adhesion domains allows collagen to present an attractive surface 
for cell attachment. Collagen is enzymatically biodegradable and has a 
tendency to degrade quickly, limiting its mechanical properties. Cross-
linking collagen with chemical compounds such as glutaraldehyde or 
hexamethylenediisocyanate decreases its degradation rate. Gelatin is a 
collagen derivative acquired by denaturing (via heating) the triple helix 
structure of collagen into single-stranded molecules. It is water-soluble and 
entangles easily to form a gel by lowering the denaturation temperature. 
Gelatin is broken down enzymatically by numerous enzymes (e.g., the 
gelatinases MMP-2 and MMP-9), whereas native (triple helical) collagen 
can be degraded by only a few enzymes (e.g., the collagenases MMP-1, 
MMP-8, MMP-13 and MMP-14, and cathepsin K). 
Collagen products are supplied in various physical forms, including 
powders, solutions, gels, sponges, fibres and membranes. Furthermore, 
the biodegradability of collagen allows for its replacement by newly 
synthesised tissue. As a naturally derived scaffolding biomaterial for 
tissue engineering and regenerative medicine, extensive studies have been 
conducted on the architecture, surface characteristics and biomechanical 
properties of collagen scaffolds. However, few studies have been published 
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on the biodegradability of collagen scaffolds. Therefore, the precise in 
vivo molecular and cellular mechanisms involved in the degradation of 
implanted collagen scaffolds remain largely unknown.
2 The foreign body reaction to collagen 
scaffolds
Implantation of any type of medical device or tissue-engineered 
construct, including collagen scaffolds, will provoke an inflammatory 
reaction known as the FBR. The FBR is a complex interaction between 
the host and the implanted biomaterial. Our previous studies have 
shown that, with respect to collagen scaffolds, the FBR depends on the 
physicochemical state of the scaffold, the animal species, and the location 
where the collagen scaffold is implanted, among other factors. A short 
overview of our previous findings follows.
• The FBR is biomaterial-dependent  
The FBR to different types of biomaterials, including the non-
degradable biomaterial Dacron, the synthetic biomaterial 
PCLdiUPy and hexamethylenediisocyanate cross-linked dermal 
sheep collagen (HDSC), has been previously investigated in rats. 
These three biomaterials exhibited completely different types of 
tissue responses with respect to the morphology and biological 
behaviours of foreign body giant cells (fused macrophages), 
which play a crucial role in the FBR. For Dacron, small giant 
cells (with 3-7 nuclei) formed and surrounded the Dacron fibres. 
For PCLdiUPy, the biomaterial was degraded by phagocytosis by 
giant cells, which were large with a regular shape (with greater 
than 10 nuclei). In HDSC, degradation occurred in association 
with the formation of large and irregular giant cells (with greater 
than 10 nuclei), which engulfed and phagocytosed the HDSC 
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bundles. These observations indicate that the giant cells in 
the FBR may differ depending on the implanted biomaterial. 
• The FBR is species-dependent 
Previous studies have shown that the FBR differs between 
species. HDSC disks were implanted subcutaneously in fiverat 
strains (AO, BN, F344, LEW and PVG) and three mouse strains 
(129 SVEV, BALB/c and C57BL/6), which resulted in distinct 
tissue responses towards the implanted biomaterial between 
mice and rats, but only negligible differences were observed 
among strains within the same species. Mice showed a less 
pronounced inflammatory response than rats towards the implant. 
• The FBR is implantation site-dependent 
Although no significant differences exist in the FBR to 
subcutaneously implanted collagen among mouse strains, it has been 
noted that the FBR does differ markedly between subcutaneous and 
epicardial implantation of collagen scaffolds in mice. The activity 
of matrix metalloproteinases, a family of enzymes that is strongly 
correlated with collagen degradation, was high in epicardial 
implants and low or nearly absent in subcutaneous implants. As 
a result, the collagen disks were degraded epicardially within 4 
weeks, whereas subcutaneous implants remained largely intact. 
• Intracellular and/or extracellular degradation of collagen
There are two major pathways for collagen degradation: (a) 
phagocytosis of collagen bundles by surrounding inflammatory 
cells, i.e., macrophages and giant cells (fused macrophages), and 
(b) enzymatic degradation by secreted enzymes such as matrix 
metalloproteinases (MMPs). We previously showed that in rats, 
subcutaneously implanted collagen disks were degraded via 
phagocytosis by giant cells. Despite the presence of giant cells 
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in subcutaneous collagen implants in mice, phagocytosis was 
not observed. In contrast, when the same collagen disks were 
epicardially implanted in mice, they were degraded rapidly through 
the enzymatic degradation pathway (MMP activity). The exact 
cellular and molecular mechanisms underlying this phenomenon 
are not fully understood.
3 The fBR MICRO-ENVIRONMENT
The FBR involves a complex cascade of spatiotemporally regulated 
and interconnected processes, including infiltration and activation of 
inflammatory cells, angiogenesis, enzymatic activity and phagocytosis, 
which ultimately resolves after the degradation of scaffolds.   
During the FBR, neutrophils are the first cells that arrive at the 
implant site and produce chemokines, including CCL2/MCP-1 and 
CCL3/MIP-1α, which are macrophage chemoattractants. Normally, 
neutrophils disappear quickly after the recruitment of macrophages. 
However, we have previously shown that the degradation of collagen 
disks implanted epicardially correlates with the presence of a second 
wave of neutrophils, which suggests that neutrophils may play an 
important role in the degradation of collagen scaffolds. Generally, there 
are two ways to activate the recruited macrophages depending on the 
different mediators present in the micro-environment. In the presence 
of pro-inflammatory IFN-γ, macrophages are activated in a classical way. 
The classically activated macrophages (M1 macrophages) promote the 
expression of MMPs and pro-inflammatory cytokines such as IL-1 and 
IL-6 but reduce the expression of TIMPs and anti-inflammatory factors 
such as IL-10 and TGF-β. In contrast, in the presence of IL-4 and/or IL-
13, alternatively activated macrophages (M2 macrophages) are generated. 
M2 macrophages can upregulate TIMPs and anti-inflammatory cytokines 
and downregulate MMPs and pro-inflammatory factors (Lacraz et 
al. 1995). In addition, IL-4 and IL-13 are also involved in the fusion 
of macrophages into giant cells in vitro. The roles of lymphocytes and 
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fibroblasts (primarily located in the capsules of implants) in the FBR are 
unclear.
In general, chemokines (e.g., MIP-1α and MCP-1) are involved in the 
recruitment of inflammatory macrophages, and cytokines (e.g., IL-1, 
IL-4, IL-6, IL-10, IL-13, IFN-γ and TGF-β) determine the behaviours of 
macrophages through different pathways of activation. The cytokines IL-4 
and IL-13 can induce multiple fusogenic effects and result in membrane 
fusion and giant cell formation. However, it is unknown whether these 
general principles regarding the roles of these inflammatory mediators, 
which are mostly derived from wound-healing studies, are also applicable 
to the particular situation described in this thesis, i.e., the FBR to a 
collagen scaffold.
Cell-matrix interactions rely on cell surface receptors that bridge the 
signal exchange between the intercellular and extracellular environment. 
In the context of collagen scaffolds, in addition to the well-known 
integrins that act with collagen (α1β1, α2β1, α10β1 and α11β1), several 
other types of collagen receptors may play an important role in the cell-
matrix interaction in the tissue response towards collagen scaffolds. 
These collagen receptors include mannose receptors (Endo180, PLA2R 
and MR), discoidin domain receptors (DDR-1 and DDR-2) and the 
leukocyte-associated IG-like receptor (LAIR-1). The collagen receptor 
Endo180 binds a range of collagens and gelatin via its fibronectin type-II-
like domain. After it binds to Endo180, collagen is efficiently internalised 
and transported to lysosomal compartments for degradation (Rivera-
Calzada et al., 2003). Discoidin domain receptor 2 (DDR-2) is expressed 
on a wide range of adult cells, including fibroblasts and smooth muscle 
cells, and is involved in activating many biological processes, such as the 
expression of MMP-13. Thus far, nothing is known about the role of the 
collagen receptors Endo180 and DDR-2 in the FBR to collagen implants. 
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Scope of this thesis
T he mechanisms involved in the degradation of collagen scaffolds during the FBR are not well characterised. A better understanding of these mechanisms is a prerequisite for modulating the rate of 
collagen scaffold degradation (to match the degradation rate to tissue 
regeneration). The overall objective of this thesis is to gain further insight 
into the molecular and cellular mechanisms of the degradation of collagen 
scaffolds and to provide indications and clues to improve future therapies 
in regenerative medicine in which the regulated degradation of collagen 
scaffolds is required. In pursuit of this overall objective, this thesis will 
focus on the following four sub-objectives:
Sub-objective 1: To gain further insight into the roles of 
proteinases in the degradation of collagen scaffolds.
a) To reveal the roles of the MMP/TIMP proteolytic network 
in the degradation of the collagen scaffold and its regulatory 
mechanisms; 
b) To investigate the involvement of cathepsin K in collagen 
degradation.
Sub-objective 2: To gain further insight into the roles of 
infiltrating inflammatory cells during the degradation of 
collagen scaffolds.
a) To study the roles of neutrophils, macrophages and giant cells 
in the FBR to the collagen scaffold;
b) To characterise the mechanisms of phagocytosis and the 
different sub-types of macrophages/giant cells in the FBR.
Sub-objective 3: To gain further insight into the correlation 
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between the micro-environment and the degradation of 
collagen scaffolds.
a) To study the involvement of cytokines (IL-4, IL-10, IL-13, 
TNF-α and IFN-β) and chemokines (CCL-2 and CCL-3) in the 
regulation of proteolytic activities and cellular phagocytosis;
b) To study the involvement of collagen receptors (Endo180 and 
DDR-2) in the degradation of collagen scaffolds.
Sub-objective 4: To gain further insight into the correlation 
of the physical status or chemical cross-linking of collagen 
scaffolds and their degradation.
a) To study the differences in the FBR to different chemically 
cross-linked collagen scaffolds;
b) To study the differences in the FBR to different physical forms 
of collagen scaffolds (native or gelatin).
The following experimental models have been established to 
facilitate the aforementioned investigation of the molecular and cellular 
mechanisms of degradation of the collagen scaffold in the FBR:
1) The following collagen disks with different chemical and 












2) The following experimental models were used (Figure 1.1.):




In vitro experiments: culture of the murine monocyte/macrophage 
cell line RAW 264.7 on plates or wells with or without a collagen 
coating in the presence of different cytokines (IFN-γ, IFN-γ + IL-
10, IL-1β or TNF-α) (Figure 1.2).
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Figure 1.1: Schematic illustration of the design of animal experiments (ECM: extracellular matrix; MMP: 
matrix  mattelloproteinase; TIMP: tissue inhibitor of mattelloproteinase; TRAP: tartrate-resistant acid 
phosphate)
Figure 1.2: Schematic illustration of the design of in vitro experiments (culture on plates)
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Abstract
We have previously shown that the foreign body reaction (FBR) against crosslinked collagen type I (Col-I) differs between subcutaneous and epicardial implantation sites; Col-I was 
quickly degraded epicardially, whereas degradation was attenuated 
subcutaneously. The current study set out to dissect the nature and 
regulation of the MMP-based degradation of implanted Col-I in mice 
during the FBR. Immunohistochemistry showed that MMP-2, MMP-
8 and MMP-13 were present in subcutaneous and epicardial implants, 
whereas only MMP-9 was also present epicardially. Western blotting 
showed that MMP-8 and MMP-9 were mainly present in their inactive 
proform. In contrast, collagenase MMP-13 and gelatinase MMP-2 were 
the predominant active MMPs at both sites. Interestingly, the major 
MMP inhibitor TIMP-1 was solely observed in subcutaneous implants, 
which is why MMP-13 and MMP-2 are not able to degrade the collagen 
scaffold at the subcutaneous implantation site. Interleukin 10 (IL-
10), a potent inducer of TIMP-1 expression, was also mainly detected 
subcutaneously; giant cells were the main source. Therefore, we surmise 
that IL-10, through regulation of the balance between MMPs and 
TIMP-1, suppresses the FBR against implanted biomaterials. Together, 
our findings would provide cues and clues to improve future therapies 
in regenerative medicine that are based on the tuned regulation of the 
degradation of biomaterial scaffolds.
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17
1. Introduction
Tissue engineering is a promising discipline that aims at the functional regeneration of damaged or otherwise impaired tissues and organs (Paquette et al., 2004; Rivron et al., 2008). In this 
approach, biomaterial scaffolds are often applied to provide transient 
support and instruction to achieve functional regeneration (Hedrick and 
Daniels, 2003; Mather et al., 2007; Mason, 2007; Petersen and Niklason, 
2007; Munirah et al., 2008). An ideal scaffold should feature the right 
porosity, appropriate surface chemistry, suitable mechanical properties 
and, above all, proper biocompatibility and controllable biodegradability 
(Hutmacher et al., 2001; Tai et al., 2007). As a naturally derived scaffold 
in tissue engineering, collagen has been frequently studied (Cummings 
et al., 2004; Daamen et al., 2005; Sachlos et al., 2006; Wahl et al., 2007). 
The majority of studies focus on the threedimensional (3D) architecture, 
surface characteristics and biomechanical properties of collagen scaffolds 
(Sachlos and Czernuszka, 2003; Sachlos et al., 2006), while few studies 
engage in the in vivo molecular and cellular mechanism of collagen 
scaffold degradation (Khouw et al., 1998, 2000; Luttikhuizen et al., 2007). 
In general, the degradation of collagen is influenced by a number of 
related proteolytic pathways, such as MMPs, ADAMs, serine proteinases 
and cysteine proteinases (Brinckerhoff and Matrisian, 2002; Jones and 
Riley, 2005; Mohamed and Sloane, 2006). Our previous studies showed 
that the degradation of crosslinked collagen type I (Col-I) in mice relies 
on the activity of matrix metalloproteinases (MMPs) (van Amerongen 
et al., 2006; Luttikhuizen et al., 2006b), yet the precise molecular nature 
and regulation of the MMP-based proteolytic network in the degradation 
process remains largely unknown.
MMPs participate in the physiological turnover of the extracellular 
matrix (ECM) through degradation of its major components, including 
collagens. Thus, MMPs are also actively involved in the regulation of 
many general (patho)physiological processes, such as wound healing, 
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immunity, cancer and inflammation (Nagase and Woessner, 1999; 
Kyriakides and Bornstein, 2003). In tissue-engineered biomaterial 
implants, such as collagen type I, inflammation and scaffold degradation 
are orchestrated by the foreign body reaction (FBR) (Kyriakides et al., 
2004; Luttikhuizen et al., 2006a). Collagen type I is also one of the major 
constituents of ECM. In general, degradation of collagen is achieved by 
the interplay between active collagenases and active gelatinases (Nagase 
and Woessner, 1999; Brinckerhoff and Matrisian, 2002). The first step of 
the degradation of collagen is cleavage of its triple helix by collagenases 
(MMP-8 and -13 in mice). Next, the cleaved collagen spontaneously 
denatures into gelatin at body temperature. Gelatinases (MMP-2 and 
-9) further degrade the gelatin into breakdown products that are easily 
disposed of by the lymphatic system (Brinckerhoff and Matrisian, 2002).
Cardiac tissue engineering requires the application of biomaterials on 
or in themyocardium. By themselves, biomaterials affect wound-healing 
processes, as they induce a FBR (van Amerongen et al., 2006). Generally, 
the FBR is assessed through subcutaneous implantation in rodents, 
but we noted that the FBR differs markedly between subcutaneous 
and epicardial implantation (Luttikhuizen et al., 2006b). We observed 
that the subcutaneously implanted scaffolds remained largely intact 
after 4 weeks, and that the MMP activity was low or nearly absent. In 
contrast, epicardially implanted Col-I scaffolds were degraded within 
4 weeks, associated with high MMP activity that co-localized with 
the presence of collagenase MMP-8. Furthermore, gene expression 
of gelatinase MMP-9 was upregulated in epicardial Col-I implants but 
absent in subcutaneous Col-I implants (van Amerongen et al., 2006; 
Luttikhuizen et al., 2006b). This observation led us to reason that MMP-
8 and MMP-9 were responsible for the degradation of Col-I during the 
FBR in mice. However, in our previous studies we did not measure the 
molecular variants of MMP-8 and MMP-9 (latent or activated) or the 
other MMPs, neither were the tissue inhibitors of MMP (TIMP) protein 
expression dynamics determined. We postulate that the difference in the 
degradation in subcutaneous and epicardial Col-I implants is due to the 
tissue-specific MMP-based proteolytic microenvironment. Additionally, 
it has been shown that the expression of MMPs and their inhibitors 
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TIMPs is strongly regulated by inflammatory mediators, of which the 
immunosuppressive cytokine IL-10 is a key player (Lacraz et al., 1995; 
Sternlicht and Werb, 2001). Thus, we also investigated the correlation 
between MMP proteolytic activity and IL-10.
The above findings have consequences for the development of cardiac 
tissue-engineering constructs. Our study set out to perform a fundamental 
investigation on the MMP-based proteolytic degradation of a model 
scaffold, i.e. crosslinked collagen, epicardially and subcutaneously.
Chapter 2
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2. Materials and methods
2.1 Animals and scaffolds
Male C57BL/6 mice (10 weeks old; Harlan, Horst, the Netherlands) were housed individually under standard conditions with food and water ad libitum. A hexamethylenediisocyanate-
crosslinked, degradable, bovine collagen type I matrix (Biomaterial 
Research, Vaals, The Netherlands) was used in the experiment and is 
referred to as Col-I. The Col-I disks were punched at 6 mm in diameter 
and 0.75 mm in thickness and then sterilized with ethylene oxide (ETO). 
The LAL method (Cambrex, LAL kinetic-QCL) was used to measure 
the endotoxin content of the Col-I disks. Endotoxin levels were <0.25 
EU/ml.
2.2 Surgical procedures
All procedures performed on animals were approved by the local 
committee for care and use of laboratory animals of the University 
of Groningen and were performed according to international and 
governmental guidelines on animal experimentation and also in line 
with the Ethical Principles and Guidelines for Scientific Experiments on 
Animals of the Swiss Academy of Medical Sciences.
2.2.1 Implantation
The Col-I disks were implanted following a standard procedure, as 
described previously (Luttikhuizen et al., 2006b). Briefly, the mice were 
anaesthetized with 4% isoflurane and maintained by 2% isoflurane 
inhalation in combination with a mixture of equal volumes of N2O 
and O2. For the subcutaneous implantations, the back was shaved and 
disinfected. The scaffolds were implanted in subcutaneous pockets 1 
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cm away from the incision site, minimizing the effect of wound healing 
on the inflammatory reaction. For epicardial implantations, the mice 
were intubated and ventilated with anaesthetics in combination with 
subcutaneous injections of the analgesic drug buprenorfine (0.03 mg/
kg). The heart was exposed via a left lateral thoracotomy. A Col-I disk 
was sutured onto the left ventricular epicardium with one suture (6- 0 
non-absorbable Prolene suture) in the middle of the Col-I disk. From 
our previous work (van Amerongen et al., 2006), we noted that the suture 
is immediately encapsulated by a few layers of fibroblasts. As a result, 
the suture does not participate or interfere in the tissue response against 
collagen. The intercostal space and skin were closed with sutures. The 
mice received pure oxygen until they awoke, after which the endotracheal 
tubes were taken out.
2.2.2. Explantation
The Col-I disks were explanted at the following time points after 
implantation that were related to the distinct phases of the FBR in 
mice: two days (day 2, onset), one week (week 1, early progression), two 
weeks (week 2, intermediate progression) and one month (month 1, late 
progression), n = 6/time point. At all time points, we explanted the disks 
together with excess surrounding tissue. Since the epicardially implanted 
disks were largely degraded after 21 days, we first explanted the entire 
heart together with disk and excess surroundings then prepared the 
scaffold from it for analyses. In this case, the encapsulated suture was 
used as a reference to determine the implant site and the remaining 
collagen scaffold. The disks were cut in half after explantation. One half 
was snap-frozen in liquid nitrogen immediately, and the other half was 
immersed in 2% glutaraldehyde (Merck, Darmstadt, Germany) in 10 
mM phosphate buffer, pH 7.4, for plastic embedding.
2.3. Histology
Our previous research showed that the newly deposited collagen bundles 
are in the nanometer size range, while the implanted scaffolds comprise 
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microsize-range bundles. Thus, the new bundles are invisible as distinct 
structures with the light microscope (van Amerongen et al., 2006). 
Implanted and newly formed collagen can be differentiated through a 
histochemical staining procedure. Tissue sections (2 μm) of T 7100 
(Heraeus Kulzer, Wehrheim, Germany) embedded explants were stained 
with toluidine blue (Fluka Chemie, Buchs, Switzerland) and mounted 
in Permount (Fisher, NJ, USA). The sections were analysed by light 
microscopy.
2.4. Immunohistochemical staining
Tissue expression of in situ localization of collagenases (MMP-8, MMP-
13), gelatinases (MMP-2, MMP-9), Membrane-type metalloproteinase 
(MT1-MMP or MMP- 14), TIMPs (TIMP-1, TIMP-2) and cytokine IL-
10 was examined with immunohistochemistry (IHC) on explants of 2 
weeks.
Tissue sections (5 μm) were mounted on silane-coated slides. Cryo-
sections were fixed with 2% paraformaldehyde (PFA) in phosphate-
buffered saline (PBS) at room temperature for 30 min, followed by 
rehydration (1× PBS, 10 min), and subsequent incubation with 0.5% 
Triton X-100 in PBS (10 min). 
The antibodies were purchased from commercial suppliers and their 
specificity was validated before use. Information on the optimization 
of all primary antibodies used is detailed in Table 2.1. For MMP-2, -8, 
-9 and - 14, TIMP-1 and IL-10, the sections were washed in PBS and 
pre-incubated in 2% normal goat or rabbit serum (depending on the 
producer of secondary antibody) for 10 min. The sections were incubated 
with primary antibody in PBS with 2% normal goat or rabbit serum for 
1 h. Thereafter, the sections were washed in 0.05% Tween PBS (three 
times, 5 min) and endogenous peroxidase was blocked with 0.1% H2O2 
in PBS (10min in the dark). Endogenous avidin and biotin were blocked 
with the avidin/biotin kit according to the manufacturer’s instructions 
(Biotin Blocking System, Dako Cytomation, Denmark). The slides were 
incubatedwith goat anti-rabbit (Dako) or rabbit anti-goat (Southern 
Biotech) biotinylated secondary antibody as appropriate (secondary 
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antibody in PBS with 2% normal mouse serum, 30 min). Dilutions that 
were used were 1 : 150 for MMP-9 and 1 : 100 for the rest, followed by 
incubation of streptavidin conjugated to peroxidase (Strep-PO, 1 : 100, 
30 min). For MMP-13, TIMP-2 detection, sections were pre-incubated 
in PBS with 2% donkey serum for 10 min and then incubated in the 
primary antibodies for 1 h. After washing (0.05% Tween PBS, 5 min, 
three times) and blocking of endogenous perioxidase (0.1% H2O2 
in PBS, 10 min in the dark), the primary antibody was detected using 
donkey anti-sheep IgG H&L (HRP, 1 : 100; ab6900, Abcam, Cambridge, 
UK) and streptavidin conjugated to peroxidase (Strep-PO, 1 : 100, 30 
min). The procedures were the same for all negative controls, except that 
the primary antibody was omitted or replaced with the same dilution of 
its host serum (i.e. sheep or rabbit) according to Table 2.1 (to exclude the 
background staining from the host serum).
Colour development was done with 3-amino-9-ethylcarbazole 
(AEC, Sigma, Steinheim, Germany) and finally the sections were 
counterstained with haematoxylin (Fluka Chemie).
2.5. Image analysis
The quantification of MMP/TIMPs expressing cells was performed by 
Table 2.1. Characteristics of the primary antibodies used for immunohistochemical staining (IHC) and 
western blotting (WB) of MMPs, TIMPs and IL-10
Antibodies Host Species IHC WB Sources
MMP-2 Rabbit 1 : 200 1: 500 Ab37150, Abcam, Cambridge, UK
MMP-8 Rabbit 1 : 100 1: 500 SA-370, BIOMOL, USA
MMP-9 Rabbit 1 : 1000 1 : 1000 Ab38898, Abcam, Cambridge, UK
MMP-13 Sheep 1 : 20 1: 500 Ab35320, Abcam, Cambridge, UK
MMP-14 Rabbit 1: 50 1 : 2000 2010-1, Epitomics Inc., CA, USA
TIMP-1 Goat 1: 50 1: 500 AF980, RnDSystems, Minneapolis, MO, USA
TIMP-2 Sheep 1 : 10 1: 500 9013-2609, AbD Seroter, Oxford, UK
IL-10 Rabbit 1 : 125 Not done AAM32, AbD Serotec, Oxford UK
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counting the number of positive cells in micrographs (×400) taken in 
six areas equally distributed in the scaffold of each disk. Disks from four 
different animals (n = 4) of each time point were used to calculate the 
mean values. All analyses and determinations were repeated at least three 
times by two independent investigators on blinded samples. In addition, 
the fraction of cells that adhered to collagen bundles and expressed 
MMPs was quantified by morphometry of the area of positive staining 
(ImageJ 1.38, NIH).
2.6. Western blotting
Proteins were isolated from the frozen explants of the two sites at all 
time points. Sections of explants from four mice (five sections of 10 μm 
fromeach mouse) were pooled to minimize the individual variation. 
Samples (10 μg) of each protein was separated in a 10% sodium dodecyl 
sulphate–polyacrylamide gel. Then the proteins were transferred by 
electro-blotting (1.5 h, 100 V) to a PROTRAN membrane, which was 
blocked with 3% BSA (shaking for 1 h).
The primary antibodies used for the western blots were the same as those 
for immunohistochemistry. The concentrations of all primary antibodies 
used are shown in Table 2.1. β-Actin (1 : 2000, mouse monocolonal 
antibody, sc-47778; Santa Cruz Biotechnology) was used as a control for 
equal loading of the protein samples. The membranes were incubated 
with primary antibodies at 4 ◦C overnight, then washed three times with 
1% Tween in PBS and incubated with secondary antibodies (for MMP-2, 
-8, -9 and -14, goat anti-rabbit AP, 1 : 1000, Jackson Immunoresearch; for 
TIMP-1, rabbit anti-goat AP, 1 : 1000, Zymax; for MMP-13 and TIMP-2, 
donkey antisheep HRPO, 1 : 1000, Abcam) and again washed with 1% 
Tween PBS three times. Antibody binding was visualized by either NBT/
BCIP (for AP) or DAB (for HRPO).
Computerized densitometry was used to measure the intensity of the 
bands and the relative intensity (relative units) was determined through 
the ratio of the intensity of MMP:β-actin (ImageJ 1.38, NIH).
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3. Results
3.1. Degradation of Col-I scaffolds
The course of the FBR against Col-I scaffolds differed between the subcutaneous and epicardial implants as showed in the histochemical staining on plastic embedded sections (Figure 
2.1). The degradation of Col-I bundles was only minor or virtually 
absent in subcutaneous implants during the one month analysis period 
(Figure 2.1E). In contrast, epicardially the degradation of Col-I had 
commenced at week 1, although only few cells had infiltrated (Figure 
2.1B). The degradation had advanced at week 2 and was characterized 
with increased cellular influx surrounding the Col-I bundles (Figure 
2.1D). Within 1 month, the majority of Col-I had been degraded (Figure 
2.1F). Significantly more giant cells were formed subcutaneously than 
epicardially from day 14 on (Figure 2.1C, D). Yet phagocytosis (as 
revealed by light microscopy) was never observed during the whole time 
course of the FBR in either subcutaneous or epicardial implants.
Based on the histological results, primarily the presence of 
numerous inflammatory cells and presence of Col- I bundles at both 
sites, week 2 (Figure 2.1C, D) was selected for the in situ detection and 
characterization of the MMP-based proteolytic network and IL-10 by 
immunohistochemistry.
3.2. Distribution and status of collagenases and 
gelatinases
The presence of active or inactive (i.e. latent proform) of collagenases and 
gelatinases was assessed by western blotting for the whole time course of 
the experiment (day 2, week 1, week 2 and month 1). For collagenases, 
the active form of both collagenases (MMP-8, -13) was detected (Figure 
2.3) in subcutaneous implants throughout the time course. Epicardially, 
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Figure 2.1. Comparison of cellular infiltration and degradation in subcutaneously and epicardially 
implanted Col-I scaffolds at week 1 (A, B), week 2 (C, D) and month 1 (E, F). Subcutaneously, the number 
of cells increased with time (A, C and E) and giant cells (g) were observed from week 2 on. The majority of 
Col-I bundles (b) remained intact until 1 month (E). Epicardially, the number of cells increased with time (B 
and D). At week 2, the infiltrating cells had adhered to most of the Col-I bundles. Far fewer giant cells were 
observed compared to that in subcutaneous implants (D). The number of Col-I bundles decreased from 
week 2 on and the Col-I had almost completely degraded after 1 month (F). All scale bars represent 20 μm
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Figure 2.2. Collagenase protein analyses by immunohistochemistry. Light micrographs show the 
presence of MMP-8 and -13 in subcutaneously (A1, B1) and epicardially (A2, B2) implanted disks at week 
2. The inserts of A1 and A2 show that cells adhered to (arrows) or were apart from (asterisks) the Col-I 
bundles (b). Scale bar represents 5 μm for the inserts (A1 and A2) and 20 μm for the rest. The number 
of positive-stained cells was counted (A), and their distribution patterns were determined through the 




the latent form of both collagenases (proMMP-8, 13) was always present, 
yet only MMP-13 was also present in its active form during the whole 
time course (Figure 2.3). For the gelatinases, subcutaneously both active 
and latent forms of MMP- 2 were present during the progression of the 
FBR, while MMP-9 was only present at day 2 and in the latent proform 
(Figure 2.5). Epicardially, MMP-2, mainly in its active form,and MMP-9, 
mainly in its latent proform, were present (Figure 2.5). This indicates that 
the main collagenase and gelatinase that were active in epicardial Col-I 
implants were MMP-13 and MMP-2, respectively.
Figure 2.3. Collagenase protein analyses by western blotting at the time points of 2 days (d2), 1 week 
(w1), 2 weeks (w2) and 1 month (m1) after implantation. Protein samples from explants of four mice 
were pooled and the proteolytic activation of MMP-8 and -13 was determined by virtue of significant 
differences in molecular weight between active form and proform. Computerized densitometry was used 
to measure the intensity of the bands and the relative intensity (relative units) was determined through 
ratio of the intensity of MMP/β-actin. Subcutaneously, both MMP-8 and MMP-13 were present and active. 
Epicardially, MMP-13 was the only active collagenase throughout the time course, whereas the present 
MMP-8 was in its proform
3.3. Presence of activators and inhibitors of 
MMPs
Collagenases and gelatinases are secreted as their inactive proforms. The 
MMP activity is regulated extracellularly by at least two mechanisms. 
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Figure 2.4. Gelatinase protein analyses by immunohistochemistry. Light micrographs show the positive 
staining of MMP-2 and -9 in subcutaneously (A1, B1) and epicardially (A2, B2) implanted disks at week 2. 
All scale bars represent 20 μm. The number of positive-stained cells was counted (A) and their distribution 
patterns were determined through the percentage of positive cells that adhered to Col-I bundles (B). 




Figure 2.5. Gelatinase protein analyses by western blotting at d2, w1, w2 and m1. Protein samples 
from explants of four mice were pooled and the status of MMP-2 and MMP-9 were determined by 
virtue of significant differences in molecular weight between active form and proform. Computerized 
densitometry was used to measure the intensity of the bands and the relative intensity (relative units) 
was determined through ratio of the intensity of MMP/β-actin. Subcutaneously MMP-2 was present and 
active, whereas MMP-9 was present only at day 2. Epicardially both gelatinases were present but MMP-9 
was mainly present in proform; in contrast, MMP-2 was mainly in active form
One is the proteolytic activation of the secreted MMPs by MMP-14 
(together with the co-activator TIMP-2) and the other is the inhibition 
of MMP activity by TIMPs. Therefore, we determined the spatiotemporal 
expression of the main MMP activators (MMP-14, TIMP-2) and inhibitors 
(TIMP- 1, TIMP-2) by immunohistochemistry and western blotting. 
Immunohistochemistry showed that at week 2 all the investigated 
activators and inhibitors were present at both implant sites (Figure 
2.6) except for TIMP-1, which was absent epicardially (Figure 2.6, C2). 
Neither the number nor the distribution pattern of MMP-14- expressing 
cells differed between the two implant sites (Figure 2.6A, B), although 
more TIMP-2-expressing cells were present in epicardial implants than in 
subcutaneous implants (Figure 2.6A) and in general TIMP-2-expressing 
cells were more associated with Col-I bundles epicardially (Figure 2.6B). 
Irrespective of the implant sites, western blotting showed that MMP-14 
and TIMP-2 were detected throughout the whole time course (Figure 
2.7). MMP-14 was only present in its ‘proform’, which, remarkably, is the 
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known conformation required for activating other MMPs, such as MMP-
2. In contrast to the continuous expression of TIMP-2 at both implant 
sites, TIMP-1 was exclusively expressed in subcutaneous implants at all 
time points (Figure 2.7). Moreover, the average expression of TIMP-2 
levels was lower subcutaneously than epicardially during the progression 
of the FBR (Figure 2.7).
3.4. Presence of IL-10
Immunohistochemical staining showed that IL-10- producing cells 
were present in subcutaneous Col-I implants at week 2 (Figure 2.8A). In 
contrast, only few IL-10-producing cells were present in epicardial Col-I 
implants and these cells produced less IL-10 compared to subcutaneous 
implants (Figure 2.8B). Subcutaneously, the majority of IL-10-expressing 
cells appeared to be giant cells (Figure 2.8A). Since few giant cells were 
observed in epicardial implants, this explains why only low levels of IL-10 
were present in the epicardial scaffold microenvironment.
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Figure 2.6. Protein analyses of MMP activators and inhibitors by immunohistochemistry. Light 
micrographs show the presence of MMP-14, TIMP-2 and TIMP-1 in subcutaneously (A1–C1) and 
epicardially (A2–C2) implanted disks at week 2. All scale bars represent 20 μm. The number of positive-
stained cells was counted (A) and their distribution patterns were determined through the percentage of 
positive cells that adhered to Col-I bundles (B). Values are depicted as mean ± SD. ∗∗p < 0.01. # Percentage 
could not be calculated (no positive cells present)
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Figure 2.7. Protein analyses of MMP activators and inhibitors by western blotting at d2, w1, w2 and 
m1. Protein samples from explants of 4 mice were pooled and then detected the presence of MMP-14, 
TIMP-1 and -2 by western blotting. Computerized densitometry was used to measure the intensity of the 
bands and the relative intensity (relative units) was determined through ratio of the intensity of (MMP 
or TIMP)/β-actin. Irrespective of the implant sites, both activators were detected. In contrast, TIMP-1 was 
only detected in subcutaneous explants during the entire time course
Figure 2.8. Light micrographs of immunohistochemical analysis of cytokine IL-10 (week 2). Representative 
images show strongly positive staining associated with the presence of giant cells (g) in subcutaneous 





MMPs are produced and secreted as zymogens (proMMPs). To degrade collagen, MMPs need to be activated. MMP-2 is among the first MMPs to be activated in the MMP proteolytic network. 
Activation of proMMP-2 is achieved through a trimolecular complex 
at the cell surface, comprising proMMP-14, TIMP-2 and proMMP-2 
(Strongin et al., 1995; Cao et al., 2005).Of note, proMMP- 14, but not its 
furin-activated form, converts proMMP-2 into its activated form (Cao et 
al., 1998; Cao et al., 1999). After liberation of active MMP-2, this enzyme 
is able to activate both proMMP-13 and proMMP-9, which can further 
activate the other MMPs in the extracellular proteolytic network.
In the current study, we investigated the molecular mechanisms 
and regulation of the MMP-based proteolytic network during the FBR 
against Col-I in mice. We show that epicardially implanted collagen 
scaffolds were degraded during the FBR, whereas there was hardly any 
degradation of the subcutaneously implanted scaffold.
Our data showed the presence of proMMP-14 and TIMP-2 at both 
implant sites during the whole time course. This likely leads to the 
activation of MMP-2, whose presence was confirmed at both implant 
sites. MMP-13, as shown by Western blotting, was present in its activated 
form at both implant sites, most likely due to the activation of MMP-
2. Interestingly, the MMP-9 present in the epicardial implants remained 
largely in its proform. Thus, MMP-9, although it is exclusively seen in 
epicardial implants, can not be responsible for the high degradation rate 
of the scaffold. In addition, we here show that the MMP-8 present in the 
epicardial implants is also only present in its latent proform. Although 
the above findings do not contradict our previous observations that 
MMP-8 protein and MMP-9 mRNA are highly present in epicardial Col-I 
implants, we now believe that the role of MMP-8 and MMP-9 during 
the FBR is negligible, because both enzymes were largely inactive. In the 
current study it turned out that the MMPs in the epicardial implants are 
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present in an activated form are MMP-2 and MMP- 13. Therefore, the 
collagenase MMP-13 and the gelatinase MMP-2 seem to be the effective 
MMPs that are responsible for the degradation of epicardial Col-I 
implants.
On the other hand, the activated forms of MMP-2 and MMP-13 were 
also found in the subcutaneously implanted scaffolds, as well as MMP-
8. Surprisingly, Col-I scaffolds were not degraded at this implant site. 
In general, the proteolytic activity of MMPs depends not only upon the 
presence of the activated form of MMPs but also upon the stoichiometric 
balance between TIMPs and the activated form of MMPs (Nagase and 
Woessner, 1999). Higher molar levels of TIMPs than active MMPs will 
put the proteolytic network in an ‘off mode’. Therefore, the apparent 
contradiction between the presence of activated MMPs and the absence 
of Col-I degradation in subcutaneous implants may be due to TIMPs. 
Among the four members of the TIMP family, only TIMP-1 and TIMP-2 
were found to participate in the FBR against biomaterials in vitro (Jones 
et al., 2008). Generally, TIMP-1 acts as an unconditional MMP inhibitor 
of MMP activity, whereas TIMP-2 can act as either an activator or an 
inhibitor, according to the protein level of TIMP-2. Low-to-moderate 
TIMP-2 levels induce the activation of MMPs, while higher levels lead 
to inhibition (Sternlicht and Werb, 2001). Here we show that the TIMP-
2 protein expression levels at both implant sites are relatively low, and 
during the progression of the FBR (weeks 1 and 2), TIMP-2 protein 
levels are lower subcutaneously than epicardially. Therefore, the low 
TIMP-2 levels would seem to suffice for MMP activition in complex 
with proMMP-14, yet TIMP-2 levels are too low to inhibit MMP activity 
in degrading the extracellular matrix and the Col-I bundles. The only 
limiting factor for the Col-I degradation subcutaneously thus remains 
TIMP- 1. Indeed, although TIMP-1 was absent in epicardial scaffolds, it 
was readily detected subcutaneously at all time points. The ratio of MMPs 
and TIMP-1 in favour of TIMP-1 likely results in the inhibition of MMP-
2, -8 and -13 activity at the subcutaneous implant site.
The balance of the MMP/TIMP network is affected by inflammatory 
mediators. In particular, the expression of TIMP-1 protein is upregulated 
by the immunosuppressive cytokine IL-10 (Lacraz et al., 1995; Sternlicht 
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and Werb, 2001). In vitro studies have shown that IL-10 is a dose-
dependent stimulator for the transcription of TIMP- 1 mRNA (Lacraz 
et al., 1995; Mostafa et al., 2001). We wondered whether the presence 
of TIMP-1 in subcutaneous implants and the absence of TIMP-1 in 
epicardial implants is due to high and low levels of IL-10, respectively. This 
was indeed the case. Here we show that TIMP-1 and IL-10 are correlated 
and co-localized, suggesting that also in vivo, in the FBR, IL-10 regulates 
TIMP-1 protein expression. Furthermore, the current results show that 
IL-10 protein seems to be produced mainly by the giant cells. Together 
with our previous findings that significantly more giant cells are formed 
in subcutaneous implants than in epicardial implants (Luttikhuizen et 
al., 2006b), this would explain the higher subcutaneous IL-10 expression 
during the FBR. Together, the current data indicate that the presence of 
the high IL- 10 level secreted by giant cells in subcutaneous implants may 
have promoted the synthesis of TIMP-1 protein and hence downregulated 
the extracellular MMP activity. Interestingly, IL-10 has also been shown 
to downregulate the level of MMP-9 gene expression (Mostafa et al., 
2001; Tziakas et al., 2003; Popi et al., 2004), which would explain our 
observation of the near absence of MMP-9 in subcutaneous explants. 
Further studies are needed to dissect the role of potential therapeutic 
candidate IL-10 in the FBR, via IL-10 deficient mice.
In summary, in subcutaneously implanted scaffolds the high number 
of IL-10-producing giant cells may have created a different inflammatory 
microenvironment that resulted in: (a) decreased MMP-9 levels; and (b) 
increased TIMP-1 levels that effectively dampened the degradation of 
the scaffolds by inhibiting MMP-13 and MMP-2. Our data provide basic 
knowledge of the MMPbased proteolytic activity against crosslinked 
collagen in mice, and hold promise for the development of future 
therapeutic modalities in cardiac tissue engineering. Based on these 
results, modulation of the FBR via MMP network is feasible through 
several routes. One is to regulate the expression of TIMP-1, while the 
regulation of cytokines, e.g. by IL-10, might also be effective.
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Abstract
In order to get more insight into the role of neutrophils on the micro-environment and consequently on macrophages in the foreign body reaction in mice, we investigated the fate of the two 
differently cross-linked dermal sheep collagen disks (glutaraldehyde 
= GDSC, hexamethylenediisocyanate = HDSC) in mice implanted in 
one anatomical location, namely subcutaneously. In GDSC massive 
infiltration of neutrophils is seen at day 2 and day 21, whereas in HDSC 
only minor infiltration is seen at day 2. The presence of neutrophils 
coincided with high levels of IFN-γ, a cytokine that activates macrophages. 
Major differences were seen in degradation rate of the two disks: GDSC 
was almost completely degraded after 28 days, whereas HDSC remained 
intact. Degradation of GDSC occurred through collagenolytic activity 
and phagocytosis by macrophages. Phagocytosis was observed at day 
2 and day 21. IL-13 was only observed in HDSC, and this resulted in 
the presence of giant cells in HDSC. These giant cells produced IL-10, 
that promoted TIMP-1 expression and that inhibits collagenolytic and 
phagocytic activity. We conclude that the function of macrophages in 
mice is largely influenced by differences in micro-environment induced 
by GDSC and HDSC and that the presence/absence of neutrophils play a 
major role in the shaping of this micro-environment.
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1. Introduction
In regenerative medicine, biomaterial scaffolds are extensively investigated for their support of attachment, proliferation and differentiation of transplanted or local cells [1], [2] and [3]. As such, 
biomaterial scaffolds provide novel clinical modalities that aid in the 
regeneration or repair of damaged tissues [4] and [5]. Yet, the application of 
biomaterial scaffolds interacts with the physiological tissue repair process 
[1], [6] and [7]. The foreign body reaction (FBR) is an inflammatory local 
tissue response induced by both the surgical trauma of implantation and 
the presence of the biomaterial scaffold in the body [8], [9] and [10]. The 
FBR may favor or adversely affect the tissue repair process. An important 
part of the FBR is the degradation of the implanted biomaterial scaffold 
and therefore it is important to get an insight in the processes that govern 
and result in scaffold degradation [11] and [12].
The FBR involves a complex cascade of spatiotemporally regulated 
and interconnected processes that include cellular activation, fluxes of 
inflammatory cells, angiogenesis, extravasation, migration, phagocytosis, 
which finally resolve after the degradation of the implant [9], [10] and [13]. 
Similar to inflammation, the FBR is mediated by soluble mediators such 
as growth factors, cytokines, chemokines and matrix metalloproteinases 
(MMPs) and their inhibitors (TIMPs) [14] and [15]. These mediators are 
produced and secreted locally by cells in the surrounding tissue and by 
infiltrated cells inside the biomaterial. The nature of these host reactions 
is to a large extent tissue-, organ- and species-dependent [11], [16], [17] 
and [18].
We have previously investigated the fate of chemically cross-linked 
collagen disks, i.e. biomaterials scaffolds, in mice and rats [11], [16], [17] 
and [18]. Subcutaneously implanted hexamethylenediisocyanate cross-
linked bovine collagen type I disks in mice are virtually not degraded 
after 4 weeks due to the very limited proteolytic response of the host. 
Although activated MMP-2, -8, -13 and -14 were present, their action 
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was inhibited by high levels of TIMP-1. In spite of large numbers of giant 
cells inside the collagen disks, these giant cells did not phagocytose the 
disk. Instead these giant cells produced IL-10, a cytokine that increases 
the expression level of TIMP-1 mRNA and protein. Interestingly, similar 
collagen disks were almost completely degraded in mice upon epicardial 
implantation. Epicardially, TIMP-1 was not expressed and therefore the 
degradation was promoted by the active forms of MMP-2 and -13 that 
were present. The degradation was predominantly caused by extracellular 
proteolysis, because phagocytosis was absent. Moreover, less giant cells 
were seen and consequently only low levels of IL-10 were observed. Thus, 
marked tissue-specific differences were observed, indicating that the 
micro-environment of the location influenced the fate of the implanted 
biomaterial [11]. 
An obvious difference between subcutaneously and epicardially 
implanted hexamethylenediisocyanate cross-linked bovine collagen 
type I disks in mice was the continuous presence of neutrophils until 
day 21 (with peaks at the start and at day 14) in epicardially implanted 
scaffolds, whereas in subcutaneously implanted scaffolds neutrophils 
were hardly detected after 2 days of implantation [11] and [12]. The 
neutrophils might account for the previously indicated difference in 
micro-environment, resulting in differences in degradation rates of the 
scaffold between both tissues. With another scaffold placed in another 
animal species, namely glutaraldehyde cross-linked dermal sheep 
collagen (GDSC) subcutaneously implanted in rats, we have observed 
degradation rates of the GDSC scaffolds that is comparable with that of 
epicardially implanted hexamethylenediisocyanate cross-linked bovine 
collagen type I disks in mice [11] and [19]. Interestingly, the continuous 
presence of neutrophils was a common denominator in both models. 
However, from these anecdotal data it is difficult to draw conclusions 
about the interrelationship between neutrophil infiltration and scaffold 
degradation, as the experiments were carried out in two animal models, 
and in each animal model with a different biomaterial. As stated before, 
large differences exist in the FBR between animal species, such as rats 
and mice.
In order to get more insight into the role of neutrophils in the FBR, 
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we investigated the fate of the two differently cross-linked dermal sheep 
collagen disks (GDSC, HDSC) in mice implanted in one anatomical 
location, namely subcutaneously. By doing so, we ruled out differences in 
tissue type and animal species. In this experimental setup, differences in 
the FBR of the two biomaterials are primarily dictated by the nature of the 
scaffold itself, as the micro-environment at the start of the experiment is 
the same. If a change is seen in the micro-environment, then this change 
is primarily triggered by the biochemical make-up of the scaffold. Here 
we hypothesize that the GDSC will create part of the epicardial micro-




2. Materials and methods
2.1. Animals and biomaterials
Male C57BL/6 mice (10 weeks old, Harlan, Horst, the Netherlands) were housed individually under conventional conditions with food and water ad libitum.
Non-cross-linked dermal sheep collagen (DSC), processed 
from sheep skin [14], was obtained from the Zuid Nederlandse 
Zeemlederfabriek (Oosterhout, the Netherlands). DSC was cross-
linked with either glutaraldehyde (henceforth referred to as GDSC) or 
hexamethylenediisocyanate (henceforth referred to as HDSC), according 
to protocols described previously [19] and [20]. Disks (6 mm in diameter, 
0.75 mm in thickness) were punched from pieces of HDSC and GDSC 
from the same batch, and sterilized with ethylene oxide. Surface-
associated endotoxin levels were below 0.25 EU/ml.
2.2. Operating procedures
All procedures performed on animals were approved by the local 
committee for care and use of laboratory animals of the University 
of Groningen and were performed according to international and 
governmental guidelines on animal experimentation.
Implantation: mice were anesthetized with 4% isoflurane and 
maintained by 2% isoflurane inhalation in combination with a mixture of 
equal volumes of N2O and O2. The back was shaved and disinfected with 
chlorhexidine, two incisions were made and subcutaneous pockets were 
created on both sides. The HDSC or GDSC disks were implanted about 
1 cm away from the incision site, thus minimizing the effect of wound 
healing on the inflammatory reaction. The incisions were closed with 6–0 
non-absorbable Prolene sutures. Finally, mice received pure oxygen until 
awakening.
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Explantation: the Col-I disks were removed at the following time points 
after implantation (related to the different phases of the FBR in mice): 2 
days (onset), 7 days (early progression), 14 and 21 days (intermediate 
progression), and 28 days (late progression), n = 6 per time point. The 
disks were snap-frozen in liquid nitrogen immediately after explantation.
2.3. Histological techniques
Tissue sections (2 μm in thickness) of T 7100 (Heraeus Kulzer, Wehrheim, 
Germany) embedded explants were stained with toluidine blue (Fluka 
Chemie, Buchs, Switzerland) and mounted in Permount (Fisher, New 
Jersey, USA). Sections were analyzed by light microscopy. The number 
of giant cells per square millimeter inside implant on blinded samples 
was counted independently by two investigators. The degradation of the 
scaffold was determined by image analysis as the percentage of the size of 
remained disk as compared with the original size (before implantation). 
The cellular ingrowth inside the disk was evaluated by image analysis as 
percentage of the entire cross-sectional area, as described in our previous 
study [16].
2.4. Gene expression analysis
Total RNA was extracted from snap-frozen explants as described 
previously  [14]. One microgram of total RNA was used to generate the 
first strand cDNA synthesis using M-MuLV reverse transcriptase (MBI 
Fermentas, St. Leon-Rot, Germany) and random hexamer primers, 
according to the manufacturer’s protocol. Ten nanogram of a cDNA 
mixture from 5 mice was pooled per time point for each reaction. The 
PCR reaction of 35 cycles was performed using primers of interleukins 
(IL-4, IL-6, IL-10, IL-13), interferon-gamma (IFN-γ), transforming 
growth factor beta (TGF-β), monocyte chemoattractant protein 1 (MCP-
1/CCL-2), macrophage inflammatory protein 1α (MIP-1α/CCL-3) and 





Tissue expression was verified by means of in situ immunohistochemistry 
staining (IHC) on explants of the two biomaterials at all time points. Tissue 
sections (5 μm) were mounted on silane-coated slides. Cryosections were 
fixed with 2% paraformaldehyde (PFA) in 1x phosphate-buffered saline 
(PBS) at room temperature for 30 min, followed by rehydration (1x PBS, 
10 min), and subsequent incubation with 0.5% Triton X-100 in PBS (10 
min). Sections were washed in PBS and pre-incubated in 2% normal goat 
serum for 10 min. Sections were incubated with 1:125 diluted rabbit-anti-
mouse IL-10 antibody (AAM32, AbD Serotec, Oxford, UK) in PBS with 
2% normal goat serum for 1h. Thereafter, sections were washed in 0.05% 
Tween PBS (5 min, 3 times), and endogenous peroxidase was blocked 
with 0.1% H2O2 in PBS (10 min, in dark). Endogenous avidin and biotin 
were blocked with the avidin/biotin kit according to the manufacturer’s 
protocol (Biotin Blocking System, DakoCytomation, Denmark). The slides 
were incubated with goat anti-rabbit biotinylated secondary antibody 
(1:100, Dako, Carpineteria, USA) with 2% normal mouse serum for 30 
min, followed by incubation of streptavidin conjugated to peroxidase 
(Strep-PO, 1:100, 30 min). The same procedures were performed for all 
negative controls except that the primary antibody was omitted. Color 
development was done with 3-amino-9-ethyl-carbazole (AEC, Sigma, 
Table 3.1. PCR primers of inflammatory mediators and the control gene 
Mediators Forward Reverse Anneal
IL-4 ATGGGTCTCAACCCCCAGCTAGT GCTCTTTAGGCTTTCCAGGAAGTC 60 ° c
IL-6 AAATCGTGGAAATGAGAAA AGATGAATTGGATGGTCTTG 60 ° c
IL-10 CCCAGAAATCAAGGAGCATTTG CATGTATGCTTCTATGCAGTTG 55 ° c
IL-13 ATGGCGCTCTGGGTGACTGCAGTCC GAAGGGGCCGTGGCGAAACAGTTGC 67 ° c
TGF-β CGGAAGCGCATCGAAGCCATCC GCAAGCGCAGCTCTGCACGG 59 ° c
IFN-γ TGGAGGAACTGGCAAAAGGATGGT TTGGGACAATCTCTTCCCCAC 56 ° c
MIP-1α CCCTTTTCTGTTCTGCTGACAAG GAAGAGTCCCTCGATGTGGCTA 60 ° c
MCP-1 TCTCTTCCTCCACCACCATGCaG GGAAAAATGGATCCACACCTTGC 60 ° c
β-actin GTGAAAAGATGACCCAGATCAT GCTTCTCTTTGATGTCACGCACGAT 60 ° c
collagen scaffold cross-linking agents and neutrophils
51
Steinheim, Germany), and finally the sections were counterstained with 
hematoxylin (Fluka Chemie, Buchs, Switzerland).
To determine the inflammatory cell infiltration during the time 
course, sections were stained for neutrophils (monoclonal rat anti-mouse 
neutrophils, Serotec Ltd. Oxford, UK), macrophages (rat anti-mouse 
F4/80, Serotec Ltd. Oxford, UK) and lymphocytes (polyclonal hamster 
anti-mouse CD3ɛ, BD Pharmingen, USA), as described previously by 
our lab [11] and [12]. 
2.6. In situ zymography (ISZ) and double-staining 
for TIMP-1
Cryosections (5 μm, n = 3 per time point) on glass slides were covered 
with DQ™ collagen type I from bovine skin conjugated to fluorescein 
(Invitrogen, Breda, the Netherlands) as a substrate. The fluorescence 
of this substrate is fully quenched. Upon cleavage by active MMPs, the 
substrate is dequenched and starts to fluoresce (excitation 495 nm/
emission 515 nm). The substrate was diluted to 100 μg/ml in 50 mm 
Tris–HCl (pH 7.4), containing 16 mm CaCl2, 0.05% Brij 35 (all obtained 
from Sigma–Aldrich, Zwijndrecht, the Netherlands) in the presence of 
the serine-protease inhibitor PMSF (5 mmol/l (Fluka Chemie, Buchs, 
Switzerland). The slides were incubated in a humified chamber in the 
dark at 37 °C for 2 h. After incubation, unbound substrate was washed 
off with distilled water, followed by incubation with 1% Triton X-100 
for 10 min. Next, the slides were incubated with 4′,6-diamidino-2-
phenylindole (DAPI) (Sigma–Aldrich, Zwijndrecht, the Netherlands) to 
stain cell nuclei and mounted in Citifluor (Agar Scientific, Stansted, UK) 
and examined under a fluorescence microscope. As a negative control the 
substrate was omitted to determine the autofluorescence of the sections. 
Other negative control slides were pre-incubated with the general MMP 
inhibitor 10-phenanthroline monohydrate (Sigma–Aldrich, Zwijndrecht, 
the Netherlands) at a concentration of 20 μg/ml in 50 mm Tris–HCl (pH 
7.4). Each section was viewed using a Leica fluorescent microscope with 
FITC filter (Leica Microsystems, Rijswijk, the Netherlands), fitted with a 
Leica DC350 FX high resolution fluorescence digital camera and Leica 
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Qwin Pro image analysis software (Leica Microsystems, Rijswijk, the 
Netherlands).
For combining ISZ with staining for TIMP-1, sections were stained 
as described above, except that the PO-conjugated antibodies were 
replaced by antibodies conjugated with Cy3 (Zymed Laboratories Inc., 
San Francisco, USA). Subsequently, ISZ was performed as described.
2.7. Quantification of TIMP-1 expression and MMP 
activity
GDSC and HDSC sections showed distinct patterns in the TIMP-1 
expression and MMP activity. To further quantify the number of cells that 
associated to TIMP-1 expression and MMP activity, three representative 
images (magnification: 40×) of each tissue section were analyzed with 
a Tissue-Quest® 2.2 software, Zeiss AxioImager Z1 Microscope System 
(Tissue-Gnostics GmbH, Vienna, Austria). Single cells were identified by 
their nuclei (DAPI staining). This identification mask was then applied to 
determine gray values in the two corresponding channels (TIMP-1 and 
ISZ) of each object in all images. The percentage of cells that associated 
with TIMP-1 expression and MMP activity was determined and depicted 
as scattergrams respectively. Each scattergram represents average values 
calculated from analysis of all three images of one entire tissue section. 
Pictures were digitalized, analyzed, and protein expression was quantified.
2.8. Statistical analyses
All quantitative data are presented as mean ± SD. The data were analyzed 
using statistical software (GraphPad Prism, GraphPad Software Inc.). 
Differences within groups were analyzed by two-way ANOVA followed 
by Tukey’s post hoc test. Differences between groups were analyzed 
by one-way ANOVA and Student’s t-test. A difference of p < 0.05 was 
considered statistically significant.
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3. Results
3.1. Degradation, cellular ingrowth and cell 
infiltration
The FBR against the subcutaneously implanted disks differed between GDSC and HDSC. During the 28 day course of the investigation, degradation took place only in GDSC disks but not 
Figure 3.1. Comparison of degradation and cellular ingrowth between HDSC and GDSC disks in the 
foreign body reaction. The upper panel shows the fate of HDSC (A) and GDSC (B) at day 7, day 14 and day 
21 (staining by means of toluidine blue; scale bar ¼ 50 mm). The lower panel shows the quantification 
of degradation (C) and cellular ingrowth (D) in HDSC and GDSC throughout the time course. Values are 
depicted as mean  S.D. (n : 5 for each group). * : p < 0.05; ** : p < 0.01.
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in HDSC disks. The average size of GDSC disks had decreased by around 
20% at day 7, and did not change until day 14. Between day 14 and day 
28, more than 90% of the GDSC disks had degraded (Fig. 3.1A, C). In 
contrast, the size of the HDSC disks remained unchanged throughout the 
time course (Fig. 3.1B, C).
The process of cellular ingrowth also differed between GDSC and 
HDSC. In GDSC, cellular ingrowth was higher at day 2 and 7 than in 
HDSC (≥40% in GDSC and <20% in HDSC), whereas cellular ingrowth 
in HDSC (≥70%) was at least twice as high at day 21 and 28 than in GDSC 
due to a steep increase in cellular ingrowth in the HDSC disk after day 
14 (Fig. 3.1A, B, D). At day 28, almost the whole HDSC disk (>80%) 
had filled with infiltrated inflammatory cells and stroma deposition (Fig. 
3.1B, D).
To determine the quality and quantity of cells involved in the FBR, 
we assessed numbers of neutrophils, macrophages, foreign body giant 
cells and lymphocytes. Inside the HDSC disks only low numbers of 
neutrophils were observed at day 2 which rapidly disappeared (Fig. 3.2A). 
The number of neutrophils was much higher (>10 fold) in GDSC than 
in HDSC during the whole process of the FBR. In the GDSC implants, 
neutrophils were always present and their numbers varied during the 
entire time course, peaking at day 2 and day 21 with a dip at day 14 (Fig. 
3.2A). This bimodal distribution is indicative for the appearance of two 
waves of neutrophils. The presence of macrophages gradually increased 
at both materials and their numbers did not differ between GDSC and 
HDSC during the whole time course except at day 28, at which 80% 
less macrophages were present in GDSC which correlates with the high 
degradation of the GDSC (Fig. 3.2B). Giant cells were first observed at 
day 7 in both biomaterials. The number of giant cells in GDSC remained 
at relatively low or near absent levels after day 7, while in HDSC, the 
number of giant cells rapidly increased, and reached a maximum after 
day 21 (Fig. 3.2C). Lymphocytes were only sporadically present (<1% of 
the cell population) during the entire FBR in both biomaterials (data not 
shown).
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Figure 3.2. Comparison of cellular infiltration between HDSC and GDSC scaffolds in the foreign body 
reaction. (A) Higher numbers of neutrophils were present in GDSC than HDSC throughout time, and 
reached peaks at day 2 and day 21 in GDSC. (B) Comparable number of macrophages were present in 
both scaffolds at all time points except day 28, by which GDSC was almost completely degraded. (C) The 
giant cells were present from day 7 onwards and the numbers were increasing according to the time in 
HDSC, while in GDSC the giant cells were nearly absent. Values are depicted as mean  S.D. (n : 6 for each 
group).  * : p < 0.05; ** : p < 0.01.
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3.2. Scaffold degradation: cellular and 
molecular regulatory mechanisms
Both extracellular (enzymatic) and intracellular (phagocytic) 
degradation was observed for GDSC implants while HDSC implants 
were not degraded either way. In situ zymography showed a high 
collagenolytic activity in GDSC disks during the progression of FBR at 
day 14 and 21 (Fig. 3.3B, D). This enzyme activity was associated with the 
collagen bundles. In contrast, MMP activity was absent in HDSC disks 
Figure. 3.3 Collagenolytic activity in HDSC and GDSC scaffolds at day 14 and day 21 after implantation. 
Nearly no collagenolytic activity in HDSC was seen at day 14 (A) and day 21 (C). Marked collagenolytic 
activity was observed in GDSC at day 14 and day 21, and the activity shifted from the fibro-capsule at 
day 14 (B) to the GDSC collagen bundles at day 21 (D). Symbols: b : collagen bundle, c : fibro-capsule; b : 
collagen bundle. Scale bar : 20 mm.
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at all time points (Fig. 3.3A, C). Phagocytosis of implanted collagen by 
macrophages was observed in GDSC at day 2 and day 21 only (Fig. 3.4B, 
D); in HDSC, phagocytosis was never observed (Fig. 3.4A, C).
As shown by immunohistochemistry, protein staining of TIMP-1 in 
HDSC was markedly higher than that in GDSC at day 14. In HDSC, 
TIMP-1 was present both in the capsule and in the biomaterial, while 
in GDSC, the expression of TIMP-1 in the biomaterial was negligible 
(Fig. 3.5A, B). Notably, the presence of TIMP-1 coincided with an 
absence of the collagenolytic activity as revealed by in situ zymography 
(Fig. 3.5A, B). The quantification of TIMP-1 and MMP activity showed 
Figure 3.4. Phagocytosis in HDSC and GDSC scaffolds during the foreign body reaction. No phagocytosis 
was observed in HDSC throughout the time course (A, C). Marked phagocytosis by macrophages was 
observed in GDSC only at day 2 (B) and day 21 (D). Symbols: F : macrophage; b : collagen bundle; dc : dead 
cell. Scale bar : 20 mm; the tissue slices are stained with toluidine blue.
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Figure 3.5. Collagenolytic activity and its relation with the expression of TIMP-1 and IL-10 in HDSC and 
GDSC scaffolds during the foreign body reaction. (A) The high level of TIMP-1 protein (red) resulted in 
the absence of collagenolytic activity (green) in HDSC. (B) In contrast, the near absence of TIMP-1 protein 
resulted in a marked collagenolytic activity in the capsule surrounding GDSC. (C,D) Immunohistochemistry 
shows the same distribution patterns of IL-10 (brown) as that of TIMP-1 in HDSC and GDSC, respectively. 
(E,F) Quantification of TIMP-1 expression and MMP activity in GDSC and HDSC using Tissue-Quest 2.2. 
Scattergrams show the percentages of cells that associated with TIMP-1 expression and MMP activity in 
HDSC (E) and GDSC (F), n : 3 for each scattergram. Symbols: c : fibro-capsule; b : collagen bundle. Scale 
bar : 20 mm.
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that in HDSC more than 80% cells express TIMP-1 while less than 
1% cells show MMP activity (Fig. 3.5E); In contrast, less than 5% cells 
express TIMP-1 and more than 60% cells show MMP activity in GDSC 
(Fig. 3.5F). Furthermore, we also investigated the presence of IL-10, 
which is a cytokine that upregulates transcription of the TIMP-1 gene. 
Immunohistochemistry showed higher IL-10 protein expression in 
HDSC than in GDSC (Fig. 3.5C, D). Indeed, the expression pattern of 
IL-10 largely coincided with the distribution pattern with TIMP-1 in the 
capsule. In contrast to TIMP-1, IL-10 was also expressed in the outer rim 
of the biomaterial in GDSC disks (Fig. 3.5C, D).
Because IL-10 apparently plays an important role in the initiation of 
TIMP-1 expression and thus in regulating the degradation rate of the 
scaffolds, we investigated the cellular origin of IL-10. As shown in the 
immunohistochemical staining, the presence of IL-10 in HDSC strongly 
correlated with IL-10 expressing giant cells but not that of macrophages 
(Fig. 3.6A, B). In fact, the majority of giant cells expressed IL-10. In 
contrast, in GDSC only few cells expressed IL-10, which may be related 
to the near absence of giant cells in this type of scaffold (Fig. 3.6A, C). 
More than 90% of giant cells in HDSC and 50% of giant cells in GDSC 
expressed IL-10 whereas less than 3% of macrophages expressed IL-10 
in both biomaterials (data not shown). Therefore, the IL-10 seems to be 
primarily produced by giant cells at all time points, albeit at levels that is 
material-dependant.
3.3. Molecular mediators/regulators during the 
FBR
To further dissect the micro-environment of the FBR, we analyzed and 
compared the expression of known mediators of macrophage and giant 
function. For this the gene expression was determined of chemokines 
(MCP-1; MIP-1α) and cytokines (IL-4, IL-6, IL-10, IL-13, IFN-γ, TGF-β) 
in HDSC and GDSC. Our data showed that both MIP-1α and MCP-1 are 
always expressed, but that there seems to be a tendency that MCP-1 is less 
expressed at later time points in both materials (Fig. 3.7). The expression of 
monocyte/macrophage attractants MCP-1 and MIP-1α were comparable 
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Figure 3.6.  IL-10 expression is largely associated with the presence of giant cells. (A,B) 
Immunohistochemistry of IL-10 (brown) show that IL-10 is mainly produced in HDSC (A) and nearly 
absent in GDSC (B). Scale bar :10 mm for the inserts and 30 mm for the rest. (C,D) classification of IL-10 
producing cells as giant cells and non-giant cells. The first IL-10 producing giant cells were seen at day 7 
in HDSC, the number increased to 150/mm2 at day 14, and peaked in HDSC at day 14 and 21 (350/mm2 
and 300/mm2, respectively). In contrast, less than 70/mm2 non-giant cells produced IL-10 throughout 
the time course (HDSC and GDSC). Hardly any giant cells were observed in GDSC. Values are depicted as 
mean S.D. (n : 4 for each group). Symbols: GC : giant cell; # : non-giant cell; ** : p < 0.01.
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Figure 3.7. Dissection of the micro-environment in HDSC and GDSC scaffolds during the foreign body 
reaction. mRNA expression show that higher levels of the pro-inflammatory cytokines IL-6 and IFN-g 
were expressed in GDSC compared to that of HDSC. In contrast, higher levels of the anti-inflammatory 
cytokines IL-10 and IL-13 were expressed in HDSC compared to that of GDSC. IL-4 was absent in both 
scaffolds.
between the two biomaterials. As a result, we found comparable numbers 
of macrophages in both biomaterials (Fig. 3.3B). Expression of IL-4 was 
near absent in both biomaterials whereas the expression of TGF-β was 
high at all time points both in GDSC and HDSC (Fig. 3.7). Remarkably, 
distinct expression patterns of the pro-inflammatory cytokines (IL-6, 
IFN-γ) and anti-inflammatory cytokines (IL-10, IL-13) were observed 
between the two biomaterials. In GDSC, IL-13 is totally absent throughout 
the time course and IL-10 was expressed only during the first week. In 
contrast, both IL-10 and IL-13 were always expressed in HDSC during 
the FBR. Both IL-6 and IFN-γ showed a dynamic expression pattern, e.g. 
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both genes are expressed at early time points, then downregulated and 
upregulated again after 3 weeks. Notably, a higher expression levels of IL-6 
and IFN-γ (day 2, day 21) are seen in GDSC compared to that of HDSC 
(Fig. 3.7). This dynamic micro-environment probably has consequences 
for the functioning of the macrophage and/or giant cells.
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4. Discussion
The main finding of our study is, that the FBR against cross-linked dermal sheep collagen is driven by the implant micro-environment. We showed that by altering the type of cross-linking, the collagen 
could alter the subcutaneous micro-environment such that it was 
degraded. In the current study, we investigated molecular and cellular 
factors that were involved in the FBR of two differently cross-linked 
dermal sheep collagen type scaffolds (HDSC and GDSC) implanted 
subcutaneously in mice. It was found that HDSC was hardly degraded 
after 28 days, whereas GDSC was almost completely degraded. Large 
differences were found, amongst others, in the infiltration of neutrophils 
with respect to cell numbers and time course: in GDSC much higher 
numbers were found at all time points and infiltration took place in two 
waves instead of one.
Our previous studies revealed that the FBR towards 
hexamethylenediisocyanate cross-linked type I collagen showed large 
differences in mice, depending on the site of implant (subcutaneously 
versus epicardially). The degradation only took place epicardially and 
seemed correlated with the presence of neutrophils during the FBR [11] 
and [12]. Moreover, also Dacron, which is a non-degradable biomaterial, 
elicited a similar response on the heart, i.e. influx of neutrophils and 
associated MMP expression [12]. Clearly, in our current animal model, 
the subcutaneously implanted GDSC created at least part of the epicardial 
micro-environment via attraction of neutrophils. Neutrophils are known 
as one of the first groups of inflammatory cells that arrive at the implant 
site. Previous studies suggested that the crucial role of neutrophils 
in the FBR was to produce chemokines to attract other inflammatory 
cells, including monocytes [10]. The current study shows that, although 
the time course of the presence of neutrophils differed between HDSC 
and GDSC, the expression of monocyte attractant chemokines, MCP-1 
and MIP-1α as well as the numbers of macrophages were comparable 
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between the two biomaterials. This indicates that – at least under the 
conditions of the current model– the neutrophils may not play an 
important role in continuously attracting inflammatory cells during the 
FBR process, although it might play a role in the early stage of the FBR. 
A more important role of neutrophils in the current model –as suggested 
by the obtained data– appears to be as a pro-inflammatory regulator. 
With the presence of neutrophils in GDSC scaffolds, pro-inflammatory 
factors (IL-6 and IFN-γ) were upregulated, while the anti-inflammatory 
factors (IL-10 and IL-13) were downregulated. It is well known that 
IFN-γ is secreted by lymphocytes, dendritic cells or NK cells [21] and 
[22]. However, our data show that none of the above cells were present 
in the FBR. Because of the strong correlation between the expression of 
IFN-γ and the presence of neutrophils (day 2 and day 21), we speculate 
that neutrophils contribute to the expression of IFN-γ during the FBR. 
Neutrophils are able to express IFN-γ [23] and [24].
The behavior of macrophages within the FBR depends on their 
micro-environment. Despite similar numbers of macrophages in both 
biomaterials, the role of macrophages in the FBR between HDSC and 
GDSC was fundamentally different. In GDSC, macrophages degraded 
the collagen bundles both by means of MMPs and by phagocytosis. 
Phagocytosis was only observed at day 2 and day 21. At these two time 
points, a high expression was found of IFN-γ a cytokine that is known to 
promote macrophage activation. The IFN-γ which was probably secreted 
by neutrophils as these cells coincided with the phagocytic behavior of 
the macrophages. In contrast, in HDSC the macrophages fused into the 
giant cells. These giant cells induced TIMP-1 expression via secretion of 
IL-10 protein, resulting in a net decrease of MMP activity. One of the 
prime factors that drives fusion of macrophages is IL-13, the difference 
in giant cell formation between GDSC (absent) and HDSC (present) 
appeared to be due to the expression of IL-13 (absent in GDSC, present 
in HDSC) [25],[26] and [27]. The absence of IFN-γ (and consequently 
the absence of phagocytic activity of macrophages) and the high levels 
of TIMP-1 (and consequent inhibition of collagenolytic activity) may 
explain the near absence of degradation of HDSC.
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The current data clearly showed that not only the implant site of the 
scaffold in the body, but also the nature of the scaffold determines the 
outcome of the FBR. The scaffold itself can create its own molecular and 
cellular micro-environment. Notably, the GDSC created subcutaneous 
micro-environment differs somewhat from the epicardial micro-
environment as described previously: in the current study phagocytosis 
occurred, which is absent in the epicardial setting. Perhaps, less IFN-γ is 
present epicardially. Therefore, we have in part mimicked the epicardial 




The current study shows that changes in scaffold composition, e.g. chemical cross-linkers, will result in a difference in the FBR, and that this difference is correlated with differences in inflammatory 
micro-environment and the presence of neutrophils. In GDSC, a strong 
pro-inflammatory milieu is observed. Inflammatory mediators such as 
IFN-γ, which seems to be secreted by neutrophils, influences the behavior 
of macrophages during the FBR, and leads to the degradation of the 
biomaterial. While in HDSC, an anti-inflammatory milieu is seen. In the 
presence of IL-13, macrophages fuse into foreign body giant cells and start 
to produce IL-10 which on its turn promoted TIMP-1 expression, finally 
resulting in a delay of the enzymatic degradation of collagen by MMPs. 
We therefore conclude that the function of macrophages in mice is largely 
influenced by differences in the local micro-environment induced by the 
implanted biomaterials and that the presence/absence of neutrophils 
play a major role in the shaping of this micro-environment. Our data 
deepen the understanding of the molecular and cellular mechanisms of 
the degradation of collagen scaffolds during the FBR.
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Abstract
Subcutaneously implanted disks of hexamethylenediisocyanate or glutaraldehyde cross-linked sheep collagen (referred to as HDSC and GDSC, respectively) in mice show large differences in degradation 
rate. Although comparable numbers of macrophages are seen in HDSC 
and GDSC, phagocytosis of collagen by macrophages occurred only 
in GDSC. The molecular mechanisms involved in the phagocytosis of 
collagen by macrophages are essentially unknown. Immunofluorescence 
and RT-PCR showed that Endo180 was expressed in GDSC only. 
TissueFaxs showed that Endo180 co-localized with MT1- MMP on F4/80 
positive cells, which is likely responsible for the phagocytosis in GDSC. 
RT-PCR further showed that Endo180 expression correlated with high 
levels of IFN- γ mRNA. In vitro, IFN-γ induced the expression Endo180 
and MT1-MMP in murine macrophages cultured on collagen type I 
(although too high levels of IFN-γ dampened the expression of Endo180 
and MT1-MMP). Moreover, the expression of Endo180 and MT1-MMP 
induced by IFN- γ can be inhibited through IL-10. The differences in 
microenvironment between GDSC and HDSC (high IFN- γ and low IL-
10 levels in GDSC, low IFN-γ and high IL- 10 levels in HDSC) provide an 
explanation why phagocytosis of collagen by macrophages is only seen in 
GDSC. In summary, we show for the first time that the IFN-γ dependent 
co-expression of Endo180 and MT1- MMP on macrophages coincides 
with collagen phagocytosis, thus providing evidence that the mechanism 
of collagen phagocytosis operating in the foreign body reaction by 
macrophages is comparable with the mechanism of intracellular collagen 
degradation by fibroblasts seen under physiological conditions.
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Introduction
The interaction of tissues with biomaterials is a field of crucial importance to all kinds of medical technologies, including tissue engineering (Sachlos et al., 2006; Tai et al., 2007; Munirah 
et al., 2008). The tissue response towards implanted biomaterials, also 
called the foreign body reaction, is influenced to a large degree by the 
morphology and composition of the biomaterial, and the location where 
the biomaterial is implanted (Luttikhuizen et al., 2006a; Anderson 
and Jones, 2007; Yeghiazaryan et al., 2007; Anderson et al., 2008; 
Dinnes et al., 2008). By changing certain biochemical or biophysical 
characteristics (Khouw et al., 1998; Van Putten et al., 2009), the tissue 
response will alter, for example by attracting more or specific cells to the 
scaffold. The microenvironment of the implant further changes due to 
the secretion of proteins by the attracted cells as they secrete cytokines 
and/or chemokines. The microenvironment by itself also has a major 
impact on the phenotypic properties of macrophages (Luttikhuizen et al., 
2006b; Luttikhuizen et al., 2007), a cell type that plays a central role in 
the outcome of the foreign body reaction (Brown et al., 2009; Valentin 
et al., 2009). Macrophage activation gives rise to different populations 
of cells with distinct functions (Mosser and Edwards, 2008), and it has 
been shown that the phenotype of the macrophages participating in the 
foreign body reaction is a determinant of biological scaffold remodelling 
(Badylak et al., 2008; Brown et al., 2009).
Collagen scaffolds are often used in tissue engineering. We have 
recently observed that there are marked differences in the degradation 
rate of two differently crosslinked dermal sheep collagen scaffolds 
(hexamethylenediisocyanate and glutaraldehyde cross-linked, referred to 
as HDSC and GDSC, respectively) in mice implanted in one anatomical 
location, namely subcutaneously (Ye et al., submitted). GDSC disks 
were almost completely degraded after four weeks, whereas HDSC 
disks did not degrade after four weeks. Phagocytosis was seen in GDSC 
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disks at certain time points (day 2 and day 21); furthermore, increased 
matrix metalloproteinase (MMP) activities were seen. In HDSC 
disks, no phagocytic activity was seen, and collagenolytic activity was 
effectively inhibited by increased levels of the tissue inhibitor of matrix 
metalloproteinase TIMP-1. Phagocytosis of GDSC coincided with 
high levels of interferon-gamma (IFN-γ) in the microenvironment; in 
HDSC disks less IFN-γ is seen in combination with increased levels of 
interleukin-10 (IL-10). The high levels of IFN-γ were attributed to the 
infiltration of neutrophils in GDSC, whereas the increased levels of IL-10 
was attributed to the presence of giant cells in HDSC (Ye et al., submitted).
Although phagocytosis of the collagen by macrophages has repeatedly 
been reported (Parakkal, 1969; Knapp et al., 1974; Deporter, 1979; 
Svoboda and Deporter, 1980; Inouye et al., 1983; Ciapetti et al., 1996; 
Lucattelli et al., 2003), and it is intuitive and logical that phagocytic cells 
such as macrophages are involved in phagocytosis of collagen bundles, 
essentially nothing is known about this phenomenon in the foreign body 
reaction and the mediators of this process. In fibroblasts, phagocytosis 
and intracellular digestion of collagen is intensively studied (Everts et 
al., 1996). The membrane-bound matrix metalloproteinase MT1-MMP 
plays an essential role in collagen phagocytosis of fibroblasts (Beertsen 
et al., 2002; Lee et al., 2006; Lee et al., 2007). It has recently been 
postulated that the urokinase plasminogen activator receptor-associated 
protein (also known as uPARAP or Endo180) is, in combination with 
the membrane-bound matrix metalloproteinase MT1-MMP, responsible 
for the phagocytic uptake of collagen by fibroblasts (Engelholm et al., 
2003b; Madsen et al., 2007). Endo180 is a membrane-bound receptor 
that is able to bind collagen and is involved in the subsequent endocytic 
collagen uptake (East et al., 2003; Behrent and Bugge (2003); Wienke et 
al., 2003; Kjoller et al., 2004; Curino et al., 2005; Mousavi et al., 2005; 
Thomas et al., 2005). Although Endo180 has been reported to be present 
on macrophages (Sheikh et al., 2000; Honardoust et al., 2006), nothing 
is known about its role in collagen phagocytosis by macrophages. In this 
paper we have investigated whether there is a relationship between the 
expression of Endo180 and MT1-MMP and the presence/absence of 
collagen phagocytosis by macrophages in GDSC and HDSC, respectively. 
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Furthermore, we investigated whether IFN-γ and IL-10 are involved in 





Non-crosslinked dermal sheep collagen (DSC), processed from sheep skin, was obtained from the Zuid-Nederlandse Zeemlederfabriek (Oosterhout, the Netherlands). DSC was 
crosslinked with either glutaraldehyde (henceforth referred to as GDSC) 
or hexamethylenediisocyanate (henceforth referred to as HDSC), 
according to the protocols described previously (Van Wachem et al., 
1994; Olde Damink et al., 1995). Disks (6 mm in diameter, 0.75 mm 
in thickness) were punched from pieces of HDSC and GDSC from the 
same batch, and sterilized with ethylene oxide. Endotoxin content of 
surface-associated endotoxin levels of Col-I disks were below 0.25 EU/
ml, as determined by the LALmethod (LAL kinetic-QCL®; Cambrex, East 
Rutherford, NJ, USA).
Animals and operating procedures
All procedures performed on animals were approved by the local 
committee for care and use of laboratory animals of the University 
of Groningen and were performed according to international and 
governmental guidelines on animal experimentation. Male C57BL/6 
mice (10 weeks old, Harlan, Horst, The Netherlands) were housed 
individually in a conventional condition with food and water ad libitum. 
Mice were anaesthetized with 4% isoflurane and maintained by 2% 
isoflurane inhalation in combination with a mixture of equal volumes of 
N2O and O2. The back was shaved and disinfected with chlorhexidine, 
two incisions were made and subcutaneous pockets were created on both 
sides. The HDSC or GDSC scaffolds were implanted about one centimetre 
away from the incision site, thus minimising the effect of wound healing 
on the foreign body reaction itself. The incisions were closed with 6-0 
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non-absorbable Prolene sutures. Finally, mice received pure oxygen 
until awakening. The Col-I disks (HDSC or GDSC) were removed at the 
following time points after implantation (related to the different phases 
of the FBR in mice): 2 days (onset), 7 days (early progression), 14 and 21 
days (intermediate progression), and 28 days (late progression), n=6 per 
time point. The disks were snap-frozen in liquid nitrogen immediately 
after explantation.
Cell culture and interventions
The murine monocytic macrophage cell line RAW 264.7 (American Type 
Culture Collection, ATCC, Manassas, VA, USA) was cultured in RPMI-
1640 (BioWhittaker, Verviers, Belgium) with 10% foetal bovine serum 
(FBS), supplemented with 2 mM glutamine, 100 μg/ml streptomycin and 
100 IU/ml penicillin.
The 6-well cell culture plates (BD Falcon™, Franklin Lakes, NJ, USA) 
and 6-well diagnostic slides (Menzel- Glaser, Braunschweig, Germany) 
were coated overnight at 37°C in a humidified 5% CO2 atmosphere using 
300 μg/ml rat tail type I collagen (BD Bioscience) in 1 mM NaOH/PBS 
(1 ml/well for culture plates and 100 μl/well for diagnostic slides). RAW 
264.7 cells (1.2 × 104 cells/ cm2) were seeded into 6-well cell culture 
plates and 6- well diagnostic slides with or without collagen coating. 
After a preincubation of 24 hours, the cells were treated with different 
concentrations of inflammatory mediators: recombinant human IFN-γ 
(PeproTech, London, UK) from 0 to 25 ng/ml, recombinant human IL-1β 
(PeproTech) from 0 to 25 ng/ml, recombinant murine TNF-α (BioVision, 
Mountain View, CA, USA) from 0 to 25 ng/ml, and recombinant murine 
IL-10 (R&D Systems Inc., Minneapolis, MN, USA) from 0 to 25 ng/
ml together with 2.5 ng/ml human IFN-γ. All cells were subsequently 
incubated at 37°C in a humidified 5% CO2 atmosphere for 48 h. The cells 
in the culture plates were then harvested for gene expression analysis 
by Reverse Transcription Polymerase Chain Reaction (RT-PCR), and 
cells on the slides were used for in situ detection of Endo 180 and MT1-





One μg of total RNA (either extracted from snap frozen explants or RAW 
267.4 cells) was used to generate the first strand cDNA synthesis using 
M-MuLV reverse transcriptase (MBI Fermentas, St. Leon-Rot, Germany) 
and random hexamer primers, according to the manufacturer’s protocol. 
Ten ng of cDNA were used for each PCR reaction. PCR for Endo180, 
IFN-γ and the housekeeping gene β- actin was performed in a final 
reaction volume of 25 μl containing 1.5 mM MgCl2, 0.25 mM dNTP mix, 











Amplification was performed on a MyCycler (Bio-Rad, Hercules, CA, 
USA) for 35 cycles at annealing temperature of 66°C, 56°C and 60°C for 
Endo180, IFN-γ and β-actin, respectively. The amplimers were separated 
in a 2% agarose gel.
Immunofluorescence microscopy
Expression of Endo180 and MT1-MMP in vivo and in vitro was verified 
by means of in situ immunofluorescent staining on explants of two 
materials at all time points and on cells cultured on the diagnostic 
slides. Tissue sections (5 μm) were mounted on silane-coated 
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slides. Both cryosections and cell cultured slides were fixed with 2% 
paraformaldehyde (PFA)/PBS at room temperature (RT) for 10 min, 
then washed in 0.1% Triton X-100 in PBS (5 min) for 3 times. After that, 
samples were incubated with 1:100 goat anti-mouse Endo180 antibody 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA ) and 1:200 rabbit anti-
mouse MT1-MMP antibody (Epitomics Inc.,Burlingame, CA, USA) in 
PBS with 0.5% Triton X-100 and 2% normal goat serum for 2.5 h in the 
dark at RT. After incubation, samples were washed in 0.1% Triton X- 
100 in PBS (5 min) for 3 times. The secondary antibody for MT1-MMP, 
namely swine anti-rabbit FITC (1:100, Dako, Carpinteria, CA, USA) in 
PBS with 4’,6-diamidino- 2-phenylindole (DAPI, 1:5000, Sigma-Aldrich, 
Zwijndrecht, The Netherlands), was incubated for 30 min. Samples were 
then washed in 0.1% Triton X-100 in PBS (5 min) for 4 times to wash 
off non-bound secondary antibodies (FITC). The secondary antibody for 
Endo180, namely rabbit anti-goat Cy3 (1:100, Zymed Laboratories Inc., 
San Francisco, CA, USA) in PBS with DAPI (1:5000) was incubated for 
30 min. Next, samples were washed 4 times in 0.1% Triton X-100 in 1x 
PBS (5 min) to wash off the secondary antibodies (Cy3). Samples were 
mounted with Citifluor (London, UK) followed by examination under 
the immunofluorescence microscope.
To unravel the identity of the Endo180 expressing cells, a double 
staining was performed as described above using the previously mentioned 
Endo180 antibodies (in combination with rabbit anti-goat Cy3) together 
with a murine macrophage marker, rat anti-mouse F4/80 antibodies 
(1:100, Serotec Ltd. Oxford, UK). After incubation in combination with 
.with primary antibodies for 2.5 h, The secondary antibody for Endo180 
(1:100, rabbit anti-goat Cy3) in PBS with DAPI (1:5000) was added and 
incubated for 30 min. Samples were then washed in 0.1% Triton X-100 
in PBS (5 min) for 4 times to wash off non-bound secondary antibodies 
(Cy 3). The secondary antibody for F4/80, namely goat anti rat FITC 
(1:100; Southern Biotech, Birmingham, AL, USA) was incubated for 30 
min. thereafter, samples were washed 4 times in 0.1% Triton X-100 in 
1x PBS (5 min) to wash off the secondary antibodies (FITC). Finally, 




For the negative controls, samples were stained as described above, 
except that the primary antibodies were replaced with the same 
dilution of serum from the same species as used for the specific first 
antibodies, namely, normal goat serum (1:100, Sanquin Pharmaceutical 
Services, Amsterdam, Netherlands), normal rabbit serum (1:200, Dako, 
Carpinteria, USA) and normal rat serum (1:100, Invitrogen, Carlsbad, 
CA, USA) for Endo180, MT1-MMP and F4/80, respectively.
Each section was viewed using a Leica DMRXA Immumofluorescence 
microscope (Leica Microsystems, Rijswijk, The Netherlands) with 
FITC and Cy3 filter, fitted with a Leica DC350 FX high resolution 
fluorescence digital camera and Leica Qwin Pro image analysis software. 
A compensation procedure was performed to prevent the influence of the 
overlap between FITC and Cy3.
Quantification of Endo180 and MT1-MMP 
immunostaining
To further quantify the number of cells with Endo180, MT1-MMP 
and F4/80 immunostaining, three representative images (magnification: 
40×) of each tissue section were analyzed with TissueFaxs®, Zeiss 
AxioImager Z1 Microscope System (Tissue-Gnostics GmbH, Vienna, 
Austria). Single cells were identified by their nuclei (DAPI staining). 
This identification mask was then applied to determine gray values in 
the two corresponding channels FITC (MT1-MMP or F4/80) and Cy3 
(Endo180) of each object in all images. The percentage of MT1-MMP 
or F4/ 80 and Endo180 positive cells was determined and depicted as 
scattergrams. Each scattergram represents average values calculated 
from analysis of all three images of one entire tissue section. Based on 
the degree of fluorescence intensity in the negative controls, appropriate 
threshold values for positive immunofluorescence staining were defined. 
Pictures were digitised, analysed, and protein expression was quantified. 
To quantify the fraction of MT1-MMP and Endo180 positive cells 
cultured on 6-well diagnostic slides, four representative fields (20×) 
were taken in each well. Percentages of MT1-MMP or Endo180 positive 
cells were determined through counting the total cell number and the 
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number of MT1-MMP or Endo180 positive cells in each micrograph. 
The experiments were repeated 4 times. Data from these experiments 
(n=5 ; x4) were presented as average percentage of positive cells.
Statistical analyses
All quantitative data are indicated as mean ± standard deviation (SD). 
The data were analyzed using statistical software (GraphPad Prism, 
GraphPad Software, La Jolla, CA, USA). Differences were analyzed by 
two-way ANOVA followed by post hoc Tukey’s test. A difference of p<0.05 




Phagocytosis of collagen bundles is correlated 
with the co-expression of the membrane proteins 
MT1- MMP and Endo180
We have shown previously that phagocytosis of implanted collagen by macrophages was observed in GDSC at day 2 and day 21 (and not at day 7, 14 and 28). Mononuclear cells closely 
aligned to the biomaterial were considered phagocytic macrophages, 
especially when the cells show an accumulation of vacuoles or when the 
biomaterial has a more irregular shape opposite the cell (Fig. 4.2E). In 
HDSC, phagocytosis was never observed. Since nothing is known about the 
molecular mechanisms how macrophages phagocytose collagen, here we 
continue our previous study regarding GDSC and HDSC disks to further 
investigate the expression of Endo180 and MT1-MMP, membranebound 
proteins that are known to be involved in the phagocytosis of collagen in 
fibroblasts. In GDSC the Endo180 gene was expressed at days 2, 7 and 
day 21, but its expression was absent in HDSC at all time points (Fig. 
4.1A). In GDSC, immunohistochemistry revealed that although MT1-
Figure 4.1 (on next page) Gene transcript and/or protein expression analysis of IFN-γ, MT1-MMP and 
Endo180 in HDSC and GDSC scaffolds during the foreign body reaction in mice. Gene transcript was 
performed for IFN-γ and Endo180 in both collagen scaffolds at all time points (A). Protein expression 
analysis of MT1-MMP and Endo180 in HDSC and GDSC scaffolds at day 14 (B1-B4, D1-D4) and day 21(C1-
C4, E1-E4): MT1-MMP protein (FITC, green) was expressed in both biomaterials (B2, C2, D2, E2). In contrast, 
the expression of Endo180 (Cy3, red) was mainly observed in GDSC at day 21 (C3) and low at day 14 (B3). 
In HDSC, Endo180 expression was not observed D3, E3). Cell nuclei were stained with DAPI (blue). Scale 
bar = 20 μm. Quantification of MT1-MMP and Endo180 expression in GDSC and HDSC using TissueFaxs® 
2.2 (F-I): Scattergrams (n=3) show the percentages of cells that co-expressed MT1-MMP and Endo180 
proteins in GDSC (F,G) and HDSC (H,I) at day 14 and day 21, respectively.




MMP was expressed throughout the whole course of the FBR (Fig. 4.1, 
B2 and C2), but the expression of Endo180 was mainly observed at day 2 
(data not shown) and day 21 (Fig. 4.1, C3). As phagocytosis of collagen by 
macrophages was observed only at day 2 and day 21, it seems likely that 
co-expression of Endo180 with MT1- MMP is needed to phagocytose 
collagen. Double immunofluorescence staining revealed that Endo180 
and MT1-MMP co-localized on the cells (Fig. 4.1, B4 and C4); this was 
further substantiated by TissueFaxs (Fig. 4.1, F and G). In HDSC, MT1-
MMP was expressed at all time points (Fig. 1, D3 and E3), yet Endo180 
protein was never expressed throughout the whole course of the foreign 
body reaction (Fig. 4.1, D3, E3, H and I). As in HDSC no phagocytosis 
of collagen is seen, the HDSC data provide additional evidence that 
expression of Endo180 seems to be a prerequisite for the phagocytosis of 
collagen by macrophages.
Double immunofluorescence staining of GDSC at day 21 (Fig. 4.2, A1-
D1) revealed that Endo180 was exclusively expressed on macrophages, as 
all Endo180 positive cells are positive for F4/80, a monoclonal antibody 
that specifically recognizes mouse macrophages (Austyn and Gordon, 
1981). This shows that the phagocytic activity seen in GDSC should be 
attributed to the macrophages, and not to e.g. fibroblasts. Interestingly, 
over 90% of the detected macrophages present in the scaffold showed 
a co-staining with Endo180 (Fig. 4.2, A2 to D2). At day 2, also high 
numbers of Endo180+F4/80+ cells are seen, but at this time point also 
many macrophages are seen that do not show Endo180 expression (data 
not shown), indicating the presence of various macrophage populations.
Figure 4.2 (on next page) Endo180 (Cy3, red) is expressed (day 21) on cells that are positive for the 
macrophage marker F4/80 (FITC, green) (A1-D1). Quantification of Endo180 and F4/80 expression on day 
21 using TissueFaxs® (A2-D2): the scattergrams show that the percentage of F4/80 positive cells that co-
expressed Endo180 is >90%. Scale bar = 50 μm. In figure E macrophages are shown (marked with m) 
that phagocytose the biomaterial (marked with b). Scale bar = 15 μm. Representative micrographs of 
the negative controls for immunostaining of Endo180 (1:100 normal goat serum + rabbit anti-goat Cy3), 
MT1-MMP (1:200 normal rabbit serum + swine anti-rabbit FITC) and F4/ 80 (1:100 normal rat serum + goat 
anti-rat FITC) are shown in figures F, G, H, respectively. Scale bar = 50 μm.




IFN-γ induces the expression of Endo180 but not 
MT1-MMP in RAW 264.7 cells cultured without 
collagen coating
The microenvironment of GDSC and HDSC disks is governed by the 
cytokines that are present. At present, the regulation of Endo180 by 
cytokines has not been investigated. In GDSC disks a high expression 
of IFN-γ was seen at day 2 and 21 with lower levels at other time points, 
while in HDSC disks low levels of IFN-γ is seen during the FBR (Fig. 
4.1A). As the high expression of IFN- γ at day 2 and 21 coincides with the 
expression as observed for Endo180 (Fig. 4.1A and C3), we surmised that 
IFN-γ induces the expression of Endo180. This was tested in vitro with 
the murine macrophage cell line RAW 264.7. Endo180 expression was 
tested in RAW 264.7 cells stimulated for 48 hours with a concentration 
series of IFN- γ. Expression of Endo180 was induced with 1 ng/ml IFN- 
γ, showed maximum levels at 2.5 and 5 ng/ml and, decreased at 10 ng/ml, 
and was near absent at 25 ng/ml (Fig. 4.2, B2-E2 and F). IFN-γ stimulation 
did not induce the expression of MT1-MMP in the absence of collagen 
coating (Fig. 4.3, B1-E1 and F). The expression of Endo180 after IFN-γ 
stimulation in macrophages was confirmed by RT-PCR (Fig. 4.3A).
Figure 4.3 (on next page) IFN-γ induces the expression of Endo180 but not MT1-MMP in RAW 264.7 
macrophages cultured without collagen coating as determined by gene transcript and protein expression 
analyses. Cells were treated with 0-1-2.5- 5-10-25 ng/ml of IFN-γ for 48 h. After that, cells on 6-well cell 
culture plates and 6-well diagnostic slides were used for RT-PCR and immunofluorescent staining, 
respectively. mRNA levels of Endo180 was induced with 1 ng/ml IFN-γ, showed maximum levels at 2.5 
and 5 ng/ml, and decreased dramatically at 10 ng/ml (A). In consistent with the gene expression, protein 
expression of Endo180 (red) also exhibited a bell-shape response to the different concentrations of IFN-γ 
(B2-E2 and F). Protein expression of MT1-MMP (green) was not observed (B1-E1 and F). Cell nuclei were 
stained with DAPI (blue). Values are depicted as mean ± S.D. (n=5). n.s.= P>0.05 (no significant difference); 
* = P<0.05 ; ** =P<0.01. Scale bar = 50 μm..





IFN-γ induces the expression of Endo180 and MT1-
MMP in RAW 264.7 cells cultured on collagen 
type I
The responses of cells depend on the extracellular matrix proteins that are 
contacted. Therefore, we repeated the experiments with RAW 264.7 cells 
cultured on collagen, because collagen is the substrate that macrophages 
encounter when they invade the collagen disks in vivo. Expression of 
Endo180 was high with 1 and 2.5 ng/ml, but the expression of Endo180 
decreased at higher levels of IFN-γ (5, 10 and 25 ng/ml) (Fig. 4.4, B2-
E2 and F). Thus as with the non-coated substrate, Endo180 is firstly 
upregulated and then down-regulated, although the sensitivity differed. 
However, a remarkable difference was seen with regard to the expression 
of MT1-MMP: on collagen, the expression pattern of MT1-MMP was 
comparable to the expression of Endo180 (Fig. 4.4, B1-E1 and F). Double 
immunofluorescence staining showed that the Endo180- expressing cells 
co-expressed MT1-MMP (Fig. 4.4, C3-E3). The expression of Endo180 
under IFN-γ stimulation in macrophages with collagen coating was 
confirmed by RTPCR (Fig. 4.4A).
Figure 4.4 (on next page) IFN-γ induces the expression of Endo180 and MT1-MMP in RAW 264.7 
cultured with collagen coating as determined by gene transcript and protein expression analyses. Cells 
were treated with 0-1-2.5-5-10-25 ng/ml of IFN-γ for 48 h, with the presence of collagen. Thereafter, cells 
on 6-well cell culture plates and 6-well diagnostic slides were used for RT-PCR and immunofluorescent 
staining, respectively. mRNA levels of Endo180 was induced with 1 ng/ml IFN-γ, showed maximum levels 
at 2.5, and decreased dramatically at 5 ng/ml or above (A). In consistent with the gene expression, the 
protein expression of Endo180 (red) also exhibited a bell-shape response to the different concentrations 
of IFN-γ (B2-E2 and F). Interestingly, the expression pattern of MT1-MMP (green) was comparable to 
the expression of Endo180 (B1-E1 and F). The Endo180 and MT1-MMP were co-localized (C3, D3). Cell 
nuclei were stained with DAPI (blue). Values are depicted as mean ± S.D. (n=5). * = P<0.05; ** =P<0.01 
(comparison within group); # = P<0.05 (Endo180 versus MT1-MMP). Scale bar = 50 μm.




Figure 4.5. TNF-α and IL-1β do not induce the expression of Endo180 and MT1-MMP in RAW 264.7 
cultured with collagen coating as determined by protein expression analyses with immunofluorescent 
staining. Neither Endo180 (red) or MT1-MMP (green) was detected on protein level, as shown in the 
merged picture of double staining of Endo180 and MT1-MMP (A-H). Cell nuclei were stained with DAPI 
(blue). Scale bar = 50μm
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IFN-γ induces the expression of Endo180 and MT1-
MMP in RAW 264.7 cells cultured on collagen 
type I
The responses of cells depend on the extracellular matrix proteins that are 
contacted. Therefore, we repeated the experiments with RAW 264.7 cells 
cultured on collagen, because collagen is the substrate that macrophages 
encounter when they invade the collagen disks in vivo. Expression of 
Endo180 was high with 1 and 2.5 ng/ml, but the expression of Endo180 
decreased at higher levels of IFN-γ (5, 10 and 25 ng/ml) (Fig. 4.4, B2-
E2 and F). Thus as with the non-coated substrate, Endo180 is firstly 
upregulated and then down-regulated, although the sensitivity differed. 
However, a remarkable difference was seen with regard to the expression 
of MT1-MMP: on collagen, the expression pattern of MT1-MMP was 
comparable to the expression of Endo180 (Fig. 4.4, B1-E1 and F). Double 
immunofluorescence staining showed that the Endo180- expressing cells 
co-expressed MT1-MMP (Fig. 4.4, C3-E3). The expression of Endo180 
under IFN-γ stimulation in macrophages with collagen coating was 
confirmed by RTPCR (Fig. 4.4A).
The expression of Endo180 and/or MT1-MMP 
induced by IFN-γ is blocked by IL-10
To determine whether the expression of Endo180 induced by IFN-γ can 
be affected by the anti-inflammatory cytokine IL-10, we stimulated RAW 
264.7 cells with a concentration series of IL-10, in the presence of 2.5 
ng/ml IFN-γ. Our data showed that, regardless with collagen coating 
or not, the expression of IFN-γ induced Endo180 was 50% blocked by 
the exposure of the cells to 1 ng/ml IL-10, and was totally blocked at 
concentrations of 25 ng/ml IL-10 and above (Fig. 4.6, B-I, J and K). The 
expression of MT1- MMP was also blocked by IL-10 in accordance with 
Endo180 in RAW 264.7 cultured on collagen type I (Fig. 4.6, F-I and 
K). The inhibition of IFN-γ induced Endo180 expression by IL-10 was 
further confirmed at mRNA levels by RT-PCR (Fig. 4.6A). 
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Figure 4.6 (above and next page) IL-10 inhibits the expression of Endo180 and/or MT1-MMP induced 
by IFN-γ in RAW 264.7 cultured with/without collagen coating as determined by gene transcript and 
protein expression analyses. Cells were treated with 0-1- 10-25-50 ng/ml of IL-10, with the presence of 
2.5 ng/ml IFN-γ, for 48 h. Next, cells on 6-well cell culture plates and 6-well diagnostic slides were used 
for RTPCR and immunofluorescent staining, respectively. Regardless with collagen coating or not, the 
mRNA levels of Endo180 induced IFN-γ was decreased rapidly at 1 ng/ml IL-10 and almost absent at 10 
ng/ml or above (A). The protein expression was consistent with the gene expression: expression of IFN-γ 
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induced Endo180 was 50% blocked by the exposure of the cells to 1 ng/ml IL-10, and was totally blocked 
at concentrations of 25 ng/ml IL-10, as shown in the merged picture of double staining of Endo180 and 
MT1-MMP (B-I) and quantification of the positive cells without collagen coating (J) or with collagen 
coating (K). Cell nuclei were stained with DAPI (blue). Values are depicted as mean ± S.D. (n=5). * = 




In the current study, we investigate the molecular mechanisms of collagen phagocytosis by macrophages in the foreign body reaction. We show for the first time that the interplay between 
Endo180 and MT1-MMP correlated with collagen phagocytosis by 
macrophages, thus providing evidence that the mechanism of collagen 
phagocytosis operating in the FBR by macrophages is comparable with 
the mechanism of intracellular collagen degradation by fibroblasts seen 
under physiological conditions. Furthermore, our data showed that the 
expression of Endo180 and MT1-MMP is regulated by IFN-γ with the 
presence of collagen scaffolds.
We have previously shown that subcutaneously implanted 
glutaraldehyde or hexamethylenediisocyanate cross-linked dermal 
sheep collagen disks (GDSC and HDSC) in mice show a high and low 
degradation rate, respectively (Ye et al., submitted). GDSC provoked 
the attraction of PMNs at day 2 and 21 after implantation. At both time 
points, increased levels of IFN-γ were seen, as well as phagocytic activity 
against the GDSC disks (Ye et al., submitted). Although phagocytosis of 
collagen by macrophages has been repeatedly mentioned, no such reports 
are available for the foreign body reaction, and surprisingly little is known 
about the molecular mechanism that is involved in this phagocytosis. A 
main finding of our current study is that the endocytic transmembrane 
glycoprotein Endo180, a receptor that is able to bind to collagen and that 
is essential for cellular uptake of collagen, is highly expressed at day 2 and 
21 in GDSC. In addition, we here show that MT1-MMP, a membrane-
bound matrix metalloproteinase that is able to cleave collagen fibrils, is 
also highly expressed at day 2 and 21. Furthermore, we also show that the 
Endo180 receptor is localized on cells that stain positive for F4/80, i.e. the 
cells in question are macrophages.
Fibroblasts that lack Endo180 fail to internalize collagen; the same is 
observed with fibroblasts that have normal Endo180 levels but lack MT1-
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MMP (Engelholm et al., 2003a; Madsen et al., 2007). This shows that the 
intracellular uptake of collagen by Endo180 depends on the liberation 
of collagen from the ECM by limited extracellular proteolysis, i.e. the 
cleavage of collagen fibrils located near the cell membrane by MT1-
MMP. It is likely that this mechanism is also involved in the phagocytic 
degradation of GDSC disks by macrophages. In this respect it is of interest 
that macrophages in the HDSC disks only show expression of MT1-MMP 
but not of Endo180, the latter being the reason why phagocytosis is not 
observed in HDSC.
A limitation of our study is, that we have not provided direct evidence 
that the Endo180+MT1-MMP+F4/80+ cells indeed phagocytosed 
collagen, as we have not shown ingested collagen in the cells themselves 
by means of electron microscopy, or carried out any functional or 
knock-down studies. In addition, we cannot exclude the possibility 
that in addition to Endo180 other receptors are involved in the uptake 
of collagen, such as macrophage scavenger receptors (Greaves and 
Gordon, 2009). However, giant foreign body cells (that are formed as 
a result of macrophage fusion) do show pieces of collagen biomaterials 
intracellularly (Khouw et al., 2000), and collagen has so far not been 
reported as a ligand for scavenger receptors. It is therefore likely, that 
the reported correlations in this study are indicative of a mechanistic 
relationship between macrophage activation by IFN-γ and collagen 
degradation and that involved mechanisms are comparable to those of 
fibroblast-mediated collagen degradation under physiological conditions.
Mechanisms on how the expression of Endo180 is regulated 
are not known. Another main finding of this study is that the pro-
inflammatory cytokine IFN-γ stimulates the expression of Endo180 in 
murine macrophages (RAW 264.7 cells), providing an explanation why 
phagocytosis is seen only at day 2 and 21: only at these time points a 
high expression of IFN-γ is seen in GDSC disks. Interestingly, IFN-γ 
also induced the expression of MT1- MMP in RAW 264.7 cells, but 
only when the cells were plated on a collagen coating. This shows the 
importance of choosing the correct substrate when studying the response 
of macrophages towards cytokines.
Interestingly, we have found in the current study that the anti-
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inflammatory cytokine IL-10 is able to counteract the expression of 
Endo180 as induced by IFN-γ. The microenvironment between the GDSC 
and HDSC disks differs with respect to IL-10 levels: a higher level of IL- 
10 is seen in HDSC disks compared to GDSC disks (Ye et al., submitted). 
The presence of lower levels of IFN-γ in HDSC disks in combination 
with higher levels of IL-10 provides an explanation why phagocytosis of 
collagen by macrophages did not occur within HDSC disks.
In summary, we conclude that MT1-MMP and Endo180 seem to be 
involved in the phagocytic processing of collagenous biomaterials by 
macrophages through the ability of macrophages to cleave collagen fibrils 
near the cell membrane by MT1-MMP followed by the lysosomal delivery 
of cleaved collagen aggregates via binding to Endo180. In addition, 
the expression of Endo180 and MT1-MMP is induced by IFN-γ in the 
presence of collagen. Based on these results, regulation of phagocytosis 
of collagen by macrophage may be feasible through modulation of the 
expression level of IFN-γ, or through the addition of anti-inflammatory 
factors that counteract with IFN-γ, e.g. IL-10.
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Despite the use of collagen-derived scaffolds in regenerative medicine, little is known about the degradation mechanisms of these scaffolds in vivo. Non-crosslinked dermal sheep (NDSC) 
and gelatin disks were implanted subcutaneously in mice. NDSC disks 
showed a very low degradation rate, despite the presence of high numbers 
of macrophages and the influx of neutrophils. This was attributed to the 
presence of the matrix metalloproteinase inhibitor TIMP-1. The limited 
degradation occurred mainly in the later stages of the foreign body 
reaction, and could be attributed to (1) phagocytosis by macrophages due 
to a co-expression of Endo180 and MT1-MMP on these cells (intracellular 
degradation) and (2) the presence of MMP-13 due to an upregulation 
of the expression of the DDR-2 receptor (extracellular degradation). In 
contrast, gelatin disks degraded quickly, due to the efficient formation 
of large giant cells as well as the presence of MMP-13; the inhibitor 
TIMP-1 was absent. The DDR-2 receptor was not expressed in the gelatin 
disks. Endo180 and MT1-MMP were expressed, but at most times no 
co-expression was seen. We conclude that the physical state of collagen 
(native or denatured) had a dramatic outcome on the degradation rate 
and provoked a completely different foreign body reaction.
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1. Introduction
Collagen is the most abundant protein in the mammalian body [1]. Especially connective tissues, like skin, bone, cartilage, tendons, and ligaments, are rich in collagen and other extracellular matrix 
molecules. Proper tissue homeostasis requires dynamic reciprocal 
interactions between cells and their environment, which often is the 
extracellular matrix in connective tissues. Connective tissues such as 
cartilage or bone have been the target for many regenerative therapies 
due to their relatively low complexity, low cellularity, and potential 
for regeneration or repair. In regenerative therapies including tissue 
engineering, biomaterial scaffolds are used, e.g. seeded with cells to 
augment tissue repair and functional restoration [2]. The performance 
of the seeded cells depends, among others, on the bio-inductive signals 
of the scaffold. Biomaterial scaffolds can be of a synthetic nature, or 
derived from natural biopolymers, such as collagen. The supposition of 
collagen scaffolds is, that seeded cells will function properly, due the close 
resemblance between scaffold and the natural cellular environment. [3] 
[4].
Like any other biomaterial, implanted collagen scaffolds induce series 
of damage-inflicted processes that include wound healing, inflammation 
and more specifically the biomaterial-directed by a foreign body reaction 
(FBR) [5] and [6]. Together these processes, which show a strong 
spatiotemporal overlap, comprise the tissue response towards implanted 
biomaterials. Macrophages play a pivotal role in the tissue response. These 
macrophages interrogate the biomaterial surface, and release proteolytic 
enzymes and may phagocytose the biomaterial too. Under certain 
circumstances, the macrophages may fuse, to form multinucleated foreign 
body giant cells [7], [8] and [9]. Collagen-based biomaterials can be 
cross-linked to enhance the stiffness and to dampen the rate of biological 
degradation. Alternatively, both non-crosslinked (native) collagen as well 
as denatured collagen, i.e. gelatin have been studied as such [10]. It is the 
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specific application that determines the choice of the biomaterial. Any 
treatment modality must take the tissue response towards biomaterials 
into account. In particular the degradation mechanism of implanted 
collagen scaffolds is important to understand, e.g. to provide cues to tune 
scaffolds to their intended application [11].
In previous studies we have shown that collagen disks treated with 
different crosslinking agents show marked differences in degradation rate 
and that the degradation rate depends on the implantation site as well 
as on the animal species [11], [12], [13], [14], [15] and [16]. Although 
several matrix metalloproteinases participate in the degradation of 
collagen scaffolds [11], the role of specific collagen receptors in this 
process has hardly been studied. With respect to the FBR, the collagen-
binding integrins α1β1, α2β1, α10β1 and α11β1, have been well-studied. 
Yet, on other important collagen receptors members, like the discoidin 
domain receptors DDR-1 and DDR-2, and the mannose receptor family 
including Endo180 little knowledge exist for the FBR [17]. Two other 
collagen receptors, lipoprotein VI and LAIR-1, are involved in platelet 
adhesion/activation and immune cell regulation, respectively [17], and 
are therefore outside the scope of this paper.
We have recently shown, that implanted glutaraldehyde cross-linked 
collagen attracts neutrophils. These neutrophils express IFN-γ, which 
induces the expression of both Endo180 and MT1-MMP on macrophages 
that are present in the implanted collagen too [15]. The co-expression of 
Endo180 and MT1-MMP is responsible for the phagocytosis of collagen 
by fibroblasts [18] and [19]. Similarly, in our previous study, we have 
provided evidence that on FBR macrophages the co-expression of Endo180 
and MT1-MMP coincides with the phagocytosis and degradation of 
implanted cross-linked collagen scaffolds [15]. As it appears from our 
previous findings the molecular nature of collagen scaffolds, i.e. chemical 
crosslinking, determines the type of degradation. Among the collagens, 
MMP-13, proved important in the FBR [11]. Interestingly, the collagen 
receptor DDR-2 is known to induce the expression of MMP-13 [20], [21], 
[22] and [23]. Thus we surmise that, together with the Endo180 – MT1-
MMP axis, DDR-2 is important in the FBR too.
The aim of this study is to investigate the role of the collagen receptors 
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Endo180 and DDR-2 in the degradation of non-crosslinked types of 
collagen, namely native as well as denatured collagen (i.e. gelatin).
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2. Materials and methods
2.1. Biomaterials
Non-crosslinked dermal sheep collagen (NDSC) sheet, processed from sheep skin [28], was obtained from the Zooid Nederland’s Zeemlederfabriek (Oosterhout, The Netherlands). Commercially 
available non-crosslinked gelatin sponges Willospon (Will-Pharma, 
Benelux) were kindly provided by the Department of Oral Surgery of the 
University Medical Center Groningen. Disks (6 mm in diameter, 0.75 
mm in thickness) were punched from pieces of NDSC and gelatin from 
the same batch, and sterilized with ethylene oxide. Surface-associated 
endotoxin levels were below 0.25 EU/ml, as determined by the LAL-
method (Cambrex, LAL kinetic-QCL®).
2.2. Animals and operating procedures
All procedures performed on animals were approved by the local 
committee for care and use of laboratory animals of the University 
of Groningen and were performed according to international and 
governmental guidelines on animal experimentation. The operation 
procedures were carried out on male C57BL/6 mice (10 weeks old, 
Harlan, Horst, the Netherlands) according to the protocol as described 
before [11], [13], [14], [15] and [16]. The disks were removed at the 
following time points after implantation (related to the different phases 
of the FBR in mice): 2 days (onset), 7 days (early progression), 14 and 21 
days (intermediate progression), and 28 days (late progression), n = 6 per 
time point. The disks were snap-frozen in liquid nitrogen immediately 
after explantation.
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2.3. Histological techniques
Tissue sections (2 μm in thickness) of T 7100 (Heraeus Kulzer, Wehrheim, 
Germany) embedded explants were stained with toluidine blue (Fluka 
Chemie, Buchs, Switzerland) and mounted in Permount (Fisher, New 
Jersey, USA). The degradation of the scaffold was determined by image 
analysis as the percentage of the size of remained disk as compared with 
the original size (before implantation). The cellular ingrowths inside the 
disk was evaluated by image analysis as percentage of the entire cross-
sectional area. The number of giant cells per square millimeter inside 
implant was counted as described in our previous study [13].
2.4. Gene expression analysis
Total RNA was extracted from snap-frozen explants as described 
previously [14]. One microgram of total RNA was used to generate the 
first strand cDNA synthesis using M-MuLV reverse transcriptase (MBI 
Fermentas, St. Leon-Rot, Germany) and random hexamer primers, 
following the instruction of the manufacturer’s protocol. Ten nanogram 
of a cDNA mixture from 4 to 5 mice was pooled per time point for each 
reaction. The PCR reaction of 35 cycles was performed using primers 
specific collagenases (MMP-8, MMP-13), gelatinases (MMP-2, MMP-
Table 5.1 PCR primers of MMPs,TIMP-1 and the control gene.
Mediators Forward Reverse Anneal
TIMP-1 CTGTGCCCCACCCCACCCAC AAGGCTTCAGGTCATCGGGC 56 ° c
MMP-2 GGCCATGGCATGGGGCTGGA CCAGTCTGATTTGATGCTTC 60 ° c
MMP-8 CAAGCAATCAATTCCGGTCT ATTCCATTGGGTCCATCAAA 60 ° c
MMP-9 TGACGAGGTTGGGAAATGGT CCGCCCCCTGATAGAGTCTT 60 ° c
MMP-13 AGGCCTTCAGAAAAGCCTTC GAAATGGCTTTTGCCAGTGT 56 ° c
β-actin GTGAAAAGATGACCCAGATCAT GCTTCTCTTTGATGTCACGCACGAT 60 ° c
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9), the tissue inhibitor of MMP (TIMP-1), as well as the reference gene 
β-actin (Table 5.1). Amplimers were separated in 2% agarose gels.
2.5. Immunohistochemistry
To determine the inflammatory cell infiltration during the time 
course, tissue expression was verified by means of in situ staining using 
immunohistochemistry (IHC) on explants of two materials at all time 
points. Tissue sections (5 μm) were mounted on silane-coated slides. 
Cryosections were fixed with 2% paraformaldehyde in PBS at room 
temperature (RT) for 30 min, followed by rehydration (1x PBS, 10 
min), and subsequent incubation with 0.5% Triton X-100 in PBS (10 
min). Sections were stained for neutrophils (monoclonal rat anti-mouse 
neutrophils, Serotec Ltd. Oxford, UK), macrophages (rat anti-mouse 
F4/80, Serotec Ltd. Oxford, UK) and lymphocytes (polyclonal hamster 
anti-mouse CD3ε, BD Pharmingen, USA), as described previously by 
our lab [12].
2.6. In situ zymography
To determine the collagenolytic activity during the foreign body reaction 
against NDSC and gelatin, an in situ zymographic technique was employed 
as described previously [16]. Briefly, cryosections (5 μm, n = 3 per time 
point) on glass slides were covered with DQ™ collagen type I from bovine 
skin conjugated to fluorescein (Invitrogen, Breda, The Netherlands) as a 
substrate. The substrate had a final concentration of 100 μg/ml in 50 mM 
Tris–HCl (pH 7.4), containing 16 mm CaCl2, 0.05% Brij 35 and 5 mm 
PMSF. After incubation (2 h in a dark, humidified chamber at 37 °C), 
unbound substrate was removed by washing in distilled water, followed 
by incubation with 1% Triton X-100 for 10 min. Next, the slides were 
incubated with 4′,6-diamidino-2-phenylindole (DAPI) to stain cell nuclei, 
and mounted in Citifluor. As a negative control the substrate was omitted 
to determine the autofluorescence of the sections. Other control slides 
were pre-incubated with the general MMP inhibitor 10-phenanthroline 
monohydrate at a concentration of 20 μg/ml in 50 mm Tris–HCl (pH 
7.4).
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2.7. Immunofluorescence microscopy
Expression of Endo180 and MT1-MMP was verified by means of in situ 
immunofluorescent double staining on explants of two materials at all 
time points. Goat anti-mouse Endo180 antibody (1:100, Santa Cruz 
Biotechnology, Santa Cruz, USA) in combination with rabbit anti-goat 
Cy3 (1:100, Zymed Laboratories Inc., San Francisco, USA), and rabbit 
anti-mouse MT1-MMP antibody (1:200, Epiomics Inc., CA, USA) in 
combination with swine anti-rabbit FITC (1:100, Dako, Carpinteria, 
USA) are applied for the double staining, as we described previously [15].
A similar double staining procedure was performed to unravel the 
expression patterns of the DDR-2 and MMP-13 in the FBR. Tissue sections 
(5 μm) were mounted on silane-coated slides. Cryosections (5 μm) were 
mounted on silane-coated slides, fixed with 2% paraformaldehyde in PBS 
at room temperature (RT) for 10 min, then washed in 0.1% Triton X-100 
in PBS (5 min) for 3 times. The sections were incubated with a rabbit 
anti-mouse DDR-2 antibody (1:150, Santa Cruz Biotechnology, Santa 
Cruz, USA) and a sheep anti-mouse MMP-13 antibody (1:50, Abcam, 
Cambridge, UK) for 2.5 h. Next, the secondary antibodies for DDR-2 and 
MMP-13, respectively swine anti-rabbit TRITC (1:100, Dako, Carpinteria, 
USA) and donkey anti-sheep FITC (1:200, Molecular Probes Inc., CA, 
USA) in PBS with DAPI (1:5000) were added and incubated for 30 min. 
Sections were washed in 0.1% Triton X-100 in PBS (5 min) for 4 times 
to remove nonbound secondary antibodies (FITC and TRITC). Finally, 
samples were mounted with Citifluor followed by examination under the 
immunofluorescence microscope.
For the negative controls, samples were stained as described above, 
except that the primary antibodies were replaced with the same dilution 
of serum from the same species as used for the specific first antibodies, 
namely, normal goat serum (1:100, Sanquin Pharmaceutical Services, 
Amsterdam, Netherlands), normal rabbit serum (1:200, Dako, Carpinteria, 
USA), normal rabbit serum (1:150, Dako, Carpinteria, USA) and normal 
sheep serum (1:50, Jackson ImmunoResearch Laboratories, Inc, PA, 
USA) for Endo180, MT1-MMP, DDR-2 and MMP-13, respectively.
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2.8. Quantification of Endo180, MT1-MMP, DDR-2 
and MMP-13 immunostaining
To further quantify the number of cells with Endo180, MT1-MMP, 
DDR-2 and MMP-13 immunostaining, three representative images 
(magnification: 40×) of each tissue section were analyzed with 
TissueFaxs®, Zeiss AxioImager Z1 Microscope System (Tissue-Gnostics 
GmbH, Vienna, Austria). Single cells were identified by their nuclei 
(DAPI staining). This identification mask was then applied to determine 
gray values in the two corresponding channels FITC (MT1-MMP or 
MMP-13) and Cy3/TRITC (Endo180 or DDR-2, referred as Cy3 in the 
scattergrams) of each object in all images. The percentage of MT1-MMP, 
Endo180, DDR-2 and MMP-13 positive cells was determined and depicted 
as scattergrams. Each scattergram represents average values calculated 
from analysis of all three images of one entire tissue section. It should be 
noted that the limitation of this technique is, that FBR giant cells are not 
recognized as such. Instead giant cells are interpreted as single cells in a 
number that corresponds to the number of their nuclei. Yet, this has little 
effect on the mean fluorescence intensity per cell, because the surface 
area of giant cells seems to correspond to the sum of the surface areas to 
the number of fused macrophages that constitute the giant cell.
2.9. Statistical analyses
All quantitative data are presented as mean ± SD. The data were analyzed 
using statistical software (GraphPad Prism, GraphPad Software Inc.). 
Differences were analyzed by two-way ANOVA followed by Tukey’s post 
hoc test or Student’s t-test, as appropriate. A difference of p < 0.05 was 
considered statistically significant.
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3. Results
3.1. Influx of macrophages and neutrophils and 
the presence of giant cells
In NDSC, a small number of macrophages was found at day 7, whereas the number of macrophages was about 7-fold higher at day 14, 21 and 28 compared to day 7 (Fig. 5.1A). No giant cells were seen at day 2, 
whereas small numbers of giant cells were seen at day 7, a number that 
increased at day 14 and 21, and showed a slight decrease at day 28 (Fig. 
5.1B). In gelatin, which had totally disappeared by day 28, a small influx 
of macrophages was seen at day 2, with increasing numbers at day 7 and 
14, and decreased at day 21 (Fig. 5.1A). In gelatin, giant cells appeared at 
day 2, increased at day 7, showed a steep increase at day 14, and decreased 
at day 21 (Fig. 5.1B), which coincided with the virtual disappearance of 
the implant. Remarkably, in gelatin the ratio of macrophages to giant 
cells at day 14 and 21 was around 10:1, whereas in NDSC the ratio was 
45:1 and 20:1, respectively (Fig. 5.1A,B). Thus, in gelatin the fusion of 
macrophages to giant cells had occurred more frequently or was more 
efficient compared to NDSC. Moreover, the giant cells in gelatin showed 
more nuclei than the giant cells in NDSC, in other words, had a by far 
greater surface area (Fig. 5.3E,F).
High numbers of neutrophils were observed in NDSC at day 2, low 
numbers on day 7 and 14, emerged again at day 21 and remained at 
similarly high levels at 28 days. In gelatin, neutrophil infiltration was 
essentially absent (Fig. 5.1C).
3.2. Scaffold degradation
The NDSC disks showed little degradation during the 28 day time course; 
the majority (80%) of the scaffold had remained (Fig. 5.2A,C). Phagocytosis 
of NDSC was mainly observed at days 21 and 28 predominantly by 
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Figure 5.1 Comparison of cellular infiltration between NDSC and gelatin scaffolds in the foreign body 
reaction. (A) Number of macrophages were present in both scaffolds at all time points except day 28, by 
which gelatin was almost completely degraded. Higher numbers of macrophages were present in NDSC 
than Gelatin at days 14 and 28. (B) The giant cells were present from day 7 onwards and the numbers 
were increasing according to the time in NDSC, while in gelatin the first giant cells were formed at day 
2, then the number is increased at day 7 and 14, and decreased at day 21. (C) In NDSC, neutrophils 
were observed at day 2 then rapidly disappeared at days 7 and 14, and emerged again from day 21 and 
day 28, while in gelatin the neutrophils were virtually absent throughout the time course. Values are 
depicted as mean  SD (n : 6 for each group). # : p < 0.05 (compare with the previous time point within 
the same biomaterial);* : p < 0.05 or ** : p < 0.01 (NDSC vs. gelatin).
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Figure 5.2. Comparison of degradation and cellular ingrowths between NDSC and gelatin disks in 
the foreign body reaction. The upper panel shows the fate of NDSC at all time points (A) and the left 
lower panel gelatin (B) at day 1, day 7 and day 14 (staining by means of toluidine blue) Symbols: b : 
collagen bundle, c : fibro-capsule; b : collagen bundle; Scale bar : 50 mm. The lower right panel shows 
the quantification of degradation (C) and cellular ingrowths (D) in NDSC and gelatin during the foreign 
body reaction. Values are depicted as mean  SD (n : 5 for NDSC and n : 3 for gelatin). # : p < 0.05 (compare 
with the previous time point within the same biomaterial); * : p < 0.05 or ** : p < 0.01 (NDSC vs. gelatin).
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Figure 5.3. Phagocytosis in NDSC and gelatin scaffolds during the foreign body reaction. Marked 
phagocytosis was observed in NDSC only at late stage: day 21 (A) and day 28 (C) mainly by macrophages 
and also by giant cells. Phagocytosis was observed in gelatin by giant cells at day 7 (B) and day 14 (D). 
The giant cells in gelatine (F) showed more nuclei and greater surface area than the giant cells in NDSC 
(E). Symbols: m : macrophage; b : collagen bundle; GC : giant cell. Scale bar : 20 mm; the tissue slices are 
stained with toluidine blue.
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macrophages as well as giant cells (Fig. 5.3A,C). Rapid degradation of 
the gelatin disks took place; after 21 days only a tiny fraction of the disk 
was present whereas no material could be traced at day 28 (Fig. 5.2B,C). 
Phagocytosis was observed at days 2, 7 and 14; mainly by multinucleated 
giant cells (Fig. 5.3B,D). In NDSC and gelatin, cellular ingrowths 
increased during the time course. Full (100%) ingrowths of the disk was 
observed at day 14 and 28 for gelatin and NDSC, respectively (Fig. 5.2D).
3.3. Gene expression of MMPs and TIMP-1
Significant differences were observed in the gene expression of the various 
MMPs and TIMP-1 in the tissue response towards NDSC and gelatin 
over time. TIMP-1 expression was observed at all time points in NDSC, 
Figure 5.4. Dissection gene expression of TIMP-1 and MMPs in NDSC and gelatin. (A) In NDSC, TIMP-1 
was expressed at all time points in NDSC, while no TIMP-1 was observed in gelatine. (B) mRNA expression 
show distinct patterns of collagenases (MMP-8,-13) and gelatinases (MMP-2,-9) between NDSC and 
gelatin during the FBR.
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whereas TIMP-1 was never expressed in gelatine (Fig. 5.4A). In NDSC 
both collagenases, MMP-8 and MMP-13, appeared to be constitutively 
expressed throughout the 28 day time period. It should be noted that 
on day 21 their expression appeared absent, yet is explained by the low 
expression of the beta-actin reference gene. MMP-13 showed the highest 
expression on days 14, 21 and 28. The gelatinases MMP-2 and MMP-9, 
were expressed from later time points on, respectively day 14 and day 21 
(Fig. 5.4B). Remarkably, in gelatin of the collagenases only MMP-13 was 
expressed (at days 7 and 14), while of the gelatinases only MMP-9 was 
expressed and only early after implantation (day 2) (Fig. 5.4B).
Figure 5.5 Collagenolytic activity in NDSC and gelatin scaffolds. Intensive collagenolytic activity was seen 
at day 21 in NDSC; much less activity was seen at day 28. In gelatin, high collagenolytic activity was seen 
at day 7, whereas this was essentially absent at day 14. Symbols: b : collagen bundle, c : fibro-capsule; b : 
collagen bundle. Scale bar : 20 mm.
The role of collagen receptors Endo180 and DDR-2
123
3.4. In situ zymography
Intensive collagenolytic activity was seen at day 21 in NDSC; much less 
activity was seen at day 28 (Fig. 5.5) and day 14, it was absent at day 2 and 
7 (data not shown). In gelatin, high collagenolytic activity was seen at day 
7, whereas this was essentially absent at day 2 and 14 (Fig. 5.5).
 
3.5. Immunofluorescence: presence of Endo180, 
DDR-2, MT1-MMP and MMP-13
In NDSC, about 50% of the infiltrated cells expressed Endo180 albeit 
just above the detection limit, at day 2 (Fig. 5.6B1), whereas Endo180 
expression was lost at day 7 and 14 (Fig. 5.6E1). At days 21 and 28 the 
majority of cells expressed Endo180, while at day 28 the expression had 
increased to its maximum (Fig. 5.6H1,K1). In NDSC, MT1-MMP was 
expressed at all time points on the majority of cells, yet only at day 28 
did the expression reach significant levels (Fig. 5.6A1, D1, G1, J1)as was 
observed for Endo180. There was a strong co-localization of Endo180 
with MT1-MMP at days 21 and 28 (Fig. 5.6I1, L1, I2, L2). In NDSC, 
DDR-2 was not expressed at days 2 and 7 (Fig. 5.7B1). By day 14 DDR-2 
was expressed by the majority of infiltrated cells (Fig. 5.7E1), at days 21 
and 28, the DDR-2 expression gradually reaches its maximum level(Fig. 
5.7H1,K1). A similar expression pattern was observed for MMP-13 
(Fig. 5.7A1, D1, G1, J1). The co-expression of MMP-13 and DDR-2 was 
observed at days 14, 21 and 28 (Fig. 5.7F1, I1, L1, F2, I2, L2).
In gelatin, about 73% of the cells expressed Endo180 at day 2 (Fig. 
5.8B1), albeit at low levels. At day 7 all cells expressed Endo180 with a 
small decline at day 14 (Fig. 5.8E1, H1). The expression levels of Endo180 
at day 7 and 14 were comparable and had increased compared to day 2. 
MT1-MMP followed the similar trend (Fig. 5.5.8A1, D1, G1). At day 2, 
Endo180 and MT1-MMP were not co-expressed (Fig. 5.8C1), whereas 
at day 7 Endo180 and MT1-MMP were co-expressed (Fig. 5.8F1, F2). 
This pattern changed at day 14: although Endo180 and MT1-MMP were 
still co-localized in many cells (Fig. 5.8I2), their molecular distribution 
pattern differed (Fig. 5.8I1). It should be noted that, in particular in 
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Figure 5.6 (next page) Protein expression analysis of MT1-MMP and collagen receptor Endo180 in NDSC 
scaffolds at days 2, 14, 21 and 28 (B1-L1): MT1-MMP protein was stained with FITC (green, A1, D1, G1, J1) 
and Endo180 with Cy3 (red, B1, E1, H1, K1). The co-localization of Endo180 and MT1-MMP was shown 
in the merged micrographs (C1, F1, I1, L1). Cell nuclei were stained with DAPI (blue). Scale bar : 20 mm. 
Quantification of MT1-MMP and Endo180 expression in NDSC using TissueFaxs/ 2.2: Scattergrams (n : 3) 
show the percentage of cells that expressed MT1-MMP (A2, D2, G2, J2) or Endo180 (B2, E2, H2, K2), and 
the percentage of cells that co-expressed MT1-MMP and Endo180 (C2, F2, I2, L2) in NDSC at the indicated 
time points.




Figure 5.7 (next page) Protein expression analysis of MMP-13 and collagen receptor DDR-2 in NDSC 
scaffolds at days 2, 14, 21 and 28 (B1-L1): MMP-13 protein was stained with FITC (green, A1, D1, G1, J1) and 
DDR-2 with TRITC (red, B1, E1, H1, K1). The co-localization of DDR-2 and MMP-13 was shown in the merged 
micrographs (C1, F1, I1, L1). Cell nuclei were stained with DAPI (blue). Scale bar : 20 mm. Quantification of 
MMP-13 and DDR-2 expression in NDSC using TissueFaxs/ 2.2: Scattergrams (n : 3) show the percentage 
of cells that expressed MMP-13 (FITC channel, A2, D2, G2, J2) or DDR-2 (Cy 3 channel, B2, E2, H2, K2), and 
the percentage of cells that co-expressed MMP-13 and DDR-2 (C2, F2, I2, L2) in NDSC at the indicated 
time points.
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Figure 5.8 (previous page) Protein expression analysis of MT1-MMP and collagen receptor Endo180 
in gelatin scaffolds at days 2, 7 and 14 (B1-I1): MT1-MMP protein was stained with FITC (green, A1, D1, 
G1) and Endo180 with Cy3 (red, B1, E1, H1). The co-localization of Endo180 and MT1-MMP was shown 
in the merged micrographs (C1, F1, I1). Cell nuclei were stained with DAPI (blue). Scale bar : 20 mm. 
Quantification of MT1-MMP and Endo180 expression in gelatin using TissueFaxs/ 2.2: Scattergrams (n 
: 3) show the percentage of cells that expressed MT1-MMP (A2, D2, G2) or Endo180 (B2, E2, H2), and 
the percentage of cells that co-expressed MT1-MMP and Endo180 (C2, F2, I2) in gelatin scaffolds at the 
indicated time points. Symbols: GC : giant cell.
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Figure 5.9. Protein expression analysis of MMP-13 and collagen receptor DDR-2 in gelatin scaffolds at 
days 2, 7 and 14 (B1-I1): MMP-13 proteinwas stained with FITC (green, A1, D1, G1) and DDR-2 with TRITC 
(red, B1, E1). The co-localization of DDR-2 and MMP-13 was shown in the merged micrographs (C1, F1, 
I1). MMP-13 was seen at day 7 and 14 whereas DDR-2 was absent throughout the time course. Cell nuclei 
were stained with DAPI (blue). Scale bar : 20 mm.
gelatin, the presence of giant cells was prominent (Fig. 5.8G1), as was 
their size which was larger than in NDSC. DDR-2 could not be observed 
(Fig. 5.9B1, E1, H1); MMP-13 was seen at day 7 and 14 (Fig. 5.9D1, G1) 
whereas it was absent at day 2 (Fig. 5.9A1).
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4. Discussion
The aim of our study was to investigate the putative role of collagen receptors in the degradation of native types of collagen during the foreign body reaction. We show that the degradation of denatured 
native collagen (gelatin) relates to the expression of Endo180 but not DDR-
2, while MT1-MMP is involved too. In contrast, intact native collagen 
(NDSC) is degraded by macrophages and giant cells that express both 
collagen receptors and the accessory molecule MT1-MMP as well active 
collagenase MMP-13. The degradation rate of gelatin was far higher than 
NDSC, which correlated with the higher ratio of giant cells compared 
to macrophages in gelatin. Furthermore, the giant cells in gelatin were 
several times larger in gelatin than NDSC, and TIMP-1 expression was 
absent in gelatin whereas it was expressed at all time points in NDSC.
4.1. Gelatin and non-crosslinked native collagen 
(NDSC) disks show different degradation rates
The tissue response towards the gelatin disks and the non-crosslinked, 
native collagen disks differed markedly. with respect to the numbers of 
macrophages, the efficiency of giant cell formation, the size of the giant 
cells, the influx of neutrophils, and the micro-environment (presence of 
TIMP-1), the expression of MMPs, and the expression of the collagen 
receptors Endo180 and DDR-2. Thus, the physical state of the collagen 
itself (denatured or native) has a dramatic impact on the outcome of the 
foreign body reaction. Gelatin disks were almost completely degraded 
within three weeks after subcutaneous implantation in mice, whereas the 
largest part of the native collagen disks (around 80%) was still present after 
28 days. We have previously seen major differences in the degradation 
rate of subcutaneously implanted disks consisting of native collagen that 
was cross-linked either by glutaraldehyde or hexamethylenediisocyanate. 
In the present study we have used non-crosslinked collagen; mainly the 
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physical state (native or denatured) differed. Clearly, the tissue response 
can be modulated by modifying the chemical and/or physical nature of 
collagen. This can be of help in the design of scaffolds that show a tuned 
regulation of degradation.
4.2. Degradation of NDSC disks
Despite the frequent use of collagen-based scaffolds in tissue engineering, 
remarkably little is known about the molecular mechanism that are 
involved in the breakdown of the scaffolds. We have here investigated the 
expression of the major collagenases MMP-8 and MMP-13, the major 
gelatinases MMP-2 and MMP-9, the membrane-bound MT1-MMP 
(also known as MMP-14) and the endogenous MMP inhibitor TIMP-1. 
Despite the presence of MMP-8 and MMP-13 expression at most time 
points, and at certain time points MMP-2, MMP-9 and MT1-MMP as 
well, only limited degradation of the NDSC disks is observed after 28 
days. An explanation for this might be the expression of TIMP-1 at all 
time points. Indeed, in situ zymography (with DQ™ collagen type I form 
bovine skin conjugated to fluorescein as the substrate) was not able to 
detect collagenolytic activity at days 2 and 7, indicating that TIMP-1 was 
able to inhibit at these two days at least MMP-8 and MMP-13, the two 
enzymes that are able to degrade DQ™ collagen. On the other hand, in 
situ zymography detected (weak to strong) collagenolytic activity at day 
14, 21 and 28. On these days, a marked increase is seen in the expression 
of MMP-13. In addition, MT1-MMP was present on these three time 
points. Since TIMP-1 is a very poor inhibitor of MT1-MMP [24] and 
[25], the collagenolytic activity as detected by in situ zymography seems 
to be due to MT1-MMP and/or the raised levels of MMP-13. The limited 
degradation of NDSC disks thus seems to be due to the presence TIMP-1, 
and the relatively late appearance of net collagenolytic activity as detected 
by DQ™ collagen. This collagenolytic activity seems to be derived from 
MMP-13 and/or MT1-MMP.
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4.3. Degradation of gelatin disks
The gelatin disks were quickly degraded: almost the entire disk was 
degraded after 21 days. At first sight this seems surprising, as expression 
of MMP-9 was only detected at day 2 and not on the other days. However, 
there is a high expression of MMP-13 at day 7; this high expression 
coincides with the high collagenolytic activity seen at day 7 with DQ™ 
collagen. MMP-13 is, apart from being a collagenase, also an efficient 
gelatinase [26]. The absence of TIMP-1 expression also provides a good 
micro-environment for enzymes that are able to degrade gelatin to 
carry out their job. Another reason why the gelatin disks have a high 
degradation rate is the presence of large multinucleated foreign body 
giant cells that were actively phagocytosing. These giant cells were of an 
order of magnitude bigger in gelatin and thus better equipped to degrade/
phagocytose the gelatin.
4.4. Possible role of Endo180 and DDR-2 in the 
degradation of the NDSC and gelatin disks
We have recently provided evidence that macrophages are able to express 
under certain circumstances both Endo180 and MT1-MMP, and that 
these cells are involved in the phagocytosis of collagen [15]. In the present 
study we showed a co-expression of Endo180 and MT1-MMP at day 21 
and 28 in NDSC; histological examination showed at these time points 
many phagocytosing mononuclear cells. It is likely that the degradation 
of NDSC, that starts rather late after implantation, is partly due to 
phagocytosis of the collagen by macrophages by means of Endo180/
MT1-MMP in a comparable way as it has been observed for fibroblasts: 
cleavage of the fibrils by MT1-MMP, binding to the Endo180 collagen 
receptor and subsequent internalization [18] and [19].
Another collagen receptor that showed interesting expression dynamics 
in NDSC disks is DDR-2, a receptor that recognizes collagen in its native 
(i.e. triple helical) state [20] and [27]. In chondrocytes and fibroblasts it 
was found that activation of the DDR-2 by native collagen induces the 
expression of MMP-13 [20], [21], [22] and [23]. In NDSC, infiltrating 
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cells started to highly express DDR-2 only late after implantation, Yet, 
DDR-2 expression coincided with gene expression of MMP-13. The 
semi-quantitative gene expression data would even suggest that an 
increased expression of MMP-13 coincides with DDR-2 upregulation. 
Our immunofluorescent staining data further strengthen this finding: in 
the NDSC disks in the areas rich in macrophages MMP-13 and DDR-2 
always co-expressed. It is therefore tempting to speculate, that the MMP-
13 expression is due to the activation of the DDR-2 receptor by the NDSC 
disks. Thus, beside phagocytosis by means of Endo180/MT1-MMP, the 
NDSC disks might also be subjected to extracellular degradation, through 
MMP-13 via the activation of DDR-2.
In the gelatin disks a different situation is seen with respect to 
Endo180 and DDR-2. Endo180 expression was already observed from 
the beginning (day 2), with increased levels at day 7 and 14. The same 
was seen for MT1-MMP. However, MT1-MMP showed a different 
cellular distribution than Endo180 at day 2 and 14, whereas they were co-
expressed at day 7. More research needs to be carried out to understand 
the meaning of this. In addition, DDR-2 expressing cells were not 
observed in the gelatin disks. The expression of MMP-13 at day 7 and 14 
in the gelatin disks cannot therefore have been induced by the activation 
of DDR. This absence of DDR-2 expression was expected, since (1) DDR-
2 only recognizes collagen only in its native form [20] and [27], and (2) 
native collagen induces the expression of DDR-2, not denatured collagen 
[20]. The gelatin disks consist of denatured collagen only.
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5. Conclusion
Degradation of gelatin disks and disks made of non-crosslinked native collagen (NDSC) showed major differences. Gelatin was almost completely degraded at day 21, whereas only about 
20% of NDSC disk was degraded at day 28. The degradation of NDSC 
occurred only late during the tissue response. Essentially nothing is 
known about the role of the collagen receptors Endo180 and DDR-2 in 
the foreign body reaction (FBR). Here we report that the degradation of 
NDSC coincided with the co-expression of Endo180 and MT1-MMP on 
macrophages that most likely led to the phagocytic behaviour of these 
cells towards NDSC. Furthermore, we report the presence of DDR-2 
on macrophages in the FBR. Cells expressing DDR-2 also co-expressed 
MMP-13 (as a consequence of DDR-2 activation), and it is likely that this 
enzyme was involved in the extracellular degradation of NDSC. No DDR-
2 expression was observed in the gelatin disks. Although many Endo180-
positive cells are seen in gelatin, they did not co-express MT1-MMP at 
most time points; the meaning of this needs to be investigated. Gelatin 
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In tissue engineering, both synthetic and natural biomaterials are used as a guidance for cells to produce de novo tissues. All these biomaterials provoke a foreign body reaction (FBR) when implanted in vivo. 
In order to accommodate new tissue formation, scaffolds needs to be 
degraded. With regard to the degradation of collagen scaffolds, all studies 
focussed on the role of matrix metalloproteinases. Yet nothing is known 
on cathepsin K, a strong collagenolytic enzyme, in the involvement of the 
FBR. This study reports for the first time that cathepsin K and TRAP, two 
enzymes that are highly expressed in osteoclasts (cells that are invowlved 
in bone degradation), are present in the FBR towards non-crosslinked 
collagen (NDSC), glutaraldehyde cross-linked collagen (GDSC) and 
hexamethylenediisocyanate cross-linked collagen (HDSC), but not in 
the FBR against gelatin implants. Cathepsin K is not involved in the fast 
degradation of gelatin due to its absence. In GDSC, cathepsin K-positive 
cells are seen at day 14 and 21, which may contribute partially to the rapid 
degradation of glutaraldehyde cross-linked collagen (GDSC) scaffolds. 
Despite the presence of cathepsin K at various time points in both non-
crosslinked collagen (NDSC) and hexamethylenediisocyanate crosslinked 
collagen (HDSC), the NDSC scaffolds are only marginally degraded and 
HDSC scaffolds essentially remain intact during the time period studied 
(4 weeks). In the FBR towards NDSC the main cells showing cathepsin K 
positivity are the multinucleated cells, whereas in the FBR towards GDSC 
the main cells showing cathepsin K positivity are the mononucleated 
cells. The giant cells in the FBR towards gelatin and NDSC show different 
phenotypic properties, as they are cathepsin K negative and cathepsin K 
positive, respectively. So far, hardly any attention has been paid to the role 
of giant cell heterogeneity and cathepsin K in the tissue response towards 
biomaterials. More investigations are needed to gain further insight into 
the role of cathesin K and giant cell heterogeneity in the foreign body 
reaction.
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Introduction
Cathepsin K, first described in 1994/1995 [1-5], is an enzyme that shows a high degrading potential towards collagen and elastin [6]. For example, it is able to cleave native (triple helical) collagen at 
multiple sites [7-9]. Its high presence in osteoclasts suggests a major role 
of cathepsin K in the proteolytic degradation of bone collagen, which 
was confirmed by knock-out studies [10-11] and by the phenotypic 
properties of pycnodysostosis, a hereditary disease caused by mutations 
in the cathepsin K gene [12, 13]. 
Osteoclasts are bone-degrading multinucleated cells derived from 
cells of the myeloid lineage [14]. In chronic inflammatory conditions, 
especially in the granulomatous response to tissue injury caused by 
micro-organisms or other foreign particles, multinucleated cells (also 
known as giant cells) are often seen as well. The same is seen in the foreign 
body reaction towards implanted biomaterials. These multinucleated 
cells are, like osteoclasts, derived from cells from the myeloid lineage, in 
particular macrophages. The fusion process of mononuclear myeloid cells 
into osteoclasts or giant cells shows many similarities [15, 16]. It seems 
therefore likely that cathepsin K, abundantly expressed in osteoclasts, is 
also present in giant cells. Indeed, cathespin K has been reported in giant 
cells from various soft tissue lesions (granulomas) of diverse aetiology 
[17-23], atherosclerotic plaques [24], synovium [25-27], and giant cell 
tumours and carcinomas [19, 28-30]. 
So far, hardly any attention has been given towards cathepsin K in 
the foreign body reaction directed against implanted materials. To our 
knowledge, only three papers mention the presence of cathepsin K-positive 
giant cells in the foreign body reaction, namely towards wear debris 
derived from the gliding surfaces of prostheses used in joint replacements 
[17, 21, 22]. Tissue engineering exploits the use of biomaterials as an 
alternative to artificial tissue substitutes such as prostheses. Numerous 
biomaterials have been developed, based on synthetic polymers and/
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or natural polymers. All of these biomaterials provoke a foreign body 
reaction after implantation. 
Collagenous biomaterials have been introduced for various tissue 
engineering applications. The degradation rate of these biomaterials is 
determined to a large extent by the course of the foreign body reaction. 
Although quite some data are available with respect to the presence of 
matrix metalloproteinases in collagenous scaffolds [45-48], nothing is 
known regarding the presence of cathepsin K. We here investigate the 
relationship between the presence of giant cells and cathepsin K in disks 
based on gelatin or (non)cross-linked collagen as well as two cross-
linked collagen (HDSC, GDSC) that are implanted in mice. In addition, 
we studied the presence of tartrate-resistant acid phosphatase (TRAP), 
an enzyme that has long been used as a histochemical marker for the 
osteoclast.
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Material & Methods
2.1 Animals and biomaterials
Male C57BL/6 mice (10 weeks old, Harlan, Horst, the Netherlands) were housed individually under conventional conditions with food and water ad libitum. 
Non-crosslinked dermal sheep collagen (NDSC), processed 
from sheep skin, was obtained from the Zuid Nederlandse 
Zeemlederfabriek (Oosterhout, the Netherlands). DSC was cross-
linked with either glutaraldehyde (henceforth referred to as GDSC) or 
hexamethylenediisocyanate (henceforth referred to as HDSC), according 
to protocols described previously [47]. Commercially available non-
crosslinked gelatin sponges Willospon (Will-Pharma, Benelux) were 
kindly provided by the Department of Oral Surgery of the University 
Medical Center Groningen. Disks (6 mm in diameter, 0.75  mm in 
thickness) were punched from pieces of HDSC and GDSC from the same 
batch, and sterilized with ethylene oxide. Surface-associated endotoxin 
levels were below 0.25  EU/ml, as determined by the LAL-method 
(Cambrex, LAL kinetic-QCL®). 
2.2 Operating procedures 
All procedures performed on animals were approved by the local 
committee for care and use of laboratory animals of the University 
of Groningen and were performed according to international and 
governmental guidelines on animal experimentation.
Implantation: mice were anesthetized with 4% isoflurane and 
maintained by 2% isoflurane inhalation in combination with a mixture 
of equal volumes of N2O and O2. The back was shaved and desinfected 
with chlorhexidine, two incisions were made and subcutaneous pockets 
were created on both sides. The HDSC or GDSC disks were implanted 
Chapter 6
146
about one centimeter away from the incision site, thus minimizing the 
effect of wound healing on the inflammatory reaction. The incisions were 
closed with 6-0 non-absorbable Prolene sutures. Finally, mice received 
pure oxygen until awakening.
Explantation: the Col-I disks were removed at the following time points 
after implantation (related to the different phases of the FBR in mice): 2 
days (onset), 7 days (early progression), 14 and 21 days (intermediate 
progression), and 28 days (late progression), n=6 per time point. The 
disks were snap-frozen in liquid nitrogen immediately after explantation.
2.3 Histological techniques 
Tissue sections (2 μm in thickness) of T 7100 (Heraeus Kulzer, Wehrheim, 
Germany) embedded explants were stained with toluidine blue (Fluka 
Chemie, Buchs, Switzerland) and mounted in Permount (Fisher, New 
Jersey, USA). Sections were analyzed by light microscopy. The number 
of giant cells per square millimeter inside implant on blinded samples 
was counted independently by two investigators. The degradation of the 
scaffold was determined by image analysis as the percentage of the size of 
remained disk as compared with the original size (before implantation). 
The cellular ingrowth inside the disk was evaluated by image analysis as 
percentage of the entire cross-sectional area, as described in our previous 
study [45]. 
2.4 Immunohistochemistry
To determine the infiltration of macrophages during the time course, 
sections were stained for macrophages (rat anti-mouse F4/80, Serotec 
Ltd. Oxford, UK), as described previously by our lab [46].
2.5 Cathepsin K activity
Cathepsin K activity was measured according to the protocol described 
previously [49]. In brief, cryo-sections (5  μm) from the snap-frozen 
explanted scaffold, cut in the middle of the explant transversally, were 
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immersed in sodium acetate buffer (0.1 M, pH 6, 0.2% Triton), extracted 
overnight in the same buffer at 4 °C, and thereafter centrifuged at 15,000 
rpm for 5 minutes. The supernatant from different samples was retained 
and equalized with respect to protein concentration, incubated with 
Z-Gly-Pro-Arg-4-MNA (1 mg/ml cathepsin K substrate) in 100 mM 
phosphate buffer (pH 6.0; in the presence of dithiothreitol, EDTA, and 
cysteine) for 1 hour, and analyzed using a multilabel counter (Wallac 
1420 Victor2; Perkin Elmer Life Sciences, Turku, Finland). A proteinase 
inhibitor (E-64) was added to the extract in the control groups. For 
the histochemistry, cryo-sections (7 μm, n = 4 per time point) on glass 
slides, prepared according to the standard procedure as previously 
described [49]. Briefly, the sections were incubated for up to 3h at 37°C 
in an aqueous solution of Z-Gly-Pro-Arg-4-MNA (1 mg/ml cathepsin 
K substrate) in 100 mM phosphate buffer (pH 6.0; in the presence of 
dithiothreitol, EDTA, and cysteine) [50]. After that, the sections were 
immediately washed with 10 mM N-ethylmaleimide in 0.1 M phosphate 
buffer (pH 8) to cease the reaction. The insoluble fluorescent (NSA) was 
added to the incubation medium to visualize liberated MNA. Control 
sections were incubated in the presence of substrate and E-64 (inhibitor). 
The insoluble fluorescent (NSA) was observed under a Leica microscope 
with or without epifluorescence and micrographs were made with Kodak 
400 ASA film. Control sections were negative.
Consecutive sections were prepared for the activity of tartrate-
resistant acid phosphatase (TRAP).
2.6 TRAP activity
Cryo-sections (5 μm) from the snap-frozen explanted scaffold, cut in the 
middle of the explant transversally, were immersed in TRAP test buffer 
(50 mM NaAc, pH 4, 0.1% Triton), extracted overnight in the same buffer 
at 4 °C, and thereafter centrifuged at 15,000 rpm for 5 minutes. Extracted 
tissue samples were equalized with respect to protein content, and TRAP 
enzyme activity was assayed in 96-well plates using pNPP as the substrate 
in an incubation medium containing 10 mM pNPP, 0.1 M Na-acetate 
(pH 5.8), 0.15 M KCl, 0.1% (v/v) Triton X-100, 10 mM Na-tartrate, 1 
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mM ascorbic acid, and 0.1 mM FeCl3. The p-nitrophenol liberated after 
1 hour of incubation at 37°C was converted into p-nitrophenylate by the 
addition of 100 μL of 0.3 M NaOH, and the absorbance was read at 405 
nm using a multilabel counter (Wallac 1420 Victor2; Perkin Elmer Life 
Sciences, Turku, Finland). One unit of TRAP activity hydrolyzes 1 μM of 
pNPP per minute at 37°C. This assay proved to be linear both within the 
range of enzyme dilutions used and for the time of incubation (up to 1 
hour). 
For the histochemistry, cryo-sections (7 μm, n = 4 per time point) 
on glass slides, were prepared according to the standard procedure as 
described previously [50].In brief, sample sections were incubated for 
1h at 37°C in ATP substrate (12.6 mg ATP, 20 ml 0.2 M TRIS-maleate, 
1.5 ml 2% lead nitrate and 2.5 ml 0.1 M magnesium nitrate, pH 6) and 
50mM disordium tartrate. Immediately after the incubation, sections 
were washed in 0.05 M acetate buffer (pH 6) with 0.2M sucrose for 2 
times, followed by 0.1% ammonium sulfide to visualize the reaction 
product of TRAP activity. The same procedures were applied for 
the control samples except for the incubation medium which either 
contained no substrate or added with inhibitor (10mM soldium-ortho-
vanadate).  Control sections were negative.
2.7 Statistical analyses
All quantitative data are presented as mean ± SEM. The data were 
analyzed using statistical software (GraphPad Prism, GraphPad Software 
Inc.). Differences within groups were analyzed by two-way ANOVA 
followed by Tukey’s post hoc test. Differences between groups were 
analyzed by one-way ANOVA and Student’s t-test. A difference of p<0.05 
was considered statistically significant. 
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Results
Influx of macrophages and presence of giant 
cells
In gelatin, a small number of macrophages was seen at day 2, with increasing numbers at day 7 and 14, decreasing at day 21 (Figure 6.1A). Giant cells appeared at day 2, increased at day 7, showed a steep 
increase at day 14, and decreased at day 21. In NDSC, a small number of 
macrophages was found at day 7, whereas the number of macrophages 
Figure 6.1. Comparison of the infiltration of macrophages (A) and the formation of giant cells (B)  in 




Figure 6.2. General histology, as well as histochemistry of TRAP and cathepsin K activity in NDSC at day 2, 
day 14 and day 21. A-B: marginal degradation, > 80% of the scaffold was still present; D-E: elevated levels 
of TRAP was observed at days 2, 14 and 21; G1-I1: no active cathepsin K was observed at day 2, whereas 
at day 14 cells were seen containing active cathepsin K. The number of cathepsin K-positive cells was 
considerably increased at day 21. The cathepsin K positive cells were mostly multinucleated cells, based 
on the size of the coloured spots (G2-I2). Scale bar = 20 µm.
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Figure 6.3. General histology, as well as histochemistry of TRAP and cathepsin K activity in gelatin at day 
7 and day 14. A-B: gelatin disks were rapidly degraded during the time course; C-D: no TRAP activity was 
observed; E1-F1: no cathepsin K activity was observed at the related site (E2-F2). Scale bar = 20 µm
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Figure 6.4. General histology, as well as histochemistry of TRAP and cathepsin K activity in HDSC and 
GDSC at day 21. A: HDSC collagen bundles remained intact at day 21; B: 70% of GDSC collagen bundles was 
degraded at day 21; C-D: TRAP activity was observed in both HDSC and GDSC at day 21; E1-F1: cathepsin K 
activities was observed in both HDSC and GDSC (E1-E2) at day 21. Scale bar = 20 µm.
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Figure 6.5. Enlarged picture of cathepsin K activity staining in NDSC at day 2 day 14. No cathepsin 
K activity was observed at day 2; the activity of cathepsin K at day 14 exhibited a dot-like pattern 
alongside the collagen bundles. Symbols: b = collagen bundles; arrows: cathepsin K activity.
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was about 7-fold higher at day 14, 21 and 28 compared to day 7 (Figure 
6.1A). No giant cells were seen at day 2, whereas small numbers of giant 
cells were seen at day 7, a number that increased at day 14 and 21, and 
showed a slight decrease at day 28. 
In HDSC, the number of macrophages was gradually increased during 
the FBR course; whereas in GDSC, the number of macrophages was 
increased steadily and reached its peak at day 21, and then rapidly 
reduced at day 28 (Figure 6.1A). The presence in time and the abundance 
of giant cells did not differ between HDSC and NDSC. Virtually no giant 
cells were observed in GDSC. 
The ratio of macrophages to giant cells at day 14 and 21 in NDSC 
and HDSC was around 40:1 and 20:1, respectively, whereas in gelatin this 
ratio was around 10:1 for both time points. Thus, the formation of giant 
cells out of macrophages was most effective in gelatin, less effective in 
NDSC and HDSC, and incapable in GDSC disks.
Scaffold degradation
Rapid degradation of the gelatin disks took place (Figure 6.3A-B); after 
21 days only a tiny fraction of the disk was present whereas no residual 
material could be traced at day 28. Phagocytosis was observed at days 
2,7 and 14 by multinucleated giant cells [45]. The NDSC disks were still 
present at day 21 (Figure 6.2C); although degradation had been taken 
place, the majority of the scaffold (> 80%) was still present. Phagocytosis 
was observed at days 21 and 28 mainly by mononucleated macrophages 
[45]. 
In HDSC, no phagocytosis was observed and the disks remained intact 
throughout the time course (Figure 6.4A). Phagocytosis of collagen by 
macrophages was observed at days 2 and 21 in GDSC [47], and more 
than 70% of the GDSC disk was degraded at day 21 (Figure 6.4B).
Presence of active cathepsin K
The activity of cathepsin K exhibited a dot-like pattern alongside the 
collagen bundles as showed in Figure 6.5. In gelatin, no cathepsin 
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K-positive cells were seen at day 7 and 14 by means of histochemistry 
(Figure 6.3); this was confirmed by the cathepsin K enzyme activity assay 
(Figure 6.6A). In NDSC, no active cathepsin K was observed at day 2 by 
means of histochemistry, whereas at day 14 cells were seen containing 
active cathepsin K (Figure 6.2 G1,H1). The number of cathepsin 
K-positive cells was even higher at day 21 (Figure 6.2 I1). The data fit with 
that of the cathepsin K enzyme activity assay: background levels at day 7, 
an increased level at day 14, a maximum level at day 21, and decreasing 
again at day 28 (Figure 6.6A). The cathepsin K positive cells were mostly 
-if not all- multinucleated cells, based on the size of the coloured spots 
(Figure 6.2 H1,H2,I1,I2).
In HDSC, low activity levels were seen at day 14, followed by a steep 
increase at day 21, and a subsequent decrease at day 28 (Figure 6.4 E1, 
Figure 6.6A). In GDSC, comparable activity levels were observed at day 
14 and 21; essentially no activity was seen at day 2, 7 and 28 (Figure 6.4 
F1, Figure 6.6A).
Presence of TRAP acitivity
In gelatin, TRAP activity remained at all days at background levels, a 
situation that was also found for cathepsin K (Figure 6.3 C,D, Figure 
6.6B). In NDSC, elevated levels of TRAP was observed at days 2, 7, 14 
and 21 (Figure 6.2 D,E,F, Figure 6.6B); the highest levels were seen at days 
7 and 21 whereas it was absent at day 28 (Figure 6.6B). This is in contrast 
with the situation seen for cathepsin K: the highest level was seen at day 
21, lower levels at day 14 and 28, background levels at day 7. 
In HDSC, high TRAP activity levels were observed at day 14 and 21 
(with a maximum at day 21), low levels at day 7 and 28, and a background 
activity at day 2. This is in contrast with the situation seen for cathepsin 
K: the highest level was seen at day 21, much lower levels at day 14 and 
28, and background levels at day 2 and 7 (Figure 6.4C, Figure 6.6B). In 
GDSC, high TRAP activity levels were found at days 14 and 21 (with 
a maximum at day 21); no activity was observed at days 2, 7 and 28. A 




Figure 6.6: Quantitification of cathepsin K activity and TRAP acitivity. A: Cathepsin K activity in the four 
biomaterials during the time course (n = 3 for each group); B: TRAP activity in the four biomaterials 
during the time course (n = 1 for each group). Values are depicted as mean ± SEM
d2                    d7                   d14               d21              d28    
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Discussion
So far, only matrix metalloproteinases were taken into consideration in the degradation of collagen scaffolds, as well as phagocytosis. This is the first report showing the presence of cathepsin K, a strong 
collagenolytic enzyme, in the foreign body reaction towards collagen/
gelatin implants. However, it is not known if cathepsin K is indeed 
involved in the degradation of these biomaterials. No cathepsin K could 
be detected in the gelatin scaffolds, indicating that the enzyme was not 
involved in the fast degradation of these scaffolds, although cathepsin 
K is known to exhibit gelatinolytic activity [6]. In GDSC, cathepsin 
K-positive cells are seen at day 14 and 21; GDSC scaffolds are quickly 
degraded and it is possible that cathepsin K takes part in this degradation 
process. On the other hand, the NDSC scaffolds are only marginally 
degraded after 4 weeks, despite the presence of cathepsin K at various 
time points. Furthermore, also HDSC scaffolds are hardly degraded after 
4 weeks, although numerous cathepsin K-positive cells are seen at day 14 
and 21.
Although we cannot conclude from our data that cathepsin K is 
in certain circumstances indeed involved in the degradation of the 
collagenous scaffolds, our study obtained some interesting observations.
Firstly, despite comparable numbers of giant cells in the gelatin and 
NDSC scaffolds at day 14, only the giant cells in the NDSC showed 
cathepsin K activity. It thus seems that the giant cells in the NDSC 
scaffolds show a different phenotype than the giant cells in the gelatin 
scaffold. This is of interest, as this contrasts with the situation seen in the 
various granulomas: in these soft tissue lesions, almost 100% of the giant 
cells are cathepsin K positive [17, 20-22]. It is tempting to speculate that 
the substrate difference (gelatin versus triple helical collagen) provoked 
the formation of subsets of giant cells with differential phenotypic and 
functional properties. A comparable situation has been observed in the 
synovial membrane-like interface tissue seen between the implant and 
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adjacent bone: the giant cells associated with the polyethylene particles 
showed a considerable lower cathepsin K expression compared to the 
giant cells on the bone surface [21]. In one of our studies, we found 
major differences in the expression of e.g. the chemokines CXCL1 and 
CXCL2 between giant cells harvested from HDSC or Dacron [31]. 
Although it is likely that in all these cases the substrate determined the 
differential phenotype of the giant cells, it cannot be excluded that the 
differences in the overall micro-environment, or differences in the nature 
of the precursor cells involved in cell fusion, also have an impact on the 
final properties of giant cells. For example, different osteoclasts can be 
obtained in vitro by changing culture conditions [32]. In either case, one 
should take into consideration that giant cells do not form a uniform cell 
population: considerable differences can occur in functional properties. 
In this context it is of interest to mention, that osteoclasts from long 
bones and osteoclasts from the calvarium exhibit different phenotypic 
properties [33]; and that the biochemical make-up of long bones and the 
calvarium is substantially different [34].
Secondly, in GDSC, giant cells are only sporadically seen; the many 
cathepsin K-positive cells in GDSC are thus mononuclear of origin. 
In granulomas, containing both giant cells and macrophages, the 
macrophages are normally cathepsin K negative [17-20]. However, 
cathepsin K-positive mononuclear cells have been reported, namely 
epithelioid cells (which are highly activated CD68+ cells) [17, 18, 20], 
dendritic cells [35], macrophages in osteolytic lesions, synovium, 
carcinomas, giant cell tumors, and atherosclerotic plaques [21, 23, 25, 29, 
30, 36, 37], and fibroblast-like cells [22, 25, 38]. Since the macrophages 
in GDSC are highly involved in the degradation of the collagenous disks, 
it is possible that part of these cells are in fact epithelioid cells, but this 
remains to be determined.
In NDSC and HDSC the amount of TRAP activity and cathepsin 
K activity did not always match. It remains to be investigated if this 
mismatch is also reflected in protein or gene expression levels. On the 
other hand, TRAP seems to have a much wider tissue distribution, as 
it has been reported in a variety of tissues [39-40]. TRAP has also been 
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found in activated macrophages in soft tissues [41], and seems to be 
involved in e.g. cytokine production by macrophages [42-44]. A partial 
uncoupling of cathepsin K and TRAP expression in macrophages or giant 
cells seems therefore likely.
In summary, we have shown for the first time that cathepsin K and 
TRAP, two enzymes that are highly expressed in osteoclasts, can also 
be observed in the foreign body reaction towards cross-linked and 
non-crosslinked collagen, but not in the foreign body reaction towards 
gelatin. In the FBR towards non-crosslinked collagen (NDSC) the main 
cells showing cathepsin K positivity are the multinucleated cells, whereas 
in the FBR towards glutaraldehyde cross-linked collagen (GDSC) the 
main cells showing cathepsin K positivity are the mononucleated cells. 
The giant cells in the FBR towards gelatin or NDSC show different 
phenotypic properties, as they are cathepsin K negative and cathepsin K 
positive, respectively. So far, hardly any attention has been paid to the role 
of giant cell heterogeneity and cathepsin K in the tissue response towards 
biomaterials; clearly, this field needs to be explored in more detail in 




1. Tezuka K, Tezuka Y, Maejima A, Sato T, Nemoto K, Kamioka H, Hakeda Y, 
Kumegawa M: Molecular cloning of a possible cysteine proteinase predomi-
nantly expressed in osteoclasts. J Biol Chem 1994; 269: 1106-1109.
2. Brömme D, Okamoto K: Human cathepsin O2, a novel cysteine protease 
highly expressed in osteoclastomas and ovary. Molecular cloning, sequencing 
and tissue distribution. Biol Chem Hoppe Seyler 1995; 376: 379-384. 
3. Inaoka T, Bilbe G, Ishibashi O, Tezuka K, Kumegawa M, Kokubo T: Mo-
lecular cloning of human cDNA for capthepsin K: novel cysteine proteinase 
predominantly expressed in bone. Biochem Biophys Res Commun 1195; 206: 
89-96.
4. Shi GP, Chapman HA, Bhairi SM, DeLeeuw C, Reddy VY, Weiss SJ: Molecu-
lar cloning of human cathepsin O, a novel endoproteinase and homologue of 
rabbit OC2. FEBS Lett 1995; 357: 129-134.
5. Li YP, Alexander M, Wucherpfennig AL, Yelick P, Chen W, Stashenko P: 
Cloning and complete coding sequence of a novel human cathepsin expressed 
in giant cells of osteoclastomas. J Bone Miner Res 1995; 10: 1197-1202.
6. Brömme D, Okamoto K, Wang BB, Biroc S: Human cathepsin O2, a matrix 
protein-degrading cysteine protease expressed in osteoclasts. Functional 
expression of human cathepsin O2 in Spodoptera frugiperda and character-
ization of the enzyme. J Biol Chem 1996; 271: 2126-2132.
7. Kafienah W, Brömme D, Buttle DJ, Croucher LJ, Hollander AP: Human 
cathepsin K cleaves native type I and II collagens at the NH2-terminal end of 
the triple helix. Biochem J 1998; 331: 727-732.
The presence of cathepsin K in the foreign body reaction
161
8. Li Z, Hou WS, Brömme D: Collagenolytic activity of cathepsin K is specifi-
cally modulated by cartilage-resident chondroitin sulfates. Biochemistry 
2000; 39: 529-536.
9. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged 
NT, Delmas PD, Delaissé JM: The collagenolytic activity of cathepsin K is 
unique among mammalian proteinases. J Biol Chem 1998; 273: 32347-32352.  
10. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, 
Moritz JD, Schu P & Figura K von: Impaired osteoclastic bone resorption 
leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acac Sci USA 
1998; 95: 13453-13458.
11. Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, Bertoncello 
I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I: Cathepsin K 
knockout mice develop osteopetrosis due to a deficit in matrix degradation 
but not demineralization. J Bone Miner Res 1999; 14: 1654-1663. 
12. Gelb BD, Shi GP, Chapman HA, Desnick RJ: Pycnodysostosis, a lysosomal 
disease caused by cathepsin K deficiency. Science 1996; 273: 1236-1238.
13. Motyckova G, Fischer DE: Pycnodysostosis: role and regulation of cathepsin 
K in osteoclast function and human disease. Curr Mol Med 2002; 2: 407-421.
14. de Vries TJ, Schoenmaker T, Hooibrink B, Leenen PJM, Everts V: Myeloid 
blasts are the mouse bone marrow cells prone to differentiate into osteoclasts. 
J. Leukoc Biol 2009; 85: 919-927.
15. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita 
K, Ninomiya K, Suzuki T, Miyamoto K et al.: DC-STAMP is essential for cell-
cell fusion in osteoclasts and foreign body giant cells. J Exp Med 2005; 203: 
345-351.
16. Helming L, Gordon S: The molecular basis of macrophage fusion. Immuno-
biol 2008; 212: 785-793. 
Chapter 6
162
17. Bühling F, Reisenauer A, Gerber A, Krüger S, Weber E, Brömme D, Roessner 
A, Ansorge S, Welte T, Röcken Ch: Cathepsin K – a marker of macrophage 
differentiation? J Pathol 2001; 195: 375-382. 
18. Díaz A, Willis AC, Sim RB: Expression of the proteinase specialized in bone 
resorption, cathepsin K, in granulomatous inflammation. Molec Med 2000; 6: 
648-659.
19. Friedrich RE, Eisenmann J, Röser K, Scheuer HA, Löning T: Expression of 
proteases in giant cell lesions of the jaws, tendon sheath and salivary glands. 
Anticancer Res 2010; 30: 1645-1652.
20. Samokhin AO, Bühling F, Theissig F, Brömme D: ApoE-deficient mice on 
cholate-containing high-fat diet reveal a pathology similar to lung sarcoid-
osis. Am J Pathol 2010; 176: 1148-1156.
21. Shen Z, Crotti TN, McHugh KP, Matsuzaki K, Gravallese EM, Bierbaum BE, 
Goldring SR: The role played by cell-substrate interactions in the pathogen-
esis of osteoclast-mediated peri-implant osteolysis. Arthr Res Ther 2006; 8: 
R70
22. Mandelin J, Li TF, Hukkanen M, Liljeström M, Salo J, Santavirta S, Konttinen 
YT: Interface tissue fibroblasts from loose total hip replacement prosthesis 
produce receptor activator of nuclear factor-κB ligand, osteoprotegerin, and 
cathepsin K. J Rheuamtol 2005; 32: 713-720
23. Liu B, Yu SF, Li TJ: Multinucleated giant cells in various forms of giant cell 
containing lesions of the jaws express features of osteoclasts. J Oral Pathol 
Med 2003; 32: 367-375. 
24. Samokhin AO, Wilson S, Nho B, Gracia Lizame ML, Eliseo Musenden OE, 
Brömme D: Cholate-containing high-fat diet induces the formation of mul-
tinucleated giant cells in atherosclerotic plaques of apolipoprotein E-/- mice. 
Arterioscler Thromb Vasc Biol 2010; 30: 1166-1173. 
The presence of cathepsin K in the foreign body reaction
163
25. Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Gold-
ring SR, Brömme D: Comparison of cathepsins K and S expression within the 
rheumatoid and osteoarthritic synovium. Arthr Rheum 2002; 46: 663-674. 
26. Dodds RA, Connor JR, Drake FH, Gowen M: Expression of cathepsin K 
messenger RNA in giant cells and their precursors in human osteoarthritic 
synovial tissues. Arthr Rheum 1999; 42: 1588-1593.
27. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR: 
Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation 
factor. Arthr Rheum 2000; 43: 250-258.  
28. Lindeman JHN, Hanemaaijer R, Mulder A, Dijkstra PDS, Szuhai K, Brömme 
D, Verheijen JH, Hogendoorn PCW: Cathepsin K is the principal protease in 
giant cell tumor of bone. Am J Pathol 2004; 165: 593-600.
29. Gaumann A, Hansen T, Köhler HH, Kommoss F, Mann W, Maurer J, Kirk-
patrick CJ, Kriegsmann J: The expression of cathepsins in osteoclast-like giant 
cells of an anaplastic thyroid carcinoma with tracheal perforation. Pathol Res 
Pract 2001; 197: 257-262.
30. Hansen T, Petrow PK, Gaumann A, Keyszer GM, Otto M, Kirkpatrick CJ, 
Kriegsmann J: Expression of cysteine proteinases cathepsins B and K and of 
cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath. 
Mod Pathol 14: 318-324. 
31. Luttikhuizen DT, Dankers PYW, Harmsen MC, van Luyn MJA: Material de-
pendent differences in inflammatory gene expression by giant cells during the 
foreign body reaction. J Biomed Mater Res 2007; 83: 879-886.
32. Yuasa K, Mori K, Ishikawa H, Sudo A, Uchida A, Ito Y: Characterization of 
two types of osteoclasts from human peripheral blood monocytes. Biochem 
Biophys Res Commun 2007; 356: 354-360.
33. Everts V, de Vries TJ, Helfrich MH: Osteoclast heterogeneity: lessons from 
Chapter 6
164
osteopetrosis and inflammatory conditions. Biochim Biophys Acta 2009; 
1792: 757-765.
34. van den Bos T, Speijer D, Bank RA, Brömme D, Everts V: Differences in ma-
trix composition between calvaria and long bone in mice suggest differences 
in biomechanical properties and resorption: special emphasis on collagen. 
Bone 2008; 43: 459-468.
35. Maitra R, Follenzi A, Yaghoobian A, Montagna C, Merlin S, Cannizzo ES, 
Hardin JA, Cobelli N, Stanley ER, Santambrogio L. Dendritic cell-mediated 
in vivo bone resorption. J Immun 2010; 185: 1485-1491.
36. Barascuk N, Skjøt-Arkil H, Register TC, Larsen L, Byrjalsen I, Christian-
sen C, Karsdal MA: Human macrophage foam cells degrade atherosclerotic 
plaques through cathepsin K mediated processes. BMC Cardiovasc Disorders 
2010; 10: 19
37. Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pamde AN, Kohler RH, 
Shi GP, Libby P, Weissleder R: Optical visulaization of cathepsin K activity in 
atherosclerosis with a novel, protease-activatable fluorescence sensor. Circu-
lation 2007; 115: 2292-2298.
38. Neidhardt M, Baraliakos X, Seemayer C, Zelder C, Gay RE, Michel BA, 
Boehm H, Gay S, Braun J: Expression of cathepsin K and matrix metal-
loproteinase 1 indicate persistent osteodestructive activity in long-standing 
ankylosing spondylitis. Ann Rheum Dis 2009; 68; 1334-1339. 
39. Hayman AR, Bune AJ, Bradley JR, Rashbass J, Cox TM: Osteoclast tartrate-
resistant acid phopshatse (Acp 5): its localization to dendritic cells and 
diverse murine tissues. J Histochem Cytochem 2000; 48: 219-228.
40. Hayman AR, Macary P, Lehner PJ & Cox TM: Tartrate-resistant acid phos-
phatase (Acp 5): Identification in diverse human tissues and dendritic cells. J 
Histochem Cytochem 2001; 49: 675-683. 
The presence of cathepsin K in the foreign body reaction
165
41. Efstratiadis T, Moss DW: Tartrate-resistant acid phosphatase in human alveo-
lar macrophages. Enzyme 1987; 34: 140-143. 
42. Räisänen SR, Halleen J, Parikka V, Väänänen HK: Tartrate-resistant acid 
phosphatase facilitates hydroxyl radical formation and colocalizes with 
phagocytosed Staphylococcus aureus in alveolar macrophages. Biochem Bio-
phys Res Commun 2001; 288: 142-150. 
43. Räisänen SR, Alatalo SL, Ylipahkala H, Halleen JM, Cassady AI, Hume DA, 
Väänänen HK: Macrophages overexpressing tartrate-resitatnt acid phospha-
tase show altered profile of free radical production and enhanced capacity of 
bacterial killing. Biochem Biophys Res Commun 2005; 331: 120-126.
44. Bune AJ, Hayman AR, Evans MJ, Cox TM: Mice lacking tartrate-resistant 
acid phosphatase (Acp 5) have diordered macrophage inflammatory respons-
es and reduced clearance of the pathogen, Staphylococcus aureus. Immunol-
ogy 2001; 102: 103-113. 
45. Ye, Q,  Harmsen MC, Ren Y, Bank RA: The role of collagen receptors 
Endo180 and DDR-2 in the foreign body reaction against non-crosslinked 
collagen and gelatin. Biomaterials 2011; 32 : 1339-1350. 
46. Ye Q, Xing Q, Ren Y, Harmsen MC, Bank RA: Endo180 and MT1-MMP are 
involved in the phagocytosis of collagen scaffolds by macrophages and is reg-
ulated by interferon-gamma. European Cells & Materials 2010; 20: 197-209. 
47. Ye Q, Harmsen MC, van Luyn MJA, Bank RA: The relationship between 
collagen scaffold cross-linking agents and neutrophils in the foreign body 
reaction. Biomaterials 2010; 31: 9192-9201.
48. Ye Q, van Amerogen M, Sandham A, Bank RA, van Luyn MJA, Harmsen 
MC: Site-specific tissue inhibitor of metalloproteinase-1 governs the matrix 
metalloproteinases-dependent degradation of crosslinked collagen scaffolds 
and is correlated with interleukin-10.Journal of Tissue Engineering and Re-
generative Medicine, 2011; 5:264-274. 
Chapter 6
166
49. Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, Docherty 
AJP, Beertsen W: Functional heterogeneity of osteoclasts: matrix metallopro-
teinases participate in osteoclastic resorption of calvarial bone but not resorp-
tion of long bone. FASEB J. 1999; 13: 1219-1230. 
50. van Noorden CJF, and Frederiks WM: Enzyme Histochemistry. A Laboratory 
Manual of Current Methods. Microscopy Handbooks 26, 1993; Oxford Uni-
versity Press Inc., New York
51. Andersson GN, Marks SC: Tartrate-resistant acid ATPase as a cytochemical 





The biopolymer collagen is often used as a scaffolding biomaterial in tissue engineering. Like any other biomaterial, the implantation of collagen scaffolds induces a local inflammatory reaction 
known as a foreign body reaction (FBR). As introduced in Chapter 
1, the interaction between the scaffold and the local tissue is generally 
species-, biomaterial-, and implant site-specific. The FBR to collagen 
scaffolds involves a complex cascade of spatiotemporally regulated and 
interconnected processes that include cellular infiltration, activation of 
inflammatory cells, phagocytosis and proteolysis, which ultimately result 
in the resolution and degradation of the implanted scaffold. Degradation 
of the collagen scaffold is an important part of the FBR. Ideally, the 
degradation rate should match the speed of tissue regeneration. There 
are two major pathways for collagen degradation: (a) phagocytosis of 
collagen bundles by surrounding inflammatory cells, i.e., macrophages 
and giant cells (fused macrophages) and (b) enzymatic degradation by 
secreted enzymes such as matrix metalloproteinases (MMPs). Although 
several cellular and molecular factors have been shown to be involved in 
the degradation of collagen, the exact mechanisms are largely unknown. 
Therefore, a series of experiments was performed to investigate this 
subject.
In Chapter 2, we studied the nature and regulation of MMP-based 
proteolytic degradation of cross-linked collagen scaffolds in subcutaneous 
and epicardial implantation sites. Collagen disks were quickly degraded 
epicardially, whereas degradation was attenuated when the disks were 
implanted subcutaneously. Our data showed that collagenases and 
gelatinases were present and that the collagenase MMP-13 and the 
gelatinase MMP-2 were predominantly in their active forms at both sites. 
In contrast, the major MMP inhibitor TIMP-1 was only observed in 
subcutaneous implants, which provides an explanation for why MMP-13 
and MMP-2 cannot degrade the collagen scaffold at the subcutaneous 
implantation site. Remarkably, interleukin 10 (IL-10), a potent inducer 
of TIMP-1, was also detected and subcutaneously co-localised with giant 
cells. We surmise that IL-10 suppresses the degradation of implanted 
collagen scaffolds in the FBR via the regulation of the ratio of MMPs to 
TIMP-1. This finding indicates that the degradation of collagen scaffolds 
Summary and general disscussion
169
can be regulated via the MMP network by modulating the micro-
environment, for example, by modulating the expression levels of TIMP-
1 and/or IL-10.
In Chapter 3, we investigated the fate of dermal sheep collagen disks 
at a single implantation site (subcutaneous), although the disks were 
different with respect chemical cross-linkers (glutaraldehyde = GDSC 
and hexamethylenediisocyanate = HDSC). GDSC was almost completely 
degraded after 28 days, whereas HDSC remained intact. Major differences 
in the presence of neutrophils inside the two disks were observed; in 
GDSC disks, neutrophils were present throughout the FBR, and massive 
infiltration of neutrophils was observed at day 2 and day 21, which 
coincided with high levels of IFN-γ and the phagocytosis of collagen 
bundles by macrophages. In contrast, only minor infiltration occurred at 
day 2 in HDSC, and no phagocytosis was observed. Degradation of GDSC 
occurred via collagenolytic activity and phagocytosis by macrophages. IL-
13 was only observed in HDSC, which resulted in the formation of giant 
cells in HDSC. In agreement with Chapter 2, the giant cells produced IL-
10, which promoted TIMP-1 expression and the subsequent inhibition 
of collagenolytic activity. We conclude the following: (a) the function of 
macrophages in mice is largely influenced by differences in the micro-
environment, and the nature of the micro-environments was governed 
by the chemical features of the implanted collagen scaffold itself; and (b) 
the presence/absence of neutrophils plays a major role in the shaping of 
this micro-environment (high IFN-γ and low IL-10 levels in GDSC and 
low IFN-γ and high IL-10 levels in HDSC). This study provides insight 
into how the scaffold itself can regulate its own micro-environment.
Chapter 4 is a follow-up study to gain further insight into the role 
of molecular mediators in the micro-environment and, consequently, 
on phagocytosis in the FBR. As shown in Chapter 3, subcutaneously 
implanted HDSC or GDSC disks in mice incur significantly different 
degradation rates. Phagocytosis of collagen by macrophages occurred only 
in GDSC, although comparable numbers of macrophages were observed 
in HDSC and GDSC. This study aimed to discover the underlying 
molecular mechanisms of phagocytosis. Our data show that Endo180 
was expressed in GDSC alone, which correlated with the expression 
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of IFN-γ. Endo180 co-localised with MMP-14 on F4/80-positive cells 
(murine macrophages), which is likely responsible for the phagocytosis 
in GDSC. In vitro, IFN-γ induced the expression of Endo180 and 
MMP-14 in murine macrophages cultured on type-I collagen (although 
excessive IFN-γ dampened the expression of Endo180 and MMP-14). 
Moreover, the expression of Endo180 and MMP-14 induced by IFN-γ 
was inhibited by IL-10. The differences in the micro-environments of 
GDSC and HDSC (high IFN-γ and low IL-10 levels in GDSC and low 
IFN-γ and high IL-10 levels in HDSC) provide an explanation for why the 
phagocytosis of collagen by macrophages was only observed in GDSC. 
In summary, we show for the first time that the IFN-γ-dependent co-
expression of Endo180 and MMP-14 on macrophages coincides with the 
phagocytosis of collagen, thereby providing evidence that the mechanism 
of phagocytosis of collagen by macrophages in the FBR is similar to the 
mechanism of intracellular collagen degradation by fibroblasts observed 
under physiological tissue repair conditions. Based on these results, the 
regulation of the phagocytosis of collagen by macrophages through the 
regulation of the levels of IFN-γ or IL-10 (counterpart of IFN-γ) may be 
feasible.
 In earlier chapters (Chapters 2-4), we investigated the molecular 
and cellular basis for the degradation of collagen scaffolds modified with 
chemical cross-linkers; however, little is known about the mechanisms of 
degradation of non-cross-linked collagen scaffolds in vivo. In Chapter 5, 
non-cross-linked dermal sheep collagen (NDSC) and non-cross-linked 
gelatin (denatured collagen) disks were implanted subcutaneously in 
mice. Gelatin disks were degraded quickly due to the efficient formation 
of large giant cells and the presence of MMP-13; the inhibitor TIMP-1 
was absent. The DDR-2 receptor was not expressed in the gelatin disks. 
Endo180 and MMP-14 were expressed, but a lack of co-expression was 
primarily observed. In contrast, NDSC disks showed a very low rate 
of degradation despite the presence of high numbers of macrophages 
and the influx of neutrophils. This was attributed to the presence of the 
matrix metalloproteinase inhibitor TIMP-1. The limited degradation 
that occurred was mainly in the later stages of the FBR and could be 
attributed to (a) phagocytosis by macrophages due to the co-expression of 
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Endo180 and MMP-14 on these cells (intracellular degradation) and (b) 
the presence of MMP-13 due to the upregulation of the DDR-2 receptor 
(extracellular degradation). We conclude that the physical state of 
collagen (native or denatured) had a strong influence on the degradation 
rate and provoked a completely different FBR. 
With respect to the degradation of collagen scaffolds, all studies 
(Chapters 2-5) focused on the role of matrix metalloproteinases. 
However, nothing is known about the role of cathepsin K, a strong 
collagenolytic enzyme, in the FBR. The study in Chapter 6 reports for 
the first time that cathepsin K and TRAP, two enzymes that are highly 
expressed in osteoclasts, are present in the FBR to non-cross-linked 
collagen (NDSC), glutaraldehyde cross-linked collagen (GDSC) and 
hexamethylenediisocyanate cross-linked collagen (HDSC), but not in the 
FBR to denatured collagen (gelatin). Cathepsin K, which was absent, was 
not involved in the rapid degradation of gelatin. In the FBR to NDSC, 
the main cells that were positive for cathepsin K were the multinucleated 
cells, whereas in the FBR to GDSC, the main cells that were positive for 
cathepsin K were the mononucleated cells. The giant cells in the FBR to 
gelatin and NDSC showed different phenotypic properties because they 
were cathepsin K-negative and cathepsin K-positive, respectively. Further 
investigation is needed to gain further insight into the role of cathepsin K 
and giant cell heterogeneity in the FBR to the collagen scaffolds. 
Taken together, we can conclude the following regarding the 
degradation of collagen disks in the FBR:
1) Enzymatic degradation of collagen scaffolds
Generally, collagen is degraded via the interplay between 
collagenases and gelatinases. MMPs are produced and secreted 
as inactive precursors (proMMP) by inflammatory cells such 
as macrophages. These cells also produce membrane-bound 
MMP-14. Together, these MMPs degrade collagen and gelatin to 
smaller products. This process is inhibited by the binding of, for 
example, TIMP-1 to MMPs. This thesis (Chapter 2) has increased 
our understanding of the molecular mechanisms and regulation 
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of the MMP-based proteolytic network in the degradation of 
collagen disks during the FBR. In the absence of TIMP-1, i.e., in 
epicardial implants, both collagenases (MMP-13) and gelatinases 
(MMP-2 and MMP-9) were present as active enzymes and acted 
sequentially to completely degrade the implanted disk. However, 
subcutaneously, the elevated expression of TIMP-1 prevented the 
collagenolytic activity of the various collagenases. 
Besides MMPs, little attention has been paid to other proteinases, 
such as cathepsin K, in the FBR directed against implanted materials. 
Cathepsin K, a strong collagenolytic enzyme, was reported to be 
present in giant cells in the FBR to wear debris derived from the 
gliding surfaces of prostheses used in joint replacements. However, 
nothing is known about the involvement of cathepsin K in the FBR 
to collagen scaffolds. In this thesis (Chapter 6), we report for the 
first time the presence of cathepsin K in the FBR to subcutaneous 
collagen scaffolds in mice. Interestingly, cathepsin K was not present 
in gelatin (denatured collagen) scaffolds. Although we are unable 
to draw any conclusions about the precise roles of cathepsin K in 
the FBR at this stage, our pilot studies show that it is necessary to 
further explore the involvement of cathepsin K in the degradation 
of collagen scaffolds. 
2) Phagocytosis of collagen scaffolds
In addition to enzymatic degradation, collagen scaffolds can 
be eliminated by phagocytosis, an intracellular process of 
collagen degradation. Knowledge has accumulated regarding the 
mechanisms of the phagocytosis of collagen by fibroblasts under 
physiological conditions, but virtually nothing is known about 
whether the inflammatory cells phagocytose fibrillar collagen in the 
FBR to collagen implants. This thesis shows for the first time that 
phagocytic cells, such as macrophages and giant cells, play a critical 
role in the breakdown of collagen scaffolds via phagocytosis. 
The phagocytosis of collagen by macrophages was observed in 
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GDSC scaffolds at day 2 and 21 (Chapter 3), as well as in NDSC at 
day 21 and 28 (Chapter 5). Further study (Chapter 4) showed that 
the phagocytosis of collagen correlated with the interplay between 
the membrane-localised mediators Endo180 and MMP-14. It is 
logical that collagen phagocytosis by macrophages is achieved by 
the cleavage of collagen fibrils near the cell membrane via MMP-14 
followed by the lysosomal delivery of cleaved collagen. However, 
in HDSC, there was a different type of macrophage present that 
did not express Endo180, and therefore, no phagocytic activity was 
associated with this type of macrophage.
Furthermore, the phagocytosis of collagen by giant cells was 
also observed in gelatin scaffolds and NDSC (Chapters 5 and 6). 
Interestingly, the presence of giant cells in these two biomaterials 
Figure 7.1 Schematic illustration of the different foreign body reactions in HDSC and GDSC
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exhibited completely different characteristics. The giant cells in 
gelatin showed more nuclei and a greater surface area than the 
giant cells in NDSC. Endo180 and MMP-14 were expressed in both 
scaffolds; however, their distribution patterns differed. Endo180 and 
MMP-14 co-localised in NDSC, suggesting that the phagocytosis 
of collagen by giant cells utilised a comparable mechanism to 
that which has been observed in fibroblasts. In contrast, Endo180 
and MMP-14 were not co-localised in gelatin, indicating that the 
phagocytosis of collagen by giant cells in gelatin may occur by a 
different mechanism. Further study is required to understand this 
process. Furthermore, the giant cells in NDSC were positive for 
cathepsin K and TRAP, whereas both enzymes were absent in giant 
cells in gelatin scaffolds. Taken together, our data clearly show two 
distinct sub-sets of giant cells in terms of size, morphology and 
biological behaviours during the FBR to non-cross-linked collagen 
and gelatin scaffolds.
The phagocytosis of collagen in GDSC strongly correlated with 
the presence of neutrophils (Chapter 3), but there is no evidence 
that neutrophils are directly involved in the phagocytosis of the 
collagen scaffold. The presence of neutrophils apparently induced 
the expression of pro-inflammatory cytokines, including IFN-γ, 
which is a major activator of phagocytosis by macrophages. 
Therefore, we conclude that neutrophils play a crucial regulatory 
role in the phagocytosis of collagen by macrophages via IFN-γ 
3) Regulation of collagen degradation through changes in the molecular 
mediators in the FBR micro-environment
Extensive study of the roles of cytokines (IL-1β, IL-4, IL-6, IL-10, 
IL-13, TNF-α and IFN-γ) and chemokines (CCL-2 and CCL-3) in 
the regulation of proteolysis and cellular phagocytosis has been 
conducted in this thesis (Chapters 2-5).
We have shown that in proteolysis, the expression of TIMP-1 (a 
major regulator of MMP activity) depends on the presence of IL-10 
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(Chapter 2). IL-10 in HDSC was mainly produced by giant cells. 
One of the major mediators that drive the formation giant cells is IL-
13, which was highly expressed in HDSC (Chapter 3). Interestingly, 
the collagen receptor DDR-2 contributes to the up-regulation of 
MMP-13 (Chapter 5). These findings provide indications and clues 
to modulating the enzymatic degradation of collagen scaffolds in 
future therapies in tissue engineering: a) to reduce the MMP-based 
enzymatic degradation of collagen by increasing of the expression 
of IL-10 and/or IL-13 and b) to accelerate enzymatic degradation 
by stimulating the expression of DDR-2.
Our data also show that the collagen receptor Endo180 is critical 
for the phagocytosis of collagen by macrophages (Chapter 3) and 
that the expression of Endo180 on macrophages is dependent upon 
the presence of IFN-γ but not upon the other pro-inflammatory 
factors such as IL-1β and TNF-α. Interestingly, the induction of 
Endo180 by IFN-γ can be blocked by IL-10 in a dose-dependent 
manner (Chapter 4). Therefore, IFN-γ produced by neutrophils 
appears to be the key regulator of the phagocytosis of collagen 
by macrophages. However, the same may be not true for the 
phagocytosis of collagen by giant cells in the gelatin scaffold where 
neutrophils and IFN-γ were virtually absent (Chapter 5). This 
suggests that the phagocytosis of collagen by giant cells in gelatin 
is regulated by other unknown pathways, which require further 
investigation.
4) Regulation of collagen degradation by the nature of chemical  
cross-linking
It is known that the FBR reaction differs between species, 
biomaterials and implantation sites. Our current studies extend 
this knowledge and show that the differences in the FBR are due to 
the different micro-environments created by the different types of 
implanted collagen scaffolds. A change in the chemical nature of the 
collagen scaffold, for example by cross-linking the native collagen 
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with different chemical compounds, causes a completely different 
FBR (Figure 7.1). A pro-inflammatory micro-environment was 
created with a glutaraldehyde cross-linker in GDSC, which led 
to the rapid degradation of the collagen scaffold by enzymatic 
degradation (due to the absence of TIMP-1 expression as a result 
of the absence of IL-10-expressing giant cells) and by phagocytosis 
by macrophages (due to the expression of IFN-γ by neutrophils). 
In contrast, the hexamethylenediisocyanate cross-linker created an 
anti-inflammatory micro-environment in HDSC, which blocked 
enzymatic degradation (due to the over-expression of TIMP-1) and 
phagocytosis (due to the absence of IFN-γ) (Chapters 3 and 4).
5) Regulation of collagen degradation by changing the physical nature 
of collagen
Our data further show that not only the chemical nature but also 
the physical status of collagen (native or denatured) has a profound 
effect on the degradation rate of the scaffold. Non-cross-linked 
native collagen scaffolds (NDSC) and denatured collagen scaffolds 
(gelatin) were implanted in mice subcutaneously. Gelatin scaffolds 
were completely degraded within 3 weeks, whereas only marginal 
degradation was observed in NDSC after 4 weeks. In contrast with 
the absence of TIMP-1 in gelatin, the elevated expression of TIMP-1 
was observed in the NDSC micro-environment, which may explain 
the delay in the degradation of the NDSC scaffolds (Chapter 5).  
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Future perspectives
The aim of this thesis was to discover the molecular and cellular mechanisms of degradation of collagen scaffolds in the FBR. Our data have provided several striking findings regarding the nature 
and regulation of the enzymatic degradation and phagocytosis of collagen 
scaffolds. IL-10, IL-13, TIMP-1 and DDR-2 have been identified as 
potential therapeutic factors in the regulation of MMP-based proteolysis 
in the extracellular enzymatic degradation of collagen. IFN-γ appears to 
be the optimal activator for the phagocytosis of collagen by macrophages 
via the up-regulation of MMP-14 and Endo180. This effect can be 
neutralised by the addition of IL-10. Although our data have expanded 
our understanding of the regulation of collagen degradation, it is still a 
long way from concept to clinic. First, to apply these findings to clinical 
practice, additional laboratory studies with knock-out (of the targeting 
factor) animal models followed by well-designed randomised controlled 
clinical trials are needed. Second, the precise mechanisms underlying the 
phagocytosis of gelatin by giant cells must be considered. Third, further 
exploration of the role of cathepsin K and giant cell heterogeneity in the 
FBR to collagen scaffolds is necessary.
Taken together, it is tremendously important to choose an appropriate 
substrate and design the physical and chemical nature of the scaffolds so 
that its degradation can be tuned to the rate of tissue regeneration.







De biopolymeer collageen wordt vaak gebruikt als biostellagemateriaal (scaffold) bij weefselengineering. Net als bij ieder ander biomateriaal, veroorzaakt de implantatie van 
collageen scaffolds een lokale ontstekingsreactie die bekend staat als 
“vreemdlichaamreactie” (foreign body reaction, FBR). Zoals aangevoerd in 
Hoofdstuk 1, is de interactie tussen de scaffold en het lokale weefsel in het 
algemeen diersoort-, biomateriaal-, en implantatielocatie-specifiek. De 
vreemdlichaamreactie op collageen scaffolds omvat een complexe cascade 
van spatiotemporeel gereguleerde en onderling verbonden processen 
waaronder cellulaire infiltratie, activering van ontstekingscellen, 
fagocytose en proteolyse. Dit resulteert uiteindelijk in de ontbinding en 
afbraak van de geïmplanteerde scaffold. Afbraak van de collageen scaffold 
is een belangrijk onderdeel van de vreemdlichaamreactie. Idealiter komt 
de afbraaksnelheid overeen met de snelheid van de weefselregeneratie. Er 
zijn twee belangrijke trajecten voor collageenafbraak: (a) fagocytose van 
collageenbundels door omliggende ontstekingscellen, oftewel macrofagen 
en reuscellen (gefuseerde macrofagen) en (b) enzymatische afbraak 
door uitgescheiden enzymen zoals matrix metalloproteinasen (MMP’s). 
Hoewel verschillende cellulaire en moleculaire factoren betrokken 
blijken te zijn bij de afbraak van collageen, zijn de exacte mechanismen 
grotendeels onbekend. Derhalve werd een reeks experimenten uitgevoerd 
om dit onderwerp te onderzoeken.
In Hoofdstuk 2, bestudeerden we de aard en de regulering van op 
MMP’s gebaseerde proteolytische afbraak van gecrosslinkt collageen 
scaffolds in subcutane en epicardiale implantatielocaties. Epicardiale 
collageenschijven werden snel afgebroken, terwijl de afbraak geremd 
was wanneer de schijven subcutaan geïmplanteerd waren. De gegevens 
toonden de aanwezigheid van collagenasen en gelatinasen aan en lieten zien 
dat zowel de collagenase MMP-13 als de gelatinase MMP-2 overwegend 
in actieve vorm aanwezig waren op beide locaties. De voornaamste MMP 
inhibitor TIMP-1 daarentegen, werd alleen waargenomen in subcutane 
implantaten, hetgeen verklaart waarom MMP-13 en MMP-2 de collageen 
scaffold niet kunnen afbreken op een subcutane implantatielocatie. 
Opmerkelijk genoeg werd ook interleukine 10 (IL-10), een krachtige 
inhibitor van TIMP-1, gedetecteerd en subcutaan geco-lokaliseerd met 
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reuscellen. Verwacht wordt dat IL-10 de afbraak van geïmplanteerde 
collageen scaffolds tijdens de vreemdlichaamreactie onderdrukt via 
regulering van de verhouding tussen MMP’s en TIMP-1. Deze bevinding 
geeft aan dat de afbraak van collageen scaffolds gereguleerd kan worden via 
het MMP netwerk door de micro-omgeving te moduleren, bijvoorbeeld 
door het expressieniveau van TIMP-1 en/of IL-10 te variëren.
In Hoofdstuk 3 onderzochten we het lot van schijven dermaal 
schapencollageen op één enkele implantatielocatie (subcutaan), ofschoon 
de schijven verschilden ten aanzien van chemische cross-linkers 
(glutaaraldehyde = GDSC en hexamethyleendiisocyanaat = HDSC). 
GDSC werd bijna volledig afgebroken binnen 28 dagen, terwijl HDSC 
intact bleef. Er werden belangrijke verschillen waargenomen wat betreft 
de aanwezigheid van neutrofielen in de twee schijven; bij GDSC-schijven, 
waren gedurende de gehele vreemdlichaamreactie neutrofielen aanwezig 
en werd er massale infiltratie van neutrofielen waargenomen op dag 2 
en dag 21. Dit viel samen met hoge gehaltes IFN-γ en fagocytose van 
collageenbundels door de  macrofagen. Bij HDSC-schijven daarentegen, 
vond slechts geringe infiltratie plaats op dag 2 en werd geen fagocytose 
waargenomen. Afbraak van GDSC vond plaats via collagenolytische 
activiteit en fagocytose door macrofagen. IL-13 werd alleen 
waargenomen bij HDSC, wat resulteerde in de vorming van reuscellen 
bij HDSC. In overeenstemming met Hoofdstuk 2, produceerden de 
reuscellen IL-10, wat TIMP-1 expressie en de daaropvolgende inhibitie 
van collagenolytische activiteit bevorderde. De volgende conclusie kan 
getrokken worden: (a) de functie van macrofagen in muizen wordt 
grotendeels beïnvloed door verschillen in de micro-omgeving en de aard 
van de micro-omgeving werd beheerst door de chemische eigenschappen 
van de geïmplanteerde collageen scaffold zelf en (b) de aanwezigheid/
afwezigheid van neutrofielen speelt een belangrijke rol bij de vormgeving 
van deze micro-omgeving (hoge IFN-γ en lage IL-10 niveaus bij GDSC 
en lage IFN-γ en hoge IL-10 niveaus bij HDSC). Deze studie geeft inzicht 
in hoe de scaffold zelf zijn eigen micro-omgeving kan reguleren.
Hoofdstuk 4 is een vervolgonderzoek om meer inzicht te krijgen in 
de rol van moleculaire mediatoren in de micro-omgeving en daarmee 
in fagocytose tijdens de vreemdlichaamreactie. Zoals aangetoond in 
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Hoofdstuk 3, veroorzaken subcutaan geïmplanteerde HDSC- of GDSC-
schijven in muizen significant verschillende afbraaksnelheden. Fagocytose 
van collageen door macrofagen deed zich alleen voor bij GDSC, hoewel 
vergelijkbare aantallen macrofagen werden waargenomen bij zowel 
HDSC als GDSC. Deze studie had als doel de onderliggende moleculaire 
mechanismen van fagocytose te ontdekken. De  gegevens tonen aan 
dat Endo180 alleen bij GDSC tot expressie kwam, wat correleerde 
met de expressie van IFN-γ. Endo180 co-lokaliseerde met MMP-14 in 
F4/80-positieve cellen (murine macrofagen), hetgeen waarschijnlijk 
verantwoordelijk is voor de fagocytose bij GDSC. In vitro induceerde 
IFN-γ de expressie van Endo180 en MMP-14 in murine macrofagen 
gekweekt op collageen type I (hoewel excessieve hoeveelheden IFN-γ 
de expressie van Endo180 en MMP-14 deden afnemen). Bovendien 
werd de expressie van Endo180 en MMP-14, geïnduceerd door IFN-γ, 
geremd door IL-10. De verschillen in de micro-omgevingen van GDSC 
en HDSC (hoge IFN-γ en lage IL-10 niveaus bij GDSC en lage IFN-γ 
en hoge IL-10 niveaus bij HDSC) vormen een verklaring waarom 
fagocytose van collageen door macrofagen alleen wordt waargenomen 
bij GDSC. Samengevat, wordt er voor het eerst aangetoond dat IFN-
γ-afhankelijke co-expressie van Endo180 en MMP-14 in macrofagen 
samenvalt met fagocytose van collageen, en leveren daarmee het bewijs 
dat het mechanisme van fagocytose van collageen door macrofagen 
tijdens de vreemdlichaamreactie overeenkomt met het mechanisme 
van intracellulaire collageenafbraak door fibroblasten, waargenomen 
onder fysiologische weefselherstel omstandigheden. Gebaseerd op 
deze resultaten, zou de regulering van fagocytose van collageen door 
macrofagen door middel van regulering van het IFN-γ of IL-10 niveau 
(tegenhanger van IFN-γ) mogelijk kunnen zijn. 
In eerdere hoofdstukken (Hoofdstukken 2-4), werd de de moleculaire 
en cellulaire basis voor de afbraak van collageen scaffolds, gemodificeerd 
met chemische cross-linkers onderzocht ; er is echter maar weinig 
bekend over de mechanismen in vivo van de afbraak van niet-gecrosslinkt 
collageen scaffolds. In Hoofdstuk 5 werden schijven niet-gecrosslinkt 
dermaal schapencollageen (NDSC) en schijven niet-gecrosslinkt gelatine 
(gedenatureerd collageen) subcutaan geïmplanteerd in muizen. De 
Samenvatting & Algemene Discussien
183
schijven gelatine werden snel afgebroken door de efficiënte vorming 
van grote reuscellen en de aanwezigheid van MMP-13; de inhibitor 
TIMP-1 was afwezig. De DDR-2 receptor kwam niet tot expressie bij 
de gelatineschijven. Endo180 en MMP-14 kwamen tot expressie, maar 
er werd voornamelijk een gebrek aan co-expressie waargenomen. In 
tegenstelling tot de gelatineschijven, toonden de NDSC schijven een 
zeer lage afbraaksnelheid, ondanks de aanwezigheid van grote aantallen 
macrofagen en de influx van neutrofielen. Dit werd toegeschreven aan 
de aanwezigheid van de matrix metalloproteinase inhibitor TIMP-
1. De beperkte afbraak deed zich vooral in de latere stadia van de 
vreemdlichaamreactie voor en kon mogelijk worden toegeschreven aan 
(a) fagocytose door macrofagen vanwege co-expressie van Endo180 en 
MMP-14 in deze cellen (intracellulaire afbraak) en (b) de aanwezigheid 
van MMP-13 door de upregulatie van de DDR-2 receptor (extracellulaire 
degradatie). De conclusie kan getrokken worden dat de fysieke gesteldheid 
van het collageen (natief of gedenatureerd) een sterke invloed had op 
de afbraaksnelheid en een geheel verschillende vreemdlichaamreactie 
uitlokte.
Met betrekking tot de afbraak van collageen scaffolds, richtten alle 
studies (Hoofdstukken 2-5) zich op de rol van matrix metalloproteinasen. 
Er is echter niets bekend over de rol van cathepsine K, een sterk 
collagenolytische enzym, tijdens de vreemdlichaamreactie. Het 
onderzoek in Hoofdstuk 6, rapporteert voor het eerst dat cathepsine K 
en TRAP, twee enzymen die sterk tot expressie komen in osteoclasten, 
aanwezig zijn tijdens de vreemdlichaamreactie op niet-gecrosslinkt 
collageen (NDSC), glutaaraldehyde gecrosslinkt collageen (GDSC) en 
hexamethyleendiisocyanaat gecrosslinkt collageen (HDSC), maar niet 
tijdens de vreemdlichaamreactie op gedenatureerd collageen (gelatine). 
Cathepsine K, door zijn afwezigheid, was niet betrokken bij de versnelde 
afbraak van gelatine. Tijdens de vreemdlichaamreactie op NDSC, waren 
de belangrijkste cathepsine K-positieve cellen meerkernige cellen, terwijl 
tijdens de vreemdlichaamreactie op GDSC de belangrijkste cathepsine 
K-positieve cellen, mononucleaire cellen waren. De reuscellen tijdens 
de vreemdlichaamreactie op gelatine en NDSC toonden verschillende 
fenotypische eigenschappen, omdat ze respectievelijk cathepsine 
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K-negatief en cathepsine K-positief waren. Nader onderzoek is 
nodig om meer inzicht te verkrijgen in de rol van cathepsine K en 
reuscelheterogeniteit tijdens de vreemdlichaamreactie op collageen 
scaffolds. 
Al met al kan het volgende geconcludeerd worden met betrekking tot 
de afbraak van collageenschijven tijdens de vreemdlichaamreactie:
1) Enzymatische afbraak van collageen scaffolds
In het algemeen, wordt collageen afgebroken via de wisselwerking 
tussen collagenasen en gelatinasen. MMP’s worden geproduceerd 
en uitgescheiden als inactieve precursoren (pro-MMP) door 
inflammatoire cellen zoals macrofagen. Deze cellen produceren 
ook membraangebonden MMP-14. Samen breken deze MMP’s 
collageen en gelatine af tot kleinere producten. Dit proces wordt 
geremd door de binding van bijvoorbeeld TIMP-1 aan MMP’s. Dit 
proefschrift (Hoofdstuk 2) heeft ons begrip van de moleculaire 
mechanismen en regulering van het op MMP’s gebaseerde 
proteolytische netwerk in de afbraak van collageenschijven 
tijdens de vreemdlichaamreactie doen toenemen. In afwezigheid 
van TIMP-1, dat wil zeggen in epicardiale implantaten, waren 
zowel collagenasen (MMP-13) en gelatinasen (MMP-2 en MMP-
9) aanwezig in de vorm van actieve enzymen, die sequentieel 
optraden om de geïmplanteerde schijf volledig af te breken. 
Subcutaan echter, verhinderde de verhoogde expressie van TIMP-
1 de collagenolytische activiteit van de verschillende collagenasen.
Naast de MMP’s, is er weinig aandacht besteed aan andere 
proteinasen, zoals cathepsine K, in de vreemdlichaamreactie 
op geïmplanteerde materialen. Naar verluidt was cathepsine K, 
een sterk collagenolytisch enzym, aanwezig in reuscellen tijdens 
de vreemdlichaamreactie op slijtageprodukten van glijdende 
gewrichtsoppervlakken van prothesen die gebruikt worden voor 
gewrichtsvervanging. Er is echter niets bekend over de betrokkenheid 
van cathepsine K bij de vreemdlichaamreactie op collageen 
scaffolds. In dit proefschrift (Hoofdstuk 6), wordt voor het eerst de 
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aanwezigheid van cathepsine K tijdens de vreemdlichaamreactie 
op onderhuidse collageen scaffolds in muizen gemeld. Interessant 
is dat cathepsine K niet aanwezig was bij gelatine (gedenatureerd 
collageen) scaffolds. Het is niet mogelijk om in dit stadium over de 
exacte rol van cathepsine K tijdens de vreemdlichaamreactie. De 
pilotstudies tonen aan dat het noodzakelijk is om de betrokkenheid 
van cathepsine K bij de afbraak van collageen scaffolds nader te 
onderzoeken.
2) Fagocytose van collageen scaffolds
Behalve door enzymatische afbraak kunnen collageen scaffolds 
ook geëlimineerd worden door fagocytose, een intracellulair 
afbraakproces. Er is kennis opgebouwd met betrekking tot de 
mechanismen van fagocytose van collageen door fibroblasten onder 
fysiologische omstandigheden, maar er is vrijwel niets bekend over 
het fagocyteren van fibrillair collageen door inflammatoire cellen 
tijdens een vreemdlichaamreactie op collageenimplantaten. Dit 
proefschrift toont voor het eerst aan dat fagocyterende cellen, zoals 
macrofagen en reuscellen, een cruciale rol spelen bij de afbraak van 
collageen scaffolds via fagocytose.
Fagocytose van collageen door macrofagen werd zowel bij GDSC 
scaffolds op dag 2 en 21 (Hoofdstuk 3), als bij NDSC scaffolds op dag 21 
en 28 waargenomen (Hoofdstuk 5). Nader onderzoek (Hoofdstuk 
4) liet zien dat fagocytose van collageen gecorreleerd was aan de 
wisselwerking tussen de membraangebonden mediatoren Endo180 
en MMP-14. Het spreekt voor zich dat collageen fagocytose door 
macrofagen bereikt wordt door de splitsing van collageenfibrillen 
dichtbij het celmembraan via MMP-14, gevolgd door lysosomale 
uitscheiding van gekliefd collageen. Bij HDSC echter, was een 
ander type macrofagen aanwezig die geen expressie van Endo180 
vertoonden, waardoor er geen fagocytaire activiteit geassocieerd 
werd met dit type macrofagen.
Fagocytose van collageen door reuscellen werd tevens 
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waargenomen bij gelatine scaffolds en NDSC (Hoofdstukken 5 
en 6). Interessant is dat de aanwezigheid van reuscellen in beide 
biomaterialen totaal verschillende eigenschappen vertoonden. 
In het geval van gelatine, toonden de reuscellen meer kernen 
en een groter oppervlak dan de reuscellen bij NDSC. Endo180 
en MMP-14 kwamen tot expressie bij beide scaffolds; zij het dat 
hun distributiepatronen verschilden. Endo180 en MMP-14 co-
lokaliseerden bij NDSC, hetgeen suggereert dat de fagocytose van 
collageen door reuscellen een vergelijkbaar mechanisme benutte als 
dat wat waargenomen is bij fibroblasten. In tegenstelling tot NDSC, 
waren Endo180 en MMP-14 bij gelatine niet geco-lokaliseerd, wat 
aangeeft dat fagocytose van collageen door reuscellen bij gelatine 
mogelijk plaats vindt via een ander mechanisme. Nader onderzoek 
is vereist om dit proces te begrijpen. Daarnaast waren de reuscellen 
bij NDSC cathepsine K- en TRAP-positief, terwijl beide enzymen 
afwezig waren in reuscellen bij gelatine scaffolds. Alles bijeen 
genomen tonen onze gegevens duidelijk twee verschillende sub-sets 
reuscellen in termen van grootte, morfologie en biologisch gedrag, 
tijdens de vreemdlichaamreactie op niet-gecrosslinkt collageen en 
gelatine scaffolds.
Fagocytose van collageen bij GDSC was sterk gecorreleerd 
met de aanwezigheid van neutrofielen (Hoofdstuk 3), maar 
er is geen bewijs dat neutrofielen direct betrokken zijn bij 
fagocytose van de collageen scaffold. Ogenschijnlijk induceerde 
de aanwezigheid van neutrofielen de expressie van pro-
inflammatoire cytokines zoals IFN-γ, een belangrijke activator 
van fagocytose door macrofagen. Daarom kon de conclusie 
getrokken worden dat neutrofielen een cruciale regulerende rol 
spelen in de fagocytose van collageen door macrofagen via IFN-γ. 
3) Regulering van collageenafbraak door veranderingen in 
de moleculaire mediatoren in de micro-omgeving van de 
vreemdlichaamreactie
In dit proefschrift is uitgebreid onderzoek verricht naar de rol van 
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cytokines (IL-1β, IL-4, IL-6, IL-10, IL-13, TNF-α en IFN-γ) en 
chemokines (CCL-2 en CCL-3) in de regulering van proteolyse en 
cellulaire fagocytose (Hoofdstukken 2-5).
Er is aangetoond dat de expressie van TIMP-1 (een belangrijke 
regulator van MMP activiteit) tijdens proteolyse, afhankelijk is 
van de aanwezigheid van IL-10 (Hoofdstuk 2). IL-10 werd bij 
HDSC voornamelijk geproduceerd door reuscellen. Eén van de 
belangrijkste mediatoren die de vorming van reuscellen stimuleert 
is IL-13, dat sterk tot expressie kwam bij HDSC (Hoofdstuk 3). 
Interessant is dat de collageenreceptor DDR-2 bijdraagt aan de 
upregulatie van MMP-13 (Hoofdstuk 5). Deze bevindingen leveren 
aanwijzingen en ideeën op voor het moduleren van de enzymatische 
afbraak van collageen scaffolds in toekomstige weefselengineering-
therapieën: a) om de op MMP gebaseerde enzymatische afbraak 
van collageen te reduceren door de expressie van IL-10 en/of IL-13 
te vergroten en b ) om de enzymatische afbraak te versnellen door 
de expressie van DDR-2 te stimuleren.
De onderzochte gegevens tonen eveneens aan dat de 
collageenreceptor Endo180 essentieel is voor fagocytose van 
collageen door macrofagen (Hoofdstuk 3) en dat de expressie van 
Endo180 in macrofagen afhankelijk is van de aanwezigheid van 
IFN-γ maar niet van andere pro-inflammatoire factoren zoals IL-1β 
en TNF-α. Interessant is dat de inductie van Endo180 door IFN-γ 
op dosis-afhankelijke wijze geblokkeerd kan worden door IL-10 
(Hoofdstuk 4). Derhalve lijkt het door neutrofielen geproduceerde 
IFN-γ de centrale regulator van fagocytose van collageen door 
macrofagen. Dit zou echter mogelijk niet opgaan voor fagocytose 
van collageen door reuscellen bij gelatine scaffolds, waarbij 
neutrofielen en IFN-γ vrijwel geheel afwezig waren (Hoofdstuk 
5). Dit suggereert dat fagocytose van collageen door reuscellen bij 




4) Regulering van collageenafbraak door de aard van de chemische 
crosslinking
Het is bekend dat de vreemdlichaamreactie verschilt tussen 
diersoorten, biomaterialen en implantatielocaties. Deze huidige 
onderzoeken breiden deze kennis uit en tonen aan dat de verschillen 
in vreemdlichaamreacties te wijten zijn aan de verschillende 
micro-omgevingen die door verschillende soorten geïmplanteerde 
collageen scaffolds gecreëerd worden. Een wijziging in de chemische 
aard van de collageen scaffold, bijvoorbeeld door het crosslinken 
van natief collageen met verschillende chemische verbindingen, 
veroorzaakt een geheel andere vreemdlichaamreactie (figuur 
7.1). Een pro-inflammatoire micro-omgeving werd gecreëerd 
met een glutaaraldehyde crosslinker bij GDSC, wat leidde tot 
een snelle afbraak van de collageen scaffold door enzymatische 
afbraak (dankzij de afwezigheid van TIMP-1 expressie als gevolg 
van de afwezigheid van reuscellen met IL-10 expressie) en door 
fagocytose door macrofagen (dankzij de expressie van IFN-γ 
door neutrofielen). De hexamethyleendiisocyanaat crosslinker 
daarentegen, creëerde een anti-inflammatoire micro-omgeving 
bij HDSC, wat enzymatische afbraak (dankzij de over-expressie 
van TIMP-1) en fagocytose (dankzij de afwezigheid van IFN-γ) 
blokkeerde (Hoofdstukken 3 en 4).
5) Regulering van collageenafbraak door wijziging van de fysieke aard 
van collageen
De resultaten van deze studie laten verder zien dat niet alleen 
de chemische aard, maar ook de fysieke gesteldheid van het 
collageen (natief of gedenatureerd) een diepgaand effect heeft 
op de afbraaksnelheid van de scaffold. Niet-gecrosslinkt natief 
collageen scaffolds (NDSC) en gedenatureerd collageen scaffolds 
(gelatine) werden subcutaan geïmplanteerd in muizen. Gelatine 
scaffolds werden binnen 3 weken volledig afgebroken terwijl na 4 
weken slechts marginale afbraak werd waargenomen bij NDSC. 
Samenvatting & Algemene Discussien
189
In tegenstelling tot de afwezigheid van TIMP-1 bij gelatine, werd 
een verhoogde expressie van TIMP-1 waargenomen in de NDSC 
micro-omgeving, hetgeen de vertraging in de afbraak van de NDSC 
scaffolds kan verklaren (Hoofdstuk 5). 




Het doel van dit proefschrift was om de moleculaire en cellulaire mechanismen van afbraak van collageen scaffolds tijdens de vreemdlichaamreactie te ontdekken. Onze gegevens 
hebben een aantal opmerkelijke bevindingen met betrekking tot de 
aard en de regulatie van de enzymatische afbraak en fagocytose van 
collageen scaffolds opgeleverd. IL-10, IL-13, TIMP-1 en DDR-2 werden 
geïdentificeerd als potentiële therapeutische factoren in de regulatie 
van op MMP’s gebaseerde proteolyse in de extracellulaire enzymatische 
afbraak van collageen. IFN-γ lijkt de optimale activator van fagocytose 
van collageen door macrofagen via de upregulering van MMP-14 
en Endo180. Dit effect kan geneutraliseerd worden door toevoeging 
van IL-10. Hoewel deze gegevens het begrip van de regulering van 
collageenafbraak vergroot hebben, is er nog steeds een lange weg te 
gaan van concept tot kliniek. Om deze bevindingen toe te passen in de 
klinische praktijk, zijn ten eerste aanvullende laboratoriumonderzoeken 
met knock-out (van de doelwitfactor) diermodellen, gevolgd door goed 
opgezette gerandomiseerde gecontroleerde klinische onderzoeken 
nodig. Ten tweede moeten de precieze mechanismen die ten grondslag 
liggen aan fagocytose van gelatine door reuscellen overwogen worden. 
Ten derde is een verdere verkenning van de rol van cathepsine K en 
reuscelheterogeniteit tijdens de vreemdlichaamreactie op collageen 
scaffolds noodzakelijk.
Alles bij elkaar opgeteld, is het belangrijk om een geschikt substraat 
te kiezen en de fysische en chemische aard van de scaffolds zo te 
ontwerpen dat hun afbraak kan worden afgestemd op de snelheid van 
weefselregeneratie.
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    在组织工程中，生物大分子胶原被广泛于制造生物支架材料。与其
他生物材料一样，这类胶原支架材料的植入会引起局部组织的炎症反
应，又称作异物反应(foreign body reaction, FBR)。


















































































    前文（第二-五章）着重于研究基质金属蛋白酶在胶原支架降解中
的作用，第六章转移研究重点到胶原溶解酶方面。组织蛋白酶K (cath-











         关于异物反应的胶原片降解，总结以下几点：
1） 胶原支架的酶降解











    此外，在排斥种植材料的异物反应中其他蛋白酶受到的重视并不



























































































    本论文旨在揭示异物反应中胶原支架降解的分子学和细胞学机制。
通过一系列发现丰富了对胶原支架的酶降解和细胞吞噬降解的作用机
制和调节的认识。白介素-10、白介素-13、主要基质金属蛋白酶抑制
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